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Abstract 
Topographically modified micro-roughened titanium implants, like the clinically 
successful dental implants - sand-blasted, large grit, acid-etched (SLA) and its 
successor, the chemically modified hydrophilic SLA (modSLA) surfaces, are 
recognized to have improved osseointegration (in vivo) and osteogenic properties (in 
vitro). Micro-roughened surfaces are known to induce “contact osteogenesis”, 
wherein osseointegration occurs via direct deposition of new bone on the implant 
surface itself, making the in vitro osteogenic differentiation process an appropriate 
reflection of the in vivo osseointegration process. Micro-roughened surfaces, as such 
provide us with a unique model to explore the molecular mechanisms involved in the 
process of osteogenesis and osseointegration. Previous studies on modSLA and SLA 
surfaces have described the differential expression of several genes and pathways 
compared with smooth polished (SMO) surfaces, and have hinted on an early 
regulation of osteogenic differentiation on these surfaces; however, a structured 
approach exploring the molecular events was lacking.  
MicroRNA mediated RNA-interference mechanisms, are known to be vital 
regulators of cell differentiation by translational repression and gene silencing. This 
project hypothesized that an early modulation of molecular processes by microRNA-
mediated mechanisms on micro-roughened surfaces, like the modSLA and SLA, 
leads to their improved osteogenic differentiation and osseointegration. A whole-
genome transcriptome analysis of human osteoprogenitor cells, performed using 
Affymetrix Human Genome U133 Plus 2.0 arrays, following 3 and 24 hours 
exposure to SLA and SMO surfaces, confirmed an early pro-osteogenic response on 
micro-roughened titanium surfaces at 24 hours. An initial pro-angiogenic and 
immunomodulatory response, as seen on the SLA surfaces, was seen to condition 
them for the pro-osteogenic response. Subsequently, the microRNA expression 
profile of osteoprogenitor cells on modSLA and SLA surfaces at 24 hours revealed 
the differential expression of several microRNAs on these surfaces (compared with 
SMO). Relatively minor differences were observed between modSLA and SLA 
surfaces.  
 iv Role of MicroRNAs in Improved Osteogenicity of Topographically Modified Titanium Implant Surfaces 
The microRNAs downregulated on modSLA and SLA surfaces (compared with 
SMO), were seen to have several putative targets in the TGFβ/BMP and Wnt/Ca2+ 
pathways (based on bioinformatics-based target predictions using TargetScan); 
indicating a possible activation of these pro-osteogenic cell signaling pathways. To 
confirm whether signaling pathways are activated within 24 hours of interaction with 
these surfaces, the expression of key genes of TGFβ, Wnt, FGF, Notch, and 
Hedgehog pathways was investigated. The study concluded that TGFβ/BMP, Wnt 
(especially the Wnt/Ca
2+
), and Notch pathways show higher expression on SLA & 
modSLA (compared with SMO), as early as 24 hours. The study also demonstrated a 
relatively high expression of cell signaling genes at 24 hours compared to 72 hours, 
further highlighting the importance of the early interaction of cells with the micro-
roughened surfaces.  
The project further explored the role of two miRNAs, miR-26a and miR-17, that 
were observed to be downregulated on the modSLA and SLA surfaces (compared 
with SMO) and had putative targets in TGFβ/BMP and Wnt/Ca2+ pathways, during 
the process of osteogenic differentiation. Both of the miRNAs were found to have 
inhibitory effects on the TGFβ/BMP and Wnt/Ca2+ pathways; and over-expressing 
these miRNAs was seen to delay the process of osteogenesis. Empirical evidences 
also suggested a coordinated modulation of these two pathways, with the activation 
of the TGFβ/BMP having a stimulatory effect on the Wnt/Ca2+ pathway. To explore 
the plausibility of using miRNA modulators to regulate osteogenesis on implant 
surfaces, inhibitors of miR-26a (i-miR-26a) and miR-17 (i-miR-17) were used on 
smooth polished titanium surfaces. i-miR-26a and i-miR-17 transfected cells were 
seen to have superior osteogenic differentiation on SMO surfaces.  
Taken together, the findings of the project strongly suggest a highly regulated 
microRNA-mediated control of molecular mechanisms during the process of 
osteogenesis, that may be responsible for the superior osseointegration and 
osteogenic differentiation properties on micro-roughened titanium implant surfaces. 
The conclusions derived from the project, indicate the possibility of using microRNA 
modulators to enhance osseointegration and bone formation in clinically demanding 
circumstances.  
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 2 Introduction 
1.1 BACKGROUND 
The use of metallic implants as a clinical modality for the treatment of 
damaged bone or teeth has been in practice for ages. Implants help in restoration of 
damaged body parts by providing a supporting framework for the healing bone. This 
process of healing requires the structural and functional integration of the implant 
with the surrounding bone – a biological phenomenon known as “osseointegration”. 
Titanium (Ti) has been a material of choice clinically for a long time, owing to its 
potential to support bone regeneration with little evidence of rejection of the implant. 
Scientists working in the field of biomaterials have tried several modifications of the 
titanium implants to improve its bone regeneration properties. Empirical studies have 
revealed that surface modifications greatly influence the regenerative potential of 
these implants [1]. Rough surfaces have been found to have better osteogenic 
potential and osseointegration properties in vivo, when compared with smooth 
surfaces.  
The clinically successful dental implants – the sand-blasted, large-grit, acid-
etched (SLA) Ti implant and its successor, the chemically modified hydrophilic SLA 
(modSLA or SLActive®) are topographically modified micro-roughened implant 
surfaces designed by Institut Straumann AG (Waldenburg, Switzerland), that have 
proven superior osseointegration and osteogenic properties compared with their 
smooth counterparts [2-5]. The SLA implant surface remains the gold standard in 
implant dentistry, although recent studies claim the modSLA surface to have further 
improved osseointegration and stability at earlier time points when compared with 
SLA implants [6] and they have also been shown to reduce the healing period in vivo 
further when compared to SLA surfaces [5].  
Osseointegration, as a biological process requires the differentiation of 
“osteogenic” cells to mineralized bone cells. The molecular mechanisms of cellular 
differentiation of progenitor cells have been a perplexing and challenging process to 
decrypt. In this context, it is worth noting that superior osteogenic properties of 
micro-roughened titanium implant surfaces, and especially their ability to induce 
“contact osteogenesis” [7],  allow us to use them as physiologically relevant surfaces 
to study the possible molecular regulatory mechanisms orchestrating these 
properties. This will further allow us to gain in-depth insights into the osteogenic 
differentiation process without using chemically supplemented “osteogenic” media. 
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Numerous genes and proteins have been found to be involved in the regulation of 
osteogenic differentiation. Several signaling proteins and pathways have been found 
to be imperative in the regulation of osteogenesis and no single pathway is 
responsible for osteogenesis on its own. The interplay and crosstalk between cell 
signaling pathways is known to guide the process of osteogenesis of progenitor cells.  
Micro-RNAs (miRNAs) are small RNA molecules that have been known to 
influence the pattern of gene expression by translational repression and gene 
silencing [8]; and are known to be vital regulators of the cell differentiation process. 
However, their role in the modulation of cell signaling pathways guiding 
osteogenesis in vitro and osseointegration in vivo on implant surfaces hasn’t been 
explored in detail. Understanding the pattern of expression of miRNAs in progenitor 
cells cultured on osteogenic surfaces, will aid in deciphering the molecular basis of 
osteogenesis and the influence of implant surfaces on progenitor cells. This 
knowledge may further assist us in designing implants with faster and better 
osseointegration and also help us in achieving superior osseointegration in clinically 
demanding circumstances. Therefore, the overall aim of this project was to 
investigate the role of microRNAs in guiding the process of osteogenesis on 
topographically modified titanium implant surfaces through their influence on pro-
osteogenic cell signaling pathways.  
1.2 SCOPE OF THE PROJECT 
This prime focus of this project has been on the early stages of osteogenic 
differentiation, for which it derives empirical cues from micro-roughened titanium 
implant surfaces. The project initially explores the pro-osteogenic response on micro-
roughened surfaces and investigates the sequence of early events that lead to their 
pro-osteogenic response. The first part of the work identifies a pertinent time-point to 
study the early molecular events during osteogenesis on topographically modified 
surfaces. The pattern of microRNA expression on modSLA and SLA surfaces is 
subsequently explored. A potential correlation of this expression pattern with the 
stimulation of the pro-osteogenic TGFβ/BMP and Wnt/Ca2+ pathways is deduced 
using bioinformatic prediction models. The next part of the project attempts to 
further strengthen these findings and describes the stimulation of pro-osteogenic cell 
signaling pathways (especially the TGFβ/BMP and Wnt/Ca2+ pathways) on these 
surfaces. Finally, the role of microRNAs, miR-26a and miR-17, on the regulation of 
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the TGFβ/BMP and Wnt/Ca2+ pathways, during osteogenesis is further discussed and 
attempts to accelerate the rate of osteogenesis on polished titanium implant surfaces 
are described.  
1.3 THESIS OUTLINE 
 Hypothesis & Aims: This chapter discusses the hypothesis and key 
aims of the project. It also provides a brief overview of the different 
studies conducted to achieve the aims. 
 Literature Review: The literature review is divided into three sub-parts.  
 The first part consists of excerpts from an accepted book chapter 
discussing implant surfaces and the phenomenon of osseointegration. 
(Book chapter - accepted: Nishant Chakravorty et al. “Implant 
surface modifications and osseointegration.” In Li, Qing & Mai, Yiu-
Wing (Ed.) Biomaterials for Implants and Scaffolds. Springer Series 
in Biomaterials Science and Engineering).  
 The second part discusses the possible role of microRNAs in 
osteoblast differentiation. 
 The third part details the current concepts and knowledge regarding 
osteogenic differentiation on SLA and modSLA surfaces and is a 
review manuscript in preparation.   
(Manuscript in preparation: Nishant Chakravorty et al. “Osteogenic 
differentiation on micro-roughened titanium surfaces: A review of 
current concepts and knowledge.”). 
 The microarray study: This chapter details the study conducted for Aim 
1 of the project and is a manuscript in preparation.  
(Manuscript in preparation: Saso Ivanovski, Nishant Chakravorty, et 
al. “Genome-wide transcriptional analysis of early interactions of 
osteoprogenitor cells with micro-rough titanium implants.”). 
 The microRNA profiling study: This chapter details the study 
conducted for Aim 2 of the project and is a published manuscript.  
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(Published manuscript: Nishant Chakravorty et al. “The microRNA 
expression signature on modified titanium implant surfaces influences 
genetic mechanisms leading to osteogenic differentiation.” Acta 
Biomaterialia. 2012;8(9):3516-23). 
 Activation of cell signaling pathways on modified titanium surfaces: 
This chapter details the study conducted for Aim 3 of the project and is 
a published manuscript. 
(Published manuscript: Nishant Chakravorty et al. “Pro-osteogenic 
topographical cues promote early activation of osteoprogenitor 
differentiation via enhanced TGFβ, Wnt, and Notch signaling.” Clinical 
and Oral Implants Research, 2014;25(4):475-86). 
 The microRNAs, miR-26a & miR-17 and TGFβ/BMP & Wnt/Ca2+ 
pathways: This chapter details the study conducted for Aim 4 of the 
project and is a manuscript in preparation. 
 (Manuscript in preparation: Nishant Chakravorty et al. “The miR-26a 
and miR-17 mediated cell signaling cross-talks guide osteogenic 
differentiation and osseointegration.”). 
 General Discussion: This chapter discusses the rationale for the studies 
conducted, the key findings and the limitations of the project. 
 Concluding Remarks: Finishing comments for the project. 
Referencing style: The references for each chapter (except for Chapter 6) are in 
numbered format (consistent with the format for the journal, Acta Biomaterilia, 
where Chapter 5 was published). Chapter 6 has references in accordance with the 
format for the journal, Clinical Oral Implants Research, where it has been published. 
Ethics approvals for the PhD project 
Primary human cells/tissues used/approved: 
 Established human cell lines 
 Human ethics (neglible-low risk), Queensland Univeristy of 
Technology 
Gene Modified Organisms (GMO) ethics: 
 GMO exempt dealing, Queensland University of Technology  
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2.1  HYPOTHESIS 
MicroRNAs (miRNAs) are vital regulators of cell differentiation and are 
known to influence gene expression by translational repression and gene silencing. 
This project hypothesized that an early modulation of molecular processes by 
microRNA-mediated mechanisms on micro-roughened surfaces, like the SLA and 
modSLA, lead to their enhanced osteogenic differentiation and osseointegration 
properties. The overall aim of this project has been to explore the early molecular 
events guiding osteogenesis on micro-roughened titanium implant surfaces, with a 
particular focus on the role of microRNAs in guiding these responses. The 
observations from this project attempt to unravel the genetic control of osteogenesis 
using cues from a physiologically relevant micro-environment akin to the bone 
micro-architecture. The findings of this project could be translated to clinically 
relevant situations, like osteoporosis that demand enhanced osteogenesis. 
2.2 AIMS OF THE PROJECT 
The specific aims of the project were: 
Aim 1: To study the sequence of early molecular events leading to a pro-
osteogenic response on micro-roughened titanium implant surfaces and identify an 
early time-point to study the molecular mechanisms on micro-roughened titanium 
implant surfaces. 
Aim 2: To study the differences in microRNA expression profiles on modSLA 
and SLA surfaces in comparison with the smooth polished (SMO) surfaces and 
predict the putative regulation of key pro-osteogenic cell signaling pathways, 
following 24 hours of exposure. 
Aim 3: To confirm the activation of key pro-osteogenic cell signaling 
pathways on modSLA and SLA surfaces, following 24 hours of exposure.  
Aim 4: To explore the role of miR-26a and miR-17 in the regulation of the 
pro-osteogenic TGFβ/BMP and Wnt/Ca2+ pathways during the process of 
osteogenesis. 
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2.3 OVERVIEW OF THE PROJECT 
A flow-diagram explaining the sequence of the studies conducted for the 
project is showing in Figure 2-1. 
 
Figure 2-1: Flow-diagram describing the aims of the project 
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The project was designed as four separate studies, based on the aims as 
described above:  
2.3.1 Study 1: The microarray study 
Microarrays with their ability to comprehensively capture the expression of a 
large number of genes provide us with one of the best experimental methods to 
screen for the whole genome transcriptomic profile, and investigate the early 
molecular events on micro-roughened titanium implant surfaces. The study was 
designed as follows: 
Mineralization properties of micro-roughened SLA surfaces 
Human osteoprogenitor cells were cultured on SLA and smooth polished 
(SMO) surfaces and compared for their ability to induce osteogenic differentiation 
and mineral deposition. 
Whole genome microarray expression profiling 
A whole genome microarray expression profiling (Affymetrix Human Genome 
U133 Plus 2.0 arrays) was conducted, following exposure of human osteoprogenitor 
cells on SLA and SMO surfaces, for 3 and 24 hours, to study the early molecular 
responses on these surfaces. The comparative data analyses (between SLA and SMO, 
and the temporal comparisons) were performed using GeneSpring GX12.5 software. 
Analysis of the microarray data using DAVID and IPA 
To affirm the biological meaning of the data obtained from GeneSpring, 
functional clustering analysis was performed using the Database for Annotation, 
Visualization and Integrated Discovery (DAVID) and Ingenuity Pathways Analysis 
(IPA) tools. Molecular, physiological clusters and potential upstream regulators for 
the molecular processes enriched on SLA surfaces (compared with SMO) were 
extracted and conclusions were derived. A time-course analysis was also performed 
to explore the sequence of events. 
2.3.2 Study 2: The microRNA expression profiling study 
The expression pattern of microRNAs related to cell development and 
differentiation was assessed between modSLA, SLA, and SMO surfaces.  
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 Effect of surface topography and hydrophilicity on the differential 
regulation of genes following 24 hours of exposure to titanium surfaces  
The effect of modSLA and SLA surfaces on the differential regulation of 
BMP2, BMP6, ACVR1, FZD6, WNT5A, ITGB1, and ITGA2, following 24 hours of 
exposure of human osteoprogenitor cells was tested. These genes were found to be 
differentially regulated on micro-roughened surfaces compared with SMO at later 
time-points in previous studies. 
The microRNA expression profiling 
The differential regulation of microRNAs on modSLA, SLA, and SMO 
surfaces was assessed using Human Cell Development & Differentiation miRNA 
PCR Array (SABiosciences, Frederick, Maryland, USA), following 24 hours of 
exposure.  
Target predictions for the differentially regulated miRNAs 
Bioinformatics based target predictions for the differentially regulated miRNAs 
were performed using TargetScan. As previous studies had reported the activation of 
several genes of the TGFβ/BMP and Wnt/Ca2+ pathways, the potential regulation of 
these pathways by the differentially regulated miRNAs was assessed. 
2.3.3 Study 3: Activation of cell signaling pathways on modSLA, SLA, and 
SMO surfaces 
To confirm the correlation between the differential regulation of miRNAs (as 
observed in the previous part of the project) and cell signaling pathways, the 
activation of cell signaling pathways on modSLA, SLA, and SMO surfaces was 
tested. The study was designed as follows: 
Surface imaging and phenotypic changes in cells cultured on micro-
roughened surfaces 
The surface topography of modSLA, SLA, and SMO surfaces was visualized 
using Atomic force microscopy (AFM) and Scanning electron microscope (SEM). 
The phenotypic variations in human osteoprogenitor cells cultured on micro-
roughened surfaces and SMO surfaces was observed using SEM. 
Cell signaling pathways activation on modSLA, SLA, and SMO surfaces 
The differential regulation of key genes of the TGFβ/BMP, Wnt, FGF, 
Hedgehog, and Notch was evaluated on modSLA, SLA, and SMO surfaces using 
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Human Stem Cell Signaling PCR Array (SABiosciences, Frederick, MD, USA), 
following 24 and 72 hours of exposure. 
Mineralization properties and expression of osteogenesis associated genes on 
modSLA, SLA, and SMO surfaces 
The osteogenic differentiation potential of modSLA, SLA, and SMO surfaces 
was further explored using Alizarin Red S, ALP activity and expression analysis of 
osteogenesis associated genes. 
2.3.4 Study 4: The microRNAs, miR-26a & miR-17 and TGFβ/BMP & 
Wnt/Ca
2+
 pathways relationship 
 The microRNAs, miR-26a and miR-17, were seen to be downregulated on 
modSLA and SLA surfaces (compared with SMO) in the first part of the project. 
They were also observed to have putative targets in the TGFβ/BMP and Wnt/Ca2+ 
pathways, which in turn were found to be stimulated on the micro-roughened 
surfaces. This study explored the role of miR-26a and miR-17 in the regulation of 
TGFβ/BMP and Wnt/Ca2+ pathways during osteogenesis.  
Over-expression of miR-26a and miR-17 
 The miRNAs, miR-26a and miR-17, were confirmed to have lower 
expression on modSLA and SLA surfaces compared with SMO surfaces. This part of 
the project explored the role of miR-26a and miR-17 by transfecting synthetic 
miRNA mimics into SAOS-2 human osteoblast-like cells, and inducing osteogenic 
differentiation. The effects of over-expressing miR-26a and miR-17 on the 
TGFβ/BMP and Wnt/Ca2+ pathways were investigated at the gene and protein level. 
Target validation experiments 
 Putative TGFβ/BMP and Wnt/Ca2+ pathway gene targets for miR-26a and 
miR-17 were cloned into pmirGLO Dual-Luciferase vector. Target validation 
experiments were performed after co-transfecting the target plasmids and miRNAs 
into Hep2 cells. 
 TGFβ/BMP and Wnt/Ca2+ pathway cross-talk 
The influence of TGFβ/BMP and Wnt/Ca2+ pathways on each other was 
explored using recombinant human BMP2 and KN93 (inhibitor for Wnt/Ca
2+
 
pathway). 
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Inhibition of miR-26a and miR-17 on SMO surfaces and osteogenesis 
The impact of suppression of miR-26a and miR-17 on the osteogenic 
differentiation on SMO surfaces was investigated using Alizarin Red S staining and 
ALP activity.  
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3.3.1 Introduction 
The quest for superior osseointegration has lead researchers to experiment with 
surface modifications of titanium implants. Several studies and reviews have 
reported improved bone-to-implant contact with micro-roughened surfaces compared 
with smooth surfaces [5, 54-57]. Bone formation on implant surfaces occurs either 
via new bone deposition on the surface of existing bone (distance osteogenesis) or by 
direct osteoblastic activity on the implant surface itself (contact osteogenesis) as 
described by Osborn and Newesley (Figure 3-3) [58]. Osseointegration on machined 
(minimally rough) implant surfaces has been shown to occur by distance 
osteogenesis [59]. In contrast to this, rough (micro-roughened) implant surfaces are 
believed to integrate by contact osteogenesis [59-61]. 
 
Figure 3-3: The concept of “distance osteogenesis” on smooth and “contact osteogenesis” on rough 
implant surfaces. Adapted from Davies et al. (2003) [59]. 
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 The molecular mechanisms regulating differentiation of stem cells and 
progenitor cells are known to be complex and difficult to interpret. Studying the 
molecular mechanisms of differentiation relies on in vitro experimentation and 
validation models. Traditional methods used to study osteogenic differentiation 
involve the use of chemical mediators like dexamethasone, β-glycerophosphate and 
L-ascorbic acid; and occasionally supplements such as vitamin D3, Transforming 
Growth Factor-beta (TGF-β) and bone morphogenetic proteins (BMPs). However, 
one of the major limitations of using such models is that they do not resemble the 
osteogenic conditions encountered in vivo. In contrast to this, micro-roughened 
implant surfaces by virtue of their characteristic contact osteogenesis phenomenon 
provide us with a unique model to explore the molecular mechanisms of osteogenic 
differentiation. 
Newer implant surfaces have shown promising results for osteogenic 
differentiation of progenitor cells in vitro and superior in vivo osseointegration 
properties [62]. A chain of molecular events are initiated following the insertion of 
an implant and this ultimately leads to osteogenesis and new bone formation as 
depicted in Figure 3-4.  
 
Figure 3-4: Osteogenic differentiation process on micro-roughened implant surfaces. 
 
Osteoblasts have been shown to create an osteogenic microenvironment when 
cultured on topographically micro-roughened implant surfaces. In vitro testing of the 
interactions of osteogenic cells with implant surfaces is routinely employed for pre-
clinical testing of their efficacy. This also provides an opportunity to use implant 
surfaces to study the molecular regulation of osteogenesis. In this context, the 
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topographically modified titanium dental implants - the sand blasted, large-grit, acid-
etched (SLA) and its successor, the hydrophilic SLA (modSLA, also known as 
SLActive®), are worth mentioning. They are known to have excellent 
osseointegration properties, and have provided interesting insights into the processes 
of osteogenic differentiation and osseointegration. In fact, SLA surfaces, per se have 
been confirmed to induce “contact osteogenesis” [63]. These surfaces therefore, offer 
us excellent models to study the osteogenic differentiation process. The aim of this 
chapter is to explore the current concepts pertaining to the molecular mechanisms 
involved in osteogenesis, based on studies using these implant surfaces as prototypes 
for physiologically relevant substrates. 
3.3.2 The topographically modified titanium implant surfaces 
Sand-blasted, large grit, acid-etched (SLA) Ti implant is a micro-roughened 
implant surface designed by Institut Straumann AG (Waldenburg, Switzerland) that 
has proven superior osseointegration properties and supports osteogenesis [2, 4]. 
This was proven by Cochran et al. when they showed that the SLA surface provides 
better osseous contact at earlier time points when compared with a titanium plasma-
sprayed (TPS) surface [64]. The SLA implant surface received FDA clearance in 
1994 and has become a gold standard in implant dentistry [65]. 
Another modification of the SLA surface – modSLA (commercially known as 
SLActive®), also manufactured by Institut Straumann AG, has a higher wettability 
(hydrophilicity) compared to SLA. This implant surface has been shown to have 
better osseointegration and stability at earlier time points when compared with the 
SLA implants [66]. A faster and better structured bone formation in vivo, with 
greater vascularization and increased osteocalcin levels has been observed around 
modSLA implants when compared with SLA surfaces at 14 days [67]. This implant 
surface has also been shown to reduce the healing period further (compared with 
SLA) [68]. Further, it has been shown that the expression of osteogenic phenotype 
and differentiation of osteoblast-like cells (MG63 cells) co-cultured with human 
umbilical vein endothelial cells (HUVECs) is enhanced with hydrophilicity of Ti 
implant surfaces like modSLA [69]. A study by Vlacic-Zischke et al. suggested that 
the better osseointegration property of hydrophilic modSLA surfaces is possibly 
mediated through BMP signaling [24]. 
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3.3.3 Microstructural characteristics of modSLA and SLA implants 
The modSLA and SLA implants are essentially topographically (modSLA and 
SLA) and chemically (modSLA) modified titanium implant surfaces. Commercially 
pure (c.p.) grade II titanium (Institut Straumann AG, CH-4002, Basel, Switzerland) 
is the starting point for preparing these implant surfaces; from which the SLA surface 
is prepared by sandblasting using large grits of 0.25–0.50 mm and etching with 
hydrochloric/sulphuric acid [70]. The micro-rough topography is attributed to the 
sandblasting process. However, the acid-etching process imparts submicron scale 
roughness properties [71]. The SLA surface when rinsed under N2 protection and 
stored in an isotonic saline (NaCl) solution again protected by N2 filling, produces 
the modSLA surface [70]. Different studies have reported subtle differences in the 
micro-roughness of the topographically modified surfaces.  The study by Buser et al.  
showed the Sa of modSLA and SLA (mean arithmetic deviation of surface) to be 
1.15±0.05 µm [68]; whereas Vlacic-Zischke et al. reported it to be 1.8 µm [24] and 
Olivares-Navarrete et al. showed the Ra (the 2D counterpart of 3D descriptor Sa) to 
be of the order of 3.22 µm [72]. These differences may possibly be attributed to the 
variations in the techniques used in different studies. The topographical features of 
modSLA and SLA surfaces are fundamentally similar, showing surface micro-
roughness in contrast to the topography of polished surfaces, that have a Sa value of 
approximately 0.33 µm [26]. The modSLA and SLA surfaces are known to show 
micron (10-50 µm) and submicron (1-2 µm) scale surface roughness [26]. Scanning 
electron microscopy (SEM) images show microstructures with cavities 
approximately 10 µm, which could be a result of the sand-blasting process [73]. 
Recent studies, using high resolution imaging techniques, have also reported the 
presence of nano-structures that are present only on modSLA surfaces in contrast to 
SLA and smooth (SMO) surfaces [74-76]. Nano-scale roughness superimposed on 
microrough surfaces has been demonstrated to improve osteoblastic differentiation 
and viability on SLA surfaces [77-79]. modSLA surfaces have a hydrophilic surface 
and the contact angle testing shows a contact angle of 0
0
 as opposed to SLA surfaces 
that have contact angles in the range of 140
0 
[70].  
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Figure 3-5: Scanning electron microscope images of (a) modSLA, (b) SLA and (c) SMO (smooth 
polished) Straumann titanium implant surfaces (10,000x magnification). 
X-ray photoelectron spectroscopy analysis of modSLA and SLA surfaces has 
revealed similar spectra, with Ti, O, C, and N as the key elements for both of the 
surfaces [80]. Besides the key elements, traces of Cl [81] and Na [82] are also 
detectable on the modSLA surface. This is likely to be because these surfaces are 
stored in isotonic saline environment to preserve their hydrophilic property. There is 
an increased percentage of oxygen on modSLA surfaces when compared with SLA 
[68, 81]. The surface titanium dioxide coating formed on implant surfaces is 
responsible for the biocompatibility of titanium implants, and this gets contaminated 
when exposed to air forming hydrocarbons and carbonates, leading to a reduction in 
the surface free energy levels [70]. To preserve the surface free energy, the modSLA 
surfaces are stored in isotonic solution [70]. This could also attribute to the lower 
percentage of carbon observed on modSLA surfaces [68, 73, 83]. 
Micro-roughness and hydrophilicity of implant surfaces allow better 
physisorption and resultant enrichment of proteins on the implant surroundings (from 
blood and the bone cells), thereby enabling enrichment of factors essential for 
differentiation [84]. Further, dual acid etched surfaces are known to have better 
crosslinkage between fibrin and osteogenic cells [85]. Improved cellular attachment 
and adhesion properties of SLA and modSLA surfaces have also been explored using 
imaging techniques like scanning electron microscopy (SEM) in several studies. A 
study by Wall et al.  had shown “stellate” shaped cells with extending cellular 
processes as opposed to rounded cells on their smooth (SMO) counterparts [86]. 
However, another study demonstrated a more flattened morphology of human 
osteoblasts on smooth surfaces when compared with the roughened surfaces [87]. 
This study also compared the difference in cellular morphology between modSLA 
and SLA surfaces-osteoblasts on SLA surfaces were more elongated. Several 
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lamellopodia (cytoskeletal projections composed of actin) were shown to be 
attaching to the micro-rough irregularities on the modSLA and SLA surfaces [87]. 
Another study by Zhao et al. had reported a more elongated and cuboid shaped 
morphology of MG63 (human osteosarcoma cell line) on modSLA and SLA surfaces 
[88]. They also reported that the cells prefer to nurture in the pits created on the 
surface due to the sand-blasting process and form attachments with the micropits. As 
described in other studies, they also did not observe any appreciable difference in the 
morphology of cells between modSLA and SLA surfaces. 
3.3.4 Superior osseointegration on topographically modified titanium surfaces: 
In vivo and clinical evidences 
The positive influence that the micro-rough SLA surface has on 
osseointegration was first shown by Buser et al. in 1991 [2]. The study found SLA 
surfaces to have the best bone-to-implant contact when comparisons were made 
between SLA, electropolished, sandblasted with medium grit and acid pickled 
(SMA), sandblasted with large grit (SL), and TPS surfaces, after 3 and 6 weeks of 
implantation into the metaphyses of the tibia and femur in miniature pigs. The SLA 
surface has also been seen to have higher removal torques in miniature pigs than the 
machined and acid-etched surface-Osteotite [89]. Histometric analysis of the junction 
between the implant (SLA and TPS) and gingiva in foxhounds, conducted by 
Cochran et al. (parameters like dimensions of junction epithelium, sulcal depth and 
contact with connective tissue) did not show any significant difference indicating that 
the topographically modified surface has a direct influence on osteoblasts and 
osteogenesis [90]. SLA surfaces are also known to have superior bone filling than in 
TPS and machined surfaces during post-implantitis healing as shown in a study 
conducted in beagle dogs [91]. Furthermore, no significant differences have been 
observed in terms of bone-to-implant contact ratios when standard SLA implants 
have been compared to their phosphate treated counterparts [92].  
The improved osseointegration properties of SLA surface have been 
acknowledged clinically as well. A prospective clinical study by Cochran et al., 
demonstrated that ITI® implant screws having SLA endosseous surface could be 
restored in 6 weeks [65]. Another study by Roccuzzo et al. (one-year prospective 
study) on 32 patients also suggested similar early loading capabilities of the SLA 
implants [93]. These findings were further validated by Bornstein et al. in their three-
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year prospective study where they tested the early loading of non-submerged (re-
positioned mucoperiosteal flaps) ITI screws with SLA surfaces [94]. Successful 
osseointegration was observed in majority of the cases studied (only 2 out of 104 
implants were considered as drop-outs/failure) after loading the implants following 6 
weeks of healing. The success and efficacy of SLA surfaces was studied 
retrospectively by Buser et al [95]. Their 10-year long retrospective study on 303 
partially edentulous patients fitted with SLA implants concluded on a 98.8% survival 
rate and 97% success rate.  The modSLA surface was developed by Buser et al. in 
2004 and they introduced it as a chemically modified SLA surface [68]. They 
observed significantly higher bone-to-implant contact ratios on modSLA compared 
to SLA surfaces in miniature pigs at 2 and 4 weeks, but not at 8 weeks suggesting 
that the modSLA surface facilitates bone formation during the early stages of 
osteogenesis. Several studies subsequently confirmed the improved osteogenic 
properties of modSLA surfaces [64, 96]. Similar results were demonstrated in a later 
study by Bornstein et al. in 2008 in American foxhounds at 2 weeks but not at 4 
weeks [97]. Further, Lai et al. substantiated the Bornstein et al. sudy in 2009 [98]. 
Straumann introduced the modSLA surfaces for dental implantation in 2005 
under the name “SLActive®” and marketed it as the “first hydrophilic surface”. 
Straumann claims that the SLActive® surfaces reduce healing time to half of SLA 
surfaces. Schwarz et al. studied the early tissue reaction to modSLA and SLA 
surfaces and implanted them into the maxilla and mandibles of fox hounds [67]. 
Samples were taken at various time-points between 1 and 14 days. The positive 
influence of the modSLA surface was evidenced as early as day 4 through increased 
osteocalcin synthesis and observation of collagen dense connective tissue. The day 
14 results from this study showed trabecular bone formation on SLA and mature 
woven bone arranged as parallel fibres were seen on the modSLA surfaces. In 
another study, Schwarz et al. further studied the bone regeneration capabilities of 
modSLA and SLA surfaces in dehiscence-type defects in the mandibular and 
maxillary pre-molar regions of beagle dogs and the results were assessed between 1 
and 8 weeks [99]. This study showed lower “new bone height” and bone fill on the 
SLA surface. 
Bone-implant interface is considered an important factor for the functional load 
bearing potential of implants. Ferguson et al. explored the interfacial shear strength 
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of modSLA and SLA implants in a miniature pig model [100]. modSLA and SLA 
implants were placed in miniature pigs maxillae and assessed after 2 to 8 weeks of 
healing. The results showed that modSLA was better at augmenting interfacial shear 
strength compared to SLA. Several prospective multicenter studies have 
demonstrated the early loading capabilities of the modSLA surfaces [101-104]. In 
fact, results with loading of modSLA surfaces immediately after placing them, have 
been seen to be similar to delayed loading [105]. The stability of modSLA and SLA 
implants have been explored in prospective randomized control trials as well. The 
prospective study by Schätzle et al. investigated the stability of implants using 
resonance frequency changes at the site of insertion of implants on 40 human 
subjects and showed faster stabilization of implants with the modSLA surfaces 
compared to SLA surfaces [106]. The modSLA implants showed improved stability 
at 12 weeks (77.8±1.9 in modSLA vs. 74.5±3.9 in SLA). Similar results were 
observed by Karabuda et al. when they prospectively explored the stability and bone 
losses in modSLA and SLA surfaces implanted in 22 human patients [107].  Several 
other animal models and human clinical studies have been conducted on the 
modSLA and SLA surfaces and all point towards superior bone formation on the 
modified surfaces.  
The findings from the various in vivo and clinical studies suggest that modSLA 
and SLA surfaces have better osseointegration and osteogenic properties when 
compared with smooth surfaces. Collectively, the results indicate that the modified 
titanium implant surfaces have superior clinical success.  
3.3.5 Effect of modSLA and SLA surfaces on cell proliferation 
Studies exploring cellular proliferation characteristics on the micro-
topographically modified surfaces have been fairly consistent in their reports. Initial 
reports of decreased proliferative capability of micro-topographically modified 
surfaces came from the studies conducted on the SLA surfaces. Lohmann and 
colleagues demonstrated this phenomenon on SLA surfaces compared to PT in 1999 
[108, 109]. Reduced proliferation rates on SLA surfaces have been correlated with 
increased alkaline phosphatase (ALP) in several studies [108-112]. In 2011, Vlacic-
Zischke et al. also reported decreased proliferation rates with surface modifications 
(modSLA surfaces showing the lowest proliferation rates) [24]. These results 
corroborate well with other studies; like the work by Mamalis et al. using human 
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mesenchymal stem cells [113]; and Zhao et al. (with MG63 osteoblast like cells) [88] 
where they described reduction in cell numbers on modSLA and SLA surfaces when 
compared with smooth polished titanium and plastic surfaces. Indeed, Zhao et al. 
also demonstrated a further 30% reduction on modSLA (compared with SLA). All 
these results are in agreement with one of the earlier studies by Martin et al. 
(reported in 1995), where they showed that cell proliferation was negatively related 
to the surface roughness of implants [114]. Decreased cell proliferation on SLA and 
modSLA for the first 7 days has been substantiated in other studies as well [115]. 
The study by Klein et al. observed the lowest proliferation rates on modSLA when 
compared with SLA and smooth surfaces [87]. A previous study by Klein et al. in 
2010 had reported lowest cell numbers on modSLA up to 14 days of culture, 
although they had also observed that after 21 days, the growth rate increased only on 
modSLA surfaces [73]. Olivares-Navarrete et al. reason that the decreased 
proliferation on modSLA and SLA surface is a consequence of transition of the cells 
from a proliferative to a differentiating phenotype [72]. 
3.3.6 Molecular regulation of osteoblasts on micro-roughened titanium implant 
surfaces 
Osseointegration and osteoconduction are attributes by which osteoprogenitor 
cells create a structural and functional connection between implants and the living 
system. Improved osteogenic properties of micro-roughened surfaces compared with 
smooth surfaces have allured researchers globally to explore the mechanisms 
responsible for their properties. The concept of contact osteogenesis on roughened 
implant surfaces as described by Osborn and Newesley [58], makes them an 
interesting model to study the molecular regulation and signaling cascades guiding 
the process of osteogenic differentiation.  
Superior osteogenic differentiation on modified titanium surfaces: In vitro 
evidences 
The interactions between osteogenic cells and topographically modified 
surfaces, at molecular and cellular levels play an important role in regulating the 
outcomes of these contacts. Several studies have focused on investigating these 
mechanistic interactions between osteogenic cells like mesenchymal stem cells, 
osteoprogenitor cells or human periodontal ligament (hPDL) cells and these implant 
surfaces. An increase in expression of osteogenic genes on the modified surfaces has 
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been observed in most studies on these surfaces [25, 73, 86-88, 113, 115-119]. The 
initial in vitro confirmation of the pro-osteogenic response of SLA surfaces came 
with studies performed by Boyan and colleagues. They demonstrated higher ALP 
and osteocalcin expression on sand-blasted and acid-etched surfaces compared with 
polished titanium and plastic surfaces [109, 120]. Boyan et al. had further shown that 
supplementation of dexamethasone to osteoblast cultures increased ALP activity on 
SLA and TPS, but not on smooth surfaces [121]. They also observed bone-like 
calcium/phosphorus ratio (2:1) only on SLA and TPS. Increased expression of 
osteogenic markers was verified in their subsequent work using MG63 cells [110, 
111]. The level of ALP has been shown to decrease to base-line levels on SLA and 
TPS surfaces in presence of cycloxygenase inhibitors like indomethacin suggesting 
the role of prostaglandin mediators in their osteogenic effects [122]. A newer 
modification of SLA surface implanted with magnesium ions has been found to show 
higher cellular attachment and increased ALP activity and calcium deposition; 
however, elaborate experimental evidences for such findings are still lacking [123]. 
The modSLA surfaces have been shown to have better osteogenicity than SLA 
surfaces in vivo [68, 100]. An experimental model comparing different titanium 
surfaces (modSLA, SLA, TiOBlast™ and Osseospeed™) had documented highest 
ALP gene expression on the modSLA surface [124]. However, this study didn’t 
show higher expression of other osteogenic markers like RUNX2, osterix and 
osteocalcin, although they did find higher expression of bone sialoprotein on 
modSLA and SLA than on plastic (modSLA>SLA). Another study examining the 
long-term response of a commercial human osteoblastic cell line, HOB-c 
(PromoCell, Heidelberg, Germany) on different titanium surfaces in media 
supplemented with dexamethasone and L-glutamine (standard osteoblast cultivation 
media), demonstrated higher levels of ALP activity on modSLA and SLA surfaces 
[73]. SPP1 and OCN gene levels were also elevated on modSLA and SLA surfaces at 
each time-point (Days 1, 2, 3, 7, 14 and 21). They concluded that modSLA and SLA 
surfaces helped in maturation of osteoprogenitors into post-mitotic osteoblasts. 
Microrough topographies have also been seen to increase the number and size of 
bone-like nodules when osteoblasts are cultured on SLA surfaces [125]. Further, Qu 
et al. have demonstrated early and improved formation of clusters of osteoblastic 
cells on modSLA compared to SLA surfaces and they have argued that this could be 
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an important factor responsible for improved expression of osteogenic genes on 
modSLA surfaces [126]. After culturing MG63 (human osteoblast-like) cells on 
modSLA, SLA, hydrophilic acid-etched (modA), hydrophobic acid-etched (A) and 
tissue culture plastic surface (TCPS) in normal expansion media, they observed cell 
cluster formation on modSLA just after 2 days of culture. Surface chemistry and 
topography have been seen to have a concerted effect on formation of bony nodules 
in vitro [127]. Moreover, combined micron and submicron topographical architecture 
has been shown to have a synergistic effect with the surface energy of modSLA 
surfaces on the osteoblastic response [71]. Surfaces lacking the micron scale 
roughness as seen in modSLA and SLA surfaces have been shown to have a reduced 
osteogenic response (reduced alkaline phosphatase activity and osteocalcin levels) 
[71]. Improved osteogenic outcomes have been demonstrated at molecular levels in 
several studies. For example, Wall et al. observed higher expression of the 
osteogenic markers, osteopontin (SPP1), Runt-related transcription factor 2 
(RUNX2) and Bone sialoprotein (IBSP) on roughened surfaces (modSLA and SLA, 
with modSLA showing moderately higher response than SLA) [86]. They also 
demonstrated formation of calcified matrix at earlier time-points on the modified 
surfaces (no significant difference between modSLA and SLA). Furthermore, the 
expression of osteogenic markers like alkaline phosphatase (ALP), collagen type I 
(COL1), osteocalcin (OCN) and osteoprotegerin (OPG) has also been shown to be 
higher on modSLA surfaces [126]. OPG is known to inhibit the differentiation of 
osteoclast cells and therefore the increased expression of OPG on modSLA and SLA 
surfaces during osseointegration could play an important role in mediating the bone 
remodeling outcomes [128]. Studies have in fact, shown reduced osteoclast 
formation on modified titanium surfaces [129-131]. The study by Rausch-fan et al. 
also had demonstrated higher ALP activity on modSLA and SLA surfaces with 
MG63 cells [128]. They cultured MG63 cells on modSLA, SLA, modA, A and TCPS 
in normal expansion media and investigated the expression of osteocalcin, 
osteoprotegerin, TGFβ1 and VEGF using ELISA kits besides ALP. Their study 
revealed higher expression of these proteins on the modSLA and SLA surfaces 
compared with the smooth surfaces.  
 The in vitro studies on both of the micro-roughened surfaces (SLA and 
modSLA surfaces) have demonstrated their superior osteogenic differentiation 
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properties compared with smooth and polished surfaces. However, studies comparing 
between the modSLA and SLA surfaces in terms of molecular interactions with 
osteoblasts and osteoblast-like cells have managed to show only subtle differences 
between them, with essentially very similar osteo-regulatory patterns on both of the 
surfaces. This is in contrast to the in vivo reports demonstrating significantly higher 
osseointegration on modSLA compared with SLA surfaces, suggesting the role of 
“non-osteogenic” cells, like blood cells that are known to interact earlier than the 
mesenchymal stem cells and osteoblasts in vivo. 
Coagulation cascade response on the modified titanium surfaces 
The molecular mechanisms for the superior osteogenic properties of modSLA 
surfaces compared with SLA could possibly be due to reasons beyond the direct 
biological interactions of osteoprogenitor cells and osteoblasts. After implantation, 
the first tissue to come in contact with the implant surface is blood. This in turn leads 
to a series of cellular processes such as deposition of proteins, coagulation, 
inflammation, and tissue formation [132]. Therefore, the in vitro models studying the 
interactions of osteoblasts and osteoblast-like cells with modified surfaces tend to 
overlook the initial interactions that might play a key role in the process of new bone 
formation and osseointegration. SLA surfaces are known to retain the blood clot 
formed during the healing phase better compared with machined surfaces and show 
signs of new blood vessel formation as early as 3 days of implantation, as shown in 
an in vivo rabbit model [133]. Furthermore, modSLA surfaces have been shown to 
have increased thrombogenic properties compared with SLA as demonstrated by 
Hong et al. [134].  A substantial reduction (99% vs. 90%) in the platelet count and 
higher release of β-thromboglobulin was observed on modSLA surfaces compared 
with SLA surface. The study also observed higher activation of the coagulation 
system, as observed by increased thrombin-antithrombin complex (TAT). They also 
observed activation of the intrinsic coagulation cascade on the modSLA surface. 
These results therefore indicated higher thrombogenicity on modSLA surfaces 
through the activation of the intrinsic pathway. Activation of platelets and the 
coagulation cascade are well recognized precursors of osteogenesis [132, 135, 136]. 
Similar phenomena like platelet activation and cytokine release on micro-roughened 
surfaces have also been demonstrated by Kämmerer et al. [137]. They observed 
higher platelet consumption on SLA surfaces compared with polished titanium. Their 
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results however, did not reveal any substantial difference between the SLA and the 
modSLA surfaces, though a sharp decrease in platelet consumption after 30 mins was 
observed on the modSLA surface. VEGF and platelet-derived growth factor (PDGF)-
αβ levels were higher on the micro-roughened surfaces as opposed to the polished 
surfaces supporting observations discussed previously in this chapter. 
Immunomodulation on the modified titanium surfaces 
Following protein adsorption and coagulation reactions, immunological 
response to the implant surface is important in the subsequent wound healing process 
and several studies have reported regulation of such responses on the modified 
surfaces. Murine macrophage-like cells, RAW 264.7 have been seen to express 
higher amounts of pro-inflammatory cytokines like tumor necrosis factor-α (TNFα) 
and interleukin-1β (IL1β) and IL6 on SLA compared with polished surfaces [138]. 
Additionally, observations from an in vivo study on male Sprague-Dawley rats have 
found immunological macrophages to be predominant cells accumulating on SLA 
surfaces (and not on smooth surfaces) after 1 week, and these cells were present in 
conjunction with early mineralization seen on SLA surfaces at 2 weeks [139]. In 
contrast to the observations on SLA surfaces, a recent study demonstrated 
downregulation of key pro-inflammatory genes, TNFα, IL1α, IL1β and CCL2 on 
modSLA surfaces compared with smooth and SLA surfaces when RAW 264.7 were 
cultured on these surfaces [81]. In a subsequent study using a human macrophage 
cell line, THP-1, Alfarsi et al. discussed the pro-inflammatory response of SLA 
surfaces as evidenced by upregulation of 16 key cytokines and chemokines [140]. In 
contrast to this, modSLA surface was seen to downregulate 10 key genes (including 
TNF, IL1β and IL1α) compared to SLA surfaces. In a separate study conducted by 
another group, Hyzy et al., described similar findings when they cultured MG63 
osteoblast-like cells [141]. Lower expression of pro-inflammatory genes like, IL1β, 
IL6, IL7, IL8 an IL17 and higher expression of anti-inflammatory, IL10 were noted 
when modSLA surfaces were compared with SLA. Antigen-presenting cells (APCs) 
like dendritic cells are important regulators of the host cell response to any foreign 
substance and potentially play a key role in the subsequent osseointegration and 
osteoconduction properties. Kou et al. explored the response of dendritic cells to the 
modSLA, SLA and pre-treatment (PT) titanium surfaces [142]. PT and SLA surfaces 
were seen to induce a more mature phenotype of the dendritic cells (DCs) (increased 
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levels of maturation-associated markers like, CD86) in contrast to modSLA surfaces. 
The modSLA surfaces appear to result in a modulated inflammatory environment 
compared to SLA and PT surfaces. Though the study observed higher production of 
the chemokine, monocyte chemotactic protein-1 (MCP-1) on PT-treated DCs, higher 
levels of the anti-inflammatory cytokine, Interleukin 1 receptor antagonist (IL-1ra), 
was observed on PT-DCs. This has been argued as a response to mollify the pro-
inflammatory response. Secretion of cytokines: Macrophage inflammatory protein-
1α (MIP-1α), Tumor necrosis factor-α (TNFα) and IL-10 and IL-1ra was seen to be 
lower in modSLA-treated DCs especially when compared with SLA surfaces, 
however the differences were not statistically significant. 
Angiogenic response on topographically modified surfaces 
New blood vessel formation is an important process that precedes 
osseointegration. Increased expression of the predominant angiogenic molecule, 
vascular endothelial growth factor (VEGF) on the modified titanium surfaces at an in 
vitro level, could possibly indicate that the upregulated expression of angiogenic 
factors contribute to the improved osseointegration on these surfaces. In 2008, 
Rausch-fan et al. showed an increased expression of TGFβ1 and the angiogenic 
marker VEGF in alveolar osteoblast cells on modSLA and SLA (modSLA>SLA) 
surfaces compared to modA, A and TCPS [128]. A recent study has corroborated 
with similar findings after culturing endothelial progenitor cells on modified 
surfaces. Similarily, Ziebart et al. showed higher expression of VEGF-A on modSLA 
surfaces compared to SLA, modA and A surfaces [143]. As wound healing is an 
important aspect of successful dental implantation, and endothelial cells are 
important for mediation of angiogenic and inflammatory processes, An et al. 
explored the implications of modSLA and SLA surfaces on endothelial cells [144]. 
They cultured human umbilical vascular endothelial cells (HUVECs) on modSLA, 
SLA, modA and A surfaces. Angiogenic factors, like von Willebrand factor (VWF), 
thrombomodulin, endothelial cell protein C receptor, and adhesion molecules - 
intercellular adhesion molecule-1 (ICAM1) and E-selectin were most upregulated on 
modSLA. The role of endothelial cells was also explored by Zhang et al. in 2010 
[69]. In this study, HUVEC and MG63 cells were co-cultured on A, modA, SLA and 
modSLA. The co-culture set-ups were observed to have higher expression of early 
differentiation markers and osteogenic factors on the titanium surfaces when 
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compared with cultures of single cell types. These properties were enhanced by both 
micro-rough topographies and hydrophilic surfaces. Their results showed that the 
effects are greater on the modSLA surfaces. Another study by Vlacic-Zischke et al. 
also demonstrated differential expression of angiogenic gene, KDR (VEGF receptor) 
on the modified surfaces [24]. Stringent regulation of angiogenesis during 
osteogenesis and osseointegration seems to play an important role on modified 
surfaces. Raines et al. did an in-depth exploration of the regulation of angiogenesis 
on modSLA and SLA surfaces [145]. They cultured primary human osteoblasts 
(HOB), MG63 cells and α2 integrin-silenced MG63 cells on different titanium discs 
(modSLA, SLA and SMO). They observed high levels of expression of secreted 
VEGF-A, basic fibroblast growth factor (FGF-2), epidermal growth factor (EGF) and 
angiopoietin-1 (Ang-1) on modSLA and SLA (modSLA>SLA) surfaces using 
sandwich ELISA assay techniques in unsilenced controls. The upregulation of 
angiogenic factors on modified titanium surfaces correlates well with the in vivo 
improved osseointegration and osteoconductive attributes of micro-roughened 
titanium surfaces, as increased blood vessel formation ensures better availability of 
osteogenic proteins and mediators. 
Role of integrins and other associated molecules 
Integrins are known to play an important role in the initial cell adhesion and 
attachment and an increased expression of α2 integrin subunit on modSLA and SLA 
surfaces as reported in different studies indicates a crucial role for the α2 integrin 
subunit in cellular attachment on micro-rough surfaces [146, 147]. A study by Raz et 
al. utilized MG63 cells cultured on SLA and polished titanium (PT) in the presence 
of 1,25-dihydroxyvitamin D3 (1α,25(OH)2D3) to study the expression of α2, α5, αv, 
β1 and β2 at different time-points [146]. The expression of α2 and β1 was observed 
to be consistently higher on the micro-rough titanium surfaces. α5 expression was 
seen to be downregulated on SLA, whereas αv and β2 levels remained unaffected. 
This study concluded that α2 is probably the favorable binding partner for β1 on 
titanium surfaces with micro-rough topographies. Integrin α5 subunit is known to 
influence interaction of cells with surfaces; however it does not have an effect on the 
differentiation characteristics of osteoblasts cultured on surfaces with micro-rough 
topographies [148]. The study by Raines et al. observed that α2 integrin-silenced 
MG63 cells cultured on titanium surfaces have ALP activity similar to normal MG63 
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cells cultured on TCPS [145]. α2 integrin-silencing did not show any effect on ALP 
activity on TCPS. The α2 integrin subunit is known to be important for the activation 
of the key osteogenic transcription factor, RUNX2 [149]. The importance of the β1 
integrin subunit was confirmed further by Wang et al. [150]. In a later study, Lai et 
al. investigated whether cell adhesion is influenced by surface energy  and observed 
higher attachment of alveolar osteoblasts on modSLA compared with SLA surfaces 
[151]. They also observed clearer actin filaments and higher expression of focal 
adhesion kinase (FAK) on modSLA surfaces. Another study exploring the 
osteoblastic commitment of MSCs on modSLA and SLA surfaces using co-culture 
experiments found that the soluble factors released from osteoblasts cultured on 
modSLA and SLA surfaces can induce osteogenic differentiation of MSCs [72]. 
They further observed increased expression of VEGF, TGFβ1, OCN and OPG in 
MSCs cultured in media enriched with soluble factors from osteoblasts cultured on 
modSLA and SLA. The levels of expression were more robust from cultures with 
factors from osteoblasts seeded on modSLA surfaces. α2 integrin-silencing studies 
performed by their group also confirmed that α2β1 signaling is required to mediate 
the paracrine effects of osteoblasts on MSCs [72]. Integrins α1, α2, α5, β1, and β3 
are known to be responsive in mediating superior properties of SLA surfaces with 
induced hydrophilicity [152]. This study also suggested that integrin α3 does not play 
a major role in the osteogenic response of modified SLA surfaces. A recent study 
explored the implications of Rho GTPases regulated molecules, Rac and RhoA 
(through Rho Kinase - ROCK), and concluded that inhibition of the ROCK signaling 
pathway can stimulate osteogenic differentiation on micro-roughened titanium 
surfaces [153]. Earlier Galli et al. had demonstrated that inhibition of ROCK 
signaling on smooth surfaces stimulated Wnt/β-catenin pathway and promotes 
differentiation [154]. Further, Lumetti et al. have also shown that activation of small 
GTPase RhoA on microrough surfaces like SLA, affects the activation canonical 
Wnt/β-catenin pathway by modulation of myosin II (a molecule known to be 
important for internal cellular tension) [155]. 
Studies exploring the molecular mechanisms of improved osteogenic response 
on modSLA and SLA surfaces have shown cell signaling pathways to be 
differentially regulated on these surfaces. 
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Arachidonic acid cascade 
The interest in the role of arachidonic acid cascade comes from early studies on 
roughened implant surfaces that observed higher expression of autocrine and 
paracrine mediators like latent TGFβ (LTGFβ) and prostaglandin E2 [109, 120]. 
Boyan et al. had further demonstrated an improvement in the osteogenic response 
and expression of LTGFβ and PGE2 on roughened surfaces when cultures of MG63 
cells were supplemented with 1,25-dihydroxyvitamin D3 (1α,25(OH)2D3) [120]. 
However, this dependence was seen to be more specific with the maturation status of 
cells as shown by Lohmann et al., with immature osteoblastic cells showing higher 
response to 1α,25(OH)2D3 in terms of TGFβ1 and PGE2 [109]. Subsequently, 
Lohmann et al. in 1999, demonstrated that osteoblastic differentiation and 
responsiveness to 1α,25(OH)2D3 on micro-roughened titanium surface (SLA) is 
mediated through Phospholipase A2 [108]. Their study had shown that these effects 
are not mediated through protein kinase C (PKC) pathway. However, in a later report 
by Schwartz et al., they concluded the TGFβ1 expression on roughened titanium 
surfaces is mediated by the PKC instead of the PKA pathway, although they 
reiterated that TGFβ1 production via the 1α,25(OH)2D3 is independent of the PKC 
pathway [156]. They also reported that although the PGE2 production is regulated by 
PKA; however, even this is not involved in the roughness-related increase in PGE2. 
Earlier Batzer et al. in 1998 had implicated the role of prostaglandins in the 
roughness-response of MG63 cells [157]. Addition of indomethacin to the cultures 
had inhibited roughness-mediated increase in OCN and latent transforming growth 
factor-β (LTGFβ). A study by Boyan et al. on SLA surfaces in 2001 had revealed 
that cycloxygenase-1 (Cox-1) and Cox-2 were involved in production of 
prostaglandin E2, transforming growth factor-β1 (TGFβ1) and OCN [122]. Later, in 
2010, Fang et al. observed upregulation of osteogenic markers, OCN and OPG on 
modSLA and SLA surfaces and explored the role of phospholipase D (PLD) on the 
differentiation of osteoblasts on micro-roughened surfaces like modSLA and SLA 
[158]. They concluded that the improved cellular responses on these surfaces are 
mediated by PLD through protein-kinase C (PKC) dependent signaling. 
Phospholipases have been found to be important mediators of cellular differentiation; 
however, they do not seem to play any key role on the ALP response on SLA surface 
as seen in their study. Therefore, no conclusive evidence has been derived for the 
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role of prostaglandins on the osteogenic differentiation process on micro-rough 
surfaces. 
Cell signaling pathways 
Cell signaling pathways are coordinated chain of events that lead to a 
sequential activation of different genes and proteins, eventually leading to 
culmination of different cellular activities, maturation and differentiation. To 
understand the molecular mechanisms guiding osteogenic differentiation, it becomes 
important to explore the different cell signaling pathways that get modulated by 
virtue of the interactions of osteoblastic cells with the physiologically relevant 
surfaces like SLA and modSLA. Several groups globally have recently started 
investigating the regulation of different cellular signaling molecules (genes and 
proteins) on these substrates. An early report exploring the improved osteogenic 
responses with 1α,25(OH)2D3 on micro-roughened SLA surfaces concluded it to 
work through the activation of the Mitogen-activated protein kinase (MAPK) 
pathway [110]. However, Zhuang et al. reported that inhibition of the extracellular 
signal-regulated kinase 1/2 (ERK1/2) pathway (a well characterized MAPK 
pathway) may play a role in the enhanced osteogenic properties of SLA surfaces 
[159]. Similar findings have been reported by Jiang et al. [160]. In 2004, Brett et al. 
observed the differential regulation of several genes on SLA surfaces compared to 
SMO surfaces; however, this study didn’t explore specific cell signaling pathways 
enriched [80]. Later, Galli et al. studied the activation of Wnt/β-catenin signaling 
pathway in mediation of cellular responses to SLA surfaces [161]. Their study 
described activation of the target genes of the Wnt pathway on SLA compared with 
polished surfaces. A higher Wnt/β-catenin pathway response along with lower 
expression of AXIN2 (important for degradation of β-catenin) was observed when 
WNT3A transfected C2C12 (murine cell line) were cultured on SLA surfaces 
(compared with polished). Their results were further consolidated when improved 
osteogenic responses of SLA surfaces were reversed upon inhibition of the β-catenin 
pathway. Their group has further shown that an alternate β-catenin mediated pathway 
(β-catenin/FoxB instead of conventional β-catenin/TCF) is activated on SLA 
surfaces when they need to prevent oxidative stresses by reactive oxygen species 
[162]. 
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Researchers started focusing their attention further on the Wnt pathway and 
superior osteogenic response on modified surfaces subsequently. Wall et al. 
demonstrated higher expression of WNT5A (representative of the non-canonical 
Wnt/Ca
2+
 pathway) on modSLA and SLA surfaces (modSLA>SLA>SMO) [86]. 
Pathway analysis after a microarray based study on the modSLA and SLA surfaces 
by Vlacic-Zischke et al. in 2011 demonstrated upregulation of TGFβ/BMP and Wnt 
signaling cascades, when they performed a whole genome expression analysis after 
culturing human osteoblasts on modSLA and SLA surfaces for 72 hours [24]. They 
also observed differential regulation of genes associated with processes related to 
bone remodeling, like proteolysis, angiogenesis and osteoclast differentiation. 
Further, the Wnt pathway genes catenin (cadherin-associated protein), alpha 1 
(CTNNA1), f-box and wd-40 domain protein 4 (FBXW4) and frizzled homolog 6 
(drosophila) (FZD6) were observed to be upregulated on modSLA and SLA surfaces. 
The Wnt signaling pathway potentially plays a key role in modulation of the effects 
of modSLA and SLA on cells. These observations are in agreement with in vivo 
results as described by Donos et al. in 2011 [117]. Osteogenesis and angiogenesis 
associated genes have been shown to be upregulated after seven days of implantation 
of modSLA implants in humans and this seems to be regulated by the BMP and 
VEGF signaling pathway [117]. In another study, Ivanovski et al. studied the 
transcriptional profile during osseointegration in humans and described the role of  
TGFβ/BMP, Wnt and Notch pathways in the osteogenic phase of osseointegration 
[118]. This study performed a gene ontology (GO) analysis on the temporal profiles 
of transcriptional changes during osseointegration in humans. The GO analysis was 
performed using the online tool: DAVID - Database for Annotation, Visualization, 
and Integrated Discovery, which is an important tool used to decipher biological 
meaning from large datasets of gene expression [163]. Interestingly, the results 
indicated a maturing osteogenic process between 4-14 days of implantation. Cell 
signaling pathways are important regulators for cell fate transitions and several 
studies on the micro-roughened surfaces have indicated upregulation of pro-
osteogenic and pro-angiogenic pathways during the process of osseointegration on 
these surfaces. 
The role of canonical Wnt/β-catenin pathway in the early stages of 
differentiation of MG63 cells was described by Olivares-Navarrete et al. in 2010 
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[164]. Exogenous addition of canonical Wnt inhibitors Dickkopf-1 (Dkk1) and Dkk2 
was shown to decrease osteogenic marker expression on the modified surfaces. They 
also demonstrated that Dkk1 and Dkk2 are important in the autocrine regulation of 
committed osteoblasts and have different effects on cells. Dkk2 was found to be 
important for the regulation of cells on smooth surfaces and Dkk1 for cells grown on 
micro-structured surfaces. Indeed, Dkk2 silencing was shown to decrease the 
expression of osteogenic markers like OCN. This study showed that Dkk2 may have 
an antagonistic role in the early stages and an agonistic role in the late stage of 
osteogenic differentiation. The role of canonical Wnt pathway on modSLA and SLA 
surfaces was also recently explored by Galli et al. [165]. Stimulation of the canonical 
Wnt pathway was shown to increase osteogenic differentiation on modified surfaces 
compared to controls. Recent studies have focused on the role of the non-canonical 
Wnt/Ca
2+
 pathway on micro-roughened surfaces. The Wnt/Ca
2+
 pathway was 
considered to be important in the late stage of differentiation on micro-roughened 
surfaces. Earlier, Wall et al. had indicated that activation of the WNT5A gene on 
modSLA possibly plays a key role in improved osteogenic differentiation [86]. The 
WNT5A gene is considered as a representative of the non-canonical Wnt/Ca
2+
 
pathway [166]; and therefore upregulation of WNT5A is considered indicative of 
Wnt/Ca
2+
 pathway activation. The study by Olivares-Navarrete et al. in 2011 on 
these surfaces also corroborates with the previous reports on the role of the non-
canonical Wnt pathway [26]. They demonstrated increased expression of WNT5A on 
micro-structured titanium surfaces which coincided with an increased osteogenic 
response. This study also explored the autocrine and paracrine effects of WNT3A 
(canonical Wnt/β-catenin pathway) and WNT5A (non-canonical Wnt/Ca2+ pathway). 
Human mesenchymal stem cells were cultured on titanium surfaces either with 
exogenous WNT3A and WNT5A or with antibodies against WNT3A and WNT5A. 
They observed a decrease in the level of OCN with exogenous WNT3A on all of the 
surfaces and an increase in the same with anti-WNT3A treatment. The findings were 
opposite in the WNT5A group. The levels of BMP2 and BMP4 were significantly 
higher on all the surfaces with exogenous WNT5A treatment when compared with 
the ones treated with anti-WNT5A. Their results tend to suggest that WNT3A has a 
negative influence on osteoblastogenesis on modified titanium surfaces. However, 
their findings also revealed an increase in the levels of VEGF-A and TGFβ1 
expression with exogenous WNT3A. TGFβ1 (a member of the TGFβ/BMP pathway) 
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has been shown to be important in bone formation in several studies [167-169]. 
Similarly, VEGF upregulation has also been demonstrated in several reports on 
osteogenesis [170, 171]. Thus, increased levels of TGFβ1 and VEGF-A with 
WNT3A seem contradictory to the hypothesis that WNT3A is inhibitory to all 
aspects of osteogenic differentiation. The findings; however, substantiate the role of 
the non-canonical Wnt/Ca
2+
 pathway. The same group explored the role of the 
Wnt/Ca
2+
 pathway further in a subsequent study [25]. The study explored the 
expression pattern of genes related to the Wnt pathway (receptors, activators and 
inhibitors) after culturing MG63 cells on modSLA, SLA and smooth surfaces. 
WNT1, WNT3A, WNT7B, WNT10B (activators of Wnt/β-catenin pathway) were 
seen to be downregulated on the modified surfaces. WNT5A and WNT11 (non-
canonical Wnt/Ca
2+
 pathway) were upregulated at the same time. They also observed 
upregulation of the classical inhibitor of the Wnt/β-catenin pathway, AXIN2 on these 
surfaces. This study further confirmed the observations as seen with exogenous 
addition of WNT3A and WNT5A, previously. However, they did not find any 
significant effect of WNT3A on the production of TGFβ1 and VEGF. In contrast, 
increased levels of BMP2, BMP4, VEGF, latent and active TGFβ1, and OPG were 
seen with the addition of WNT5A. These studies suggest that the non-canonical 
Wnt/Ca
2+
 pathway is essential for the induction of osteogenic differentiation of cells 
on micro-structured titanium surfaces. However, it is evident that much work is 
further needed to establish the role of this pathway in osteogenic differentiation. The 
difficulty in analysis of Wnt proteins by conventional Enzyme-linked 
immunosorbent assay (ELISA) and Western Blot techniques due to their 
hydrophobicity and affinity towards heparin and chondroitin sulphates makes efforts 
more challenging and research is still in progress [25, 172]. The current knowledge 
presented by different groups identifies an important role of the Wnt/Ca
2+
 pathway in 
osteogenic differentiation on micro-roughened surfaces. The role of PI3K/Akt 
signaling pathway on the modified titanium surfaces has been demonstrated by Gu et 
al. [173]. Their study suggests that the improved osteogenic response to modSLA 
and SLA surfaces could be due to the activity of the PI3K/Akt signaling pathway. 
A chain of highly controlled and coordinated sequence of molecular events is 
known to modulate the process of bone formation on micro-roughened titanium 
implant surfaces, like the modSLA and SLA surfaces. Evidences from available 
 Literature Review 51 
literature on the regulation of bone formation on modSLA and SLA surfaces reveal 
stimulation of several “pre-osteogenic” events like, response of blood cells, 
vascularization and cellular adhesions (Figure 3-6) that condition these surfaces for 
osteogenesis and bone formation.  
The pre-conditioning of the modSLA and SLA surfaces, along with their 
ability to induce “contact osteogenesis” lead to superior bone formation in vivo and 
osteogenic differentiation in vitro on the modSLA and SLA surfaces and provide us 
with excellent in vitro models to study the complex mechanisms involved in the 
process of osteogenesis and osseointegration. 
 
 
Figure 3-6: Sequence of events on modSLA and SLA surfaces promoting osteogenic differentiation 
and osseointegration. 
 
 52 Literature Review 
3.4 SUMMARY 
Osseointegration is a biological process that ensures a structural and functional 
integration of a foreign implant material and is dependent on the principles of 
osteogenesis and bone formation. Micro-roughened titanium implants, like the SLA 
and modSLA surfaces have been known to exhibit superior osseointegrative 
properties in comparison to their smoother counterparts and are considered to induce 
“contact osteogenesis”. This chapter has attempted to summarize the available 
knowledge pertaining to the SLA and modSLA surfaces with a particular focus on 
the studies exploring the molecular mechanisms of osteogenesis and osseointegration 
on these surfaces. As is evident from the literature, studies on these surfaces have 
been investigating the “pre-osteogenic” and “pro-osteogenic” molecular events 
conditioning these surfaces for bone formation; however, none of the studies have 
focused on the role of small non-coding RNA molecules known as microRNAs that 
have been found to be critical in the development of tissues and organs with reports 
claiming that 40-70% of the human genes are potentially under the control of 
miRNAs. Therefore this present study focuses on investigating the role of 
microRNAs in modulating pro-osteogenic cell signaling pathways and thereby the 
process of osteogenic differentiation, extracting cues from the SLA and modSLA 
topographically modified titanium implant surfaces. Newer physically and 
chemically modified implant designs like electrochemical modification through 
potentiostatic anodization (ECH) and sandblasting, alkali heating, and etching 
(SMART), which are beginning to gain popularity are also expected to benefit from 
these findings [174]. It is believed that the inferences drawn from this study will aid 
us in designing tools to assess the clinical success of newer physically and 
chemically modified implant materials. 
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Abstract 
 
 Topographically modified micro-roughened titanium implant surfaces are 
known to have superior osseointegration properties when compared with their 
polished counterparts. Osseointegration is the biological process integrating an 
implant structurally and functionally with the surrounding bone, and involves a series 
of molecular processes culminating in new bone formation around the implant. The 
aim of this study was to investigate the early molecular events following exposure to 
micro-roughened sand-blasted, large grit, acid-etched (SLA) surfaces that lead to 
their enhanced osteogenic properties in comparison with smooth polished (SMO) 
implants. Whole genome transcriptional analysis was performed using Affymetrix 
Human Genome U133 Plus 2.0 arrays following the exposure of primary human 
osteoprogenitor cells to SLA and SMO surfaces for 3 and 24 hours. A clear pro-
osteogenic response was observed on SLA surfaces compared with SMO surfaces 
following 24 hours of exposure. The bone morphogenetic protein, BMP2 (fold-
change: FC >5.7) and the key osteogenic transcription factor, RUNX2 (FC=2.2) were 
seen to have higher expression on SLA compared with SMO within 24 hours. 
Analysis using the Database for Annotation, Visualization and Integrated Discovery 
(DAVID) and Ingenuity Pathways Analysis (IPA) tool, revealed clusters related to 
skeletal system development as the earliest physiological clusters enriched on SLA 
surfaces. Assessment of the immediate response to SLA and SMO surfaces, showed 
differential expression of clusters related to cell-mediated immune response, immune 
cell trafficking and nervous system development between them after 3 hours of 
exposure. An immediate pro-angiogenic and immunomodulatory response on SLA 
surfaces as demonstrated by a time-course analysis (3 hours vs. base-line) possibly 
lays the foundation for the pro-osteogenic niche provided by the SLA surface, as 
confirmed by higher mineralization on SLA surfaces. These results describe a 
sequential pattern of molecular events that may be responsible for the enhanced 
osseointegration observed on micro-roughened surfaces and emphasize the biological 
relevance of studying the early cellular response to micro-roughened titanium 
implant surfaces. 
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4.1 INTRODUCTION 
Titanium surfaces are established as dental and orthopedic implant surfaces 
owing to their superior osseointegration and osteointegrative properties. The key 
challenge in implantology is the early structural and functional restoration of body 
parts. Researchers have been constantly exploring physical and chemical alterations 
to implant surfaces and have come up with several modifications. The 
topographically modified titanium dental implant surface - sand blasted, large-grit, 
acid-etched (SLA), has been a clinically successful dental implant with superior 
osseointegration and osteogenic properties compared with smooth (SMO) surfaces 
[1-5].  
The bone matrix formed by mineralization of osteoid deposited by osteoblastic 
activity, has a multi-dimensional micro-rough architecture and this makes the micro-
rough SLA surface an interesting substrate to study osteogenesis. Moreover, Osborn 
and Newesley have described osteogenesis on micro-roughened surfaces as “contact 
osteogenesis”, wherein new bone is deposited by direct osteoblastic activity on the 
surface of the implant [6]. The micro-roughened structure of topographically 
modified titanium surfaces as such, provides a substrate akin to the native bone 
architecture. Therefore, it is reasonable to consider the use of such surfaces to study 
the mechanistic regulation of osteogenesis instead of conventional techniques 
inducing osteogenic differentiation using chemical methods.  
The transcriptome of a living organism is the repository of genetic information 
necessary for the growth and development of various organs and physiological 
systems. Activation and repression of different mRNA molecules in the genome 
regulate different biological processes like cell and tissue differentiation. Whole 
genome transcriptome analysis tools like microarrays, provides us with a powerful 
instrument to study the inter-relationship between different messenger molecules. 
Osteogenic differentiation and osseointegration are biological processes guided by 
series of molecular events resulting in activation of signaling pathways. These 
processes eventually lead to matrix deposition, mineralization and finally a structural 
and functional integration of implant with the surrounding bone. Several studies have 
used the micro-roughened SLA surface as a physiologically relevant model to 
explore the molecular mechanisms of osteogenic differentiation and osseointegration 
in vitro [1, 2, 7-9]. Studies have revealed an early modulation of gene expression and 
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have also shown differential expression of cell signaling pathways on these surfaces 
[2, 3, 9]. Although, these surfaces have been frequently used to study the osteo-
differentiation process, none of the studies have confirmed whether such surfaces can 
actually be substantial models to study the process of osteogenesis and 
osseointegration and neither have they identified a time-course of events that lead to 
the pro-osteogenic mechanisms. The aim of this study was to explore the genetic 
mechanisms and biological processes regulated on micro-roughened surfaces that 
lead to their superior osseointegration properties compared to smooth/polished 
surfaces. 
4.2 MATERIALS AND METHODS 
4.2.1 Titanium discs 
The SLA and SMO discs were supplied by Institut Straumann (Basel, 
Switzerland). They were prepared from grade II commercially pure titanium (15 mm 
in diameter, 1 mm in thickness). The SLA surfaces were prepared by blasting the 
titanium surface with 250-500 µm corundum grit and acid etching with a hot solution 
of hydrochloric/sulfuric acids. Polished smooth titanium surfaces (SMO) were used 
as control surfaces for the study. 
4.2.2 Cell culture 
Alveolar bone derived primary osteoprogenitor cells (BCs) were obtained from 
three human volunteers. The cells were established after culturing redundant tissues 
obtained following third molar extraction surgery using methods described in 
previous studies from our research group [10-12]. The BCs were seeded at a density 
of 5 × 10
4
 cells/titanium disc placed in 24 well tissue culture plates (BD Falcon, 
North Ryde, NSW, Australia), and incubated at 37 °C in a 5% CO2 atmosphere in 
Dulbecco's modified Eagle's medium (DMEM) (Invitrogen, Mt Waverley, VIC, 
Australia) supplemented with fetal bovine serum (FBS) (Thermo, In Vitro 
Technologies, Nobel Park, VIC, Australia) and antibiotics (100 U/ml penicillin/100 
μg/ml streptomycin). Six discs of each kind per sample per time point were used for 
the study. 
4.2.3 Mineralization study 
Mineral deposition on the SLA and SMO titanium surfaces by BCs cultured in 
either standard (SM) or osteogenic supplemented media (DEX+: SM supplemented 
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with 100 nM dexamethasone). Supplementation of low doses of dexamethasone to 
standard culture has been known to stimulate osteogenesis for a long time now [13]. 
This helps in relative quantification of mineral deposition by alleviating the response. 
The cultures were assessed for mineralization up to 4 weeks, using Alizarin Red S 
staining. This staining was carried out using a modification of the method described 
by Reinholz et al. [14]. Briefly, after removing the media and washing the cells with 
phosphate buffered saline (PBS), the cells were first fixed with 10% neutral buffered 
formalin and then stained with 40 mM Alizarin Red S for 10 min at room 
temperature. The excess stain was then removed by washing with ultrapure water and 
the samples were allowed to air dry before photographing. Semi-quantitative 
assessment of mineralization was achieved by destaining for 15 min with 10% (w/v) 
cetylpyridinium chloride in 10 mM sodium phosphate pH 7.0. The extracted stain 
was transferred to a 96-well plate and the absorbance at 570 nm measured using a 
plate reader/spectrophotometer. The calcium and phosphorus content was further 
assessed using Energy Dispersive Spectrometry (EDAX). 
4.2.4 Microarray analysis 
Microarray whole genome analysis was performed following 3 and 24 hours of 
exposure of osteoblasts to the SLA and SMO surfaces. Affymetrix Human Genome 
U133 Plus 2.0 arrays (Affymetrix, Santa Clara, California) containing 54675 probes 
for analysis, were used for the study. Total RNA was isolated (RNAqueous, Ambion) 
and cDNA was synthesized using the Affymetrix one cycle cDNA kit. Pseudo-
uridine labeled probes were prepared by synthesizing cRNA (Affymetrix IVT kit) 
before hybridization onto the microarrays. Data analysis was performed using the 
trial version of GeneSpring GX12.5 (Agilent Technologies, Inc., developed on 
avadis
TM
 platform by Strand Life Science Pvt. Ltd.).  
Comparisons between the expression profile on SLA and SMO surfaces were 
performed at each time-point (3 and 24 hours) using Student’s t-test. Correlations 
were also made between the two time-points and with the base-line expression (0 
hour) for each of the surfaces (SLA and SMO). Functional classification of the 
differentially expressed genes was subsequently performed, and pathway and 
network enrichments were further assessed using the Database for Annotation, 
Visualization and Integrated Discovery (DAVID) [15] and Ingenuity Pathways 
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Analysis (IPA) tool (Ingenuity
®
 Systems, www.ingenuity.com, Redwood City, CA, 
USA) [16]. 
4.3 RESULTS 
4.3.1 Mineralization assay 
Human BCs were seen to induce more mineral deposition on SLA surfaces 
compared to SMO (Figure 4-1). The differences were observed to become significant 
after two weeks of culture.  Osteoblasts were seen to induce mineral deposition even 
in the absence of osteogenic supplementation (in SM); however, the deposition was 
always higher in DEX+ than SM media. Increased deposition is seen throughout the 
4 weeks for all cultures. EDAX analysis confirmed increased mineralization at week 
4. Higher deposition of calcium and phosphorus was detected on the SLA surfaces 
than on the SMO surfaces, both in the presence (DEX+) or absence (SM) of 
osteogenic supplement, although the deposition was significantly higher with cells 
cultured using DEX+ (Figure 4-1).  
 
(A) 
Figure 4-1 A: Spectrophotometric quantification of Alizarin Red S staining. 
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Figure 4-1: Mineralization study on SLA and SMO surfaces: (A) Spectrophotometric quantification of 
Alizarin Red S staining after culturing alveolar bone derived primary osteoprogenitor cells (BCs) on 
SLA and SMO surfaces (with osteogenic supplementation: DEX+ and standard media: SM), showing 
higher staining on SLA than SMO surfaces. (B) Energy Dispersive Spectrometry (EDAX) 
quantification (expressed as percent surface signal) of calcium and phosphorus content after 4 weeks 
culture of osteoprogenitor cells on SLA and SMO surfaces showing higher intensities on SLA 
surfaces compared with SMO surfaces (both Ca and P)(significant in osteogenic cultures)(*: p-value 
<0.05, SLA vs. SMO).  
4.3.2 Whole genome expression analysis 
 Affymetrix Human Genome U133 Plus 2.0 array (Affymetrix, Santa Clara, 
California) were used to assess whole genome expression profile of osteoblasts 
following 3 and 24 hours of exposure to SLA and SMO surfaces.  
4.3.3 Differentially regulated genes 
 After three hours of exposure of the BCs to the two different titanium 
surfaces, 90 genes (37 upregulated and 53 downregulated) were seen to qualify the 
statistical stringency (p-value cutoff 0.05). Out of these 90 genes, 15 (9 upregulated 
and 6 downregulated) genes showed fold change (FC) beyond +/-1.5. The number of 
differentially expressed genes on SLA compared with SMO surface escalated to 636 
after 24 hours of exposure to the surfaces (381 upregulated and 255 downregulated) 
out of which 242 (136 upregulated and 106 downregulated) genes had FC beyond +/-
(B) 
Figure 4-1 B: Energy Dispersive Spectrometry (EDAX) quantification. 
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1.5 (Figure 4-2 and Table 4-1). Table 4-2 shows the top ten up- and downregulated 
genes at 3 and 24 hours. 
 
Figure 4-2: Volcano plots showing comparisons between SLA and SMO following 3 and 24 hours 
exposure. The statistically significant genes are shown in red. A clearly evident increase in the number 
of differentially regulated genes was observed between 24 and 3 hours.  
 
Table 4-1: Number of genes differentially regulated on micro-roughened SLA and polished titanium 
surfaces (SMO) (after 3 and 24 hours of exposure of BCs). 
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Table 4-2: List of top ten upregulated and downregulated genes on SLA surfaces compared with SMO 
surfaces at 3 and 24 hours time-points (FC: fold change). 
 
 
 Centrosomal protein 78 kDa (CEP78), a gene with little known function, 
showed the highest upregulation on SLA surface compared with SMO (FC=2.554, p-
value=0.0165) within 3 hours of exposure. The other genes showing FCs beyond +2 
at 3 hours were: Kinesin family member 3C (KIF3C) (FC=2.516, p-value=0.024), 
glutathione S-transferase omega 2 (GSTO2) (FC=2.385, p-value=0.0311) and 
phosphatidylinositol glycan anchor biosynthesis, class M (PIGM) (FC=2.329, p-
value=0.0244). KIF3C is a member of the KIF3 family - class of microtubule-
dependent motors that is important for cell division and intracellular transport [17]. 
Among the other two genes - GSTO2 possibly plays a vital role in cellular signaling 
[18] and PIGM is involved in the synthesis of glycosylphosphatidylinositol (GPI)-
anchor that helps to anchor proteins to the surface of cells [19]. 
 The FBJ murine osteosarcoma viral oncogene homolog B (FOSB) gene 
(FC=7.52, p-value=0.00915) was seen to be the most highly upregulated gene on the 
SLA surface (compared with SMO surface) after 24 hours. The FOS proteins are 
known to be associated with regulation of cellular proliferation and differentiation. 
Ras-related associated with diabetes (RRAD) gene showed the second highest fold-
 The Microarray Study 77 
change (FC=6.441, p-value=0.0179). This gene is seen to have roles in cell cycle 
progression and differentiation.  
 A characteristic feature observed at the 3 hours time-point was increased 
expression of the gene RHOB (FC=1.62, p-value=0.0355) which is known to be 
important for attachment of fibroblastic cells. PRKDC was observed to be 
downregulated (FC=-1.308, p-value=0.000615). This gene is known to affect G1/S 
phase transition arrest of fibroblast cell lines. Bone morphogenetic protein 2 (BMP2) 
emerged as a highly upregulated gene (FC=5.697, p-value=0.0268). The BMP2 
protein is one of the key ligands responsible for activation and functioning of the 
BMP signaling pathway. The BMP pathway is known to play an instrumental role in 
the osteogenic differentiation process. 
4.3.4 Functional clustering of differentially regulated genes 
 Functional grouping and clustering of the differentially regulated genes at 3 
and 24 hours were performed using the Database for Annotation, Visualization and 
Integrated Discovery (DAVID) [15] and Ingenuity Pathways Analysis tool [16]. 
Functional annotation using DAVID revealed higher distribution of Gene ontology 
(GO) terms related to biological processes at both time-points (65.22% at 3 hours 
and 57.34% at 24 hours) (Figure 4-3). 
 
Figure 4-3: Summary of key gene ontology (GO) terms enriched on SLA surfaces compared with 
SMO following 3 and 24 hours of  culture . GO clustering analysis was performed using Database for 
Annotation, Visualization and Integrated Discovery (DAVID) and considering the 
GOTERM_BP_FAT, GOTERM_CC_FAT and GOTERM_MF_FAT, which are summarized versions 
of the Biological Processes, Cellular Components and Molecular Functions, respectively in the gene 
ontology (medium classification stringency). 
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 Cellular component terms showed 20-30% enrichment (21.74% at 3 hours 
and 29.86% at 24 hours) and molecular function terms were seen to have ~13% 
enrichment (13.04% at 3 hours and 12.80% at 24 hours). To ascertain the biological 
meaning of the GO categories enriched, a further clustering analysis was performed 
on DAVID and the enrichment score cutoff was set at 1.3 (corresponds to non-log 
geometric mean of p-value=0.05 [20]) (Table 4-3). Only one annotation cluster 
passed the stringent criteria set at the three hours time-point. This cluster was 
primarily related to GO terms associated with nucleic acid processing and nuclear 
functions. In contrast to this, 12 annotation clusters qualified after twenty-four hours. 
The maximally enriched clusters at the 24 hours time-point were related to 
microtubular and cytoskeletal architecture, and also with cell organelle. The first 
physiological system related cluster to get highlighted at 24 hours between SLA and 
SMO surfaces was associated with skeletal system development (Table 4-3). 
 Comparative analysis of the microarray expression profile at three hours and 
twenty-hours between SLA and SMO surfaces was performed using IPA (Figure 4-
4). The analysis revealed differential expression of clusters related to cell-mediated 
immune response, immune cell trafficking and nervous system development as early 
as 3 hours. Skeletal and muscular system development clusters were observed as the 
most differentially regulated clusters at the 24 hours time-point. “Connective tissue 
development and function” cluster was the second one to get highlighted at 24 hours. 
Six upregulated genes (FOS, RUNX2, PTHLH, HEXA, MMP14 and WNT9A) on 
the SLA surface at 24 hours time-point clustered together towards the “length of 
bone” functional annotation (activation z-score=2.4, p-value=0.0021).  
Table 4-3: Functional Annotation Clustering using DAVID showing Gene Ontology (GO) annotation 
clusters with enrichment scores ≥1.3 (non-log geometric mean of p-values=0.05) for differentially 
regulated genes in BCs following 3 and 24 hours exposure to SLA and SMO surfaces (Numbers in 
parentheses indicate number of genes from the dataset matching the GO term). 
 
SLA vs SMO 3 hours 
Annotation Cluster 1: Enrichment Score: 1.30 
GO:0008380-RNA splicing (6), GO:0006396-RNA processing (8), GO:0006397-mRNA processing (6), 
GO:0016071-mRNA metabolic process (6), GO:0044451-Nucleoplasm part (7), GO:0005654-Nucleoplasm 
(9), GO:0031981-Nuclear lumen (12), GO:0070013-Intracellular organelle lumen (12), GO:0043233-
Organelle lumen (12), GO:0031974-Membrane-enclosed lumen (12), GO:0000375-RNA splicing, via 
transesterification reactions (3), GO:0000377-RNA splicing (3), via transesterification reactions with 
bulged adenosine as nucleophile (3), GO:0000398-Nuclear mRNA splicing, via spliceosome (3), 
GO:0016604-Nuclear body (3), GO:0005730-Nucleolus (5) 
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SLA vs SMO 24 hours 
Annotation Cluster 1: Enrichment Score: 6.97 
GO:0015630- Microtubule cytoskeleton (43), GO:0043228-Non-membrane-bounded organelle (121), 
GO:0043232-Intracellular non-membrane-bounded organelle (121), GO:0005856-Cytoskeleton (72), 
GO:0005874-Microtubule (25), GO:0044430-Cytoskeletal part (52) 
 
Annotation Cluster 2: Enrichment Score: 5.25 
GO:0015630-Microtubule cytoskeleton (43), GO:0000279-M phase (28), GO:0000278-Mitotic cell cycle 
(30), GO:0022402-Cell cycle process (39), GO:0022403-Cell cycle phase (32), GO:0007049-Cell cycle 
(48), GO:0000280-nuclear division (21), GO:0007067-Mitosis (21), GO:0000087-M phase of mitotic cell 
cycle (21), GO:0048285-Organelle fission (21), GO:0007017-Microtubule-based process (22), 
GO:0051301-Cell division (21), GO:0005819-Spindle (13) 
 
Annotation Cluster 3: Enrichment Score: 4.25 
GO:0015630-Microtubule cytoskeleton (43), GO:0000226-Microtubule cytoskeleton organization (14), 
GO:0005813-Centrosome (16), GO:0005815-Microtubule organizing center (17) 
 
Annotation Cluster 4: Enrichment Score: 2.82 
GO:0031974-Membrane-enclosed lumen (79), GO:0070013-Intracellular organelle lumen (75), 
GO:0031981-Nuclear lumen (63), GO:0043233-Organelle lumen (75), GO:0005730-nucleolus (34), 
GO:0005654-Nucleoplasm (34) 
 
Annotation Cluster 5: Enrichment Score: 2.23 
GO:0005739-Mitochondrion (49), GO:0031967-Organelle envelope (32), GO:0031975-Envelope (32), 
GO:0019866-Organelle inner membrane (20), GO:0005743-Mitochondrial inner membrane (18), 
GO:0031090-Organelle membrane (46), GO:0005740-Mitochondrial envelope (22), GO:0031966-
Mitochondrial membrane (19), GO:0044429-Mitochondrial part (26) 
 
Annotation Cluster 6: Enrichment Score: 2.16 
GO:0005773-Vacuole (16), GO:0005764-Lysosome (14),GO:0000323-Lytic vacuole (14) 
 
Annotation Cluster 7: Enrichment Score: 2.03 
GO:0003777-Microtubule motor activity (9), GO:0005875-Microtubule associated complex (10), 
GO:0003774-Motor activity (11), GO:0007018-Microtubule-based movement (7) 
 
Annotation Cluster 8: Enrichment Score: 1.74 
GO:0001958-Endochondral ossification (4), GO:0060348-Bone development (10), GO:0060350-
Endochondral bone morphogenesis (4), GO:0060349-Bone morphogenesis (4), GO:0001503-Ossification 
(9), GO:0001501-Skeletal system development (17), GO:0048705-Skeletal system morphogenesis (7) 
 
Annotation Cluster 9: Enrichment Score: 1.71 
GO:0042641-Actomyosin (5), GO:0001725-Stress fiber (4), GO:0032432-Actin filament bundle (4) 
 
Annotation Cluster 10: Enrichment Score: 1.40 
GO:0000793-Condensed chromosome (11), GO:0000775-Chromosome, centromeric region (10), 
GO:0034508- centromere complex assembly (3), GO:0000776-Kinetochore (7), GO:0005694-Chromosome 
(21), GO:0000777-Condensed chromosome kinetochore (5), GO:0000779-Condensed chromosome, 
centromeric region (5), GO:0044427-Chromosomal part (16), GO:0065004-Protein-DNA complex 
assembly (4) 
 
Annotation Cluster 11: Enrichment Score: 1.39 
GO:0050684-Regulation of mRNA processing (4), GO:0048024-Regulation of nuclear mRNA splicing, via 
spliceosome (3), GO:0043484-Regulation of RNA splicing (3)  
 
Annotation Cluster 12: Enrichment Score: 1.36 
GO:0051384-Response to glucocorticoid stimulus (8), GO:0031960-Response to corticosteroid stimulus 
(8), GO:0009719-Response to endogenous stimulus (19), GO:0048545-Response to steroid hormone 
stimulus (11), GO:0009725-Response to hormone stimulus (17), GO:0010033-Response to organic 
substance (25) 
 
Table 4-3 (continued) 
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(A) 
Figure 4-4 A: Functional clustering analysis (Systemic processes) of differentially regulated 
genes between SLA and SMO after 3 hours of culture. (IPA analysis) 
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(B) 
Figure 4-4 B: Functional clustering analysis (Systemic processes) of differentially regulated genes 
between SLA and SMO after 24 hours of culture. (IPA analysis) 
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(C) 
Figure 4-4 C: Functional clustering analysis (Molecular processes) of differentially regulated 
genes between SLA and SMO after 3 hours of culture. (IPA analysis) 
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Figure 4-4 (A-D): Functional clustering analysis of differentially regulated genes between SLA and 
SMO after 3 and 24 hours of culture (Analysis performed using Ingenuity Pathway Analysis: IPA). 
 
4.3.5 Time-course analysis for functional pathways 
 Functional clustering analysis of the differentially regulated genes on SLA 
and SMO over the time-course (0, 3 and 24 hours) was performed using IPA. IPA’s 
hierarchical classification organizes functional pathways on the basis of high-level 
categories. Based on activation z-score analysis of IPA, scores beyond +/- 1.5 were 
considered as significantly regulated clusters (z>+1.5: increased and z<-1.5: 
decreased). More functional clusters were seen to have increased z-scores on both 
SLA and SMO surfaces in the 3 hours vs. 0 hour (base-line) comparison (SLA=110 
and SMO=75), than 24 hours vs. 3 hours comparison (SLA=33 and SMO=53). In 
(D) 
Figure 4-4 D: Functional clustering analysis (Molecular processes) of differentially regulated 
genes between SLA and SMO after 24 hours of culture. (IPA analysis) 
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contrast to this, fewer clusters were seen to have decreased z-scores on both SLA and 
SMO surfaces in the 3 hours vs. 0 hour comparison (SLA=30 and SMO=14), than 24 
hours vs. 3 hours comparison (SLA=59 and SMO=40). Relevant clusters are 
highlighted in Table 4-4. A categorical analysis of the comparisons has been shown 
as a heatmap map analysis in Figure 4-5.  
 
Figure 4-5: Heat-map of significantly 
regulated categories of functional 
clusters differentially regulated on 
SLA and SMO surfaces over the time-
course of analysis (base-line-0 hour, 3 
hours and 24 hours) based on the 
activation z-score analysis on IPA 
(scores beyond +/- 1.5). 
 The Microarray Study 85 
 Large number of clusters belonging to the categories: cell development 
(n=23), hematological system development and function (n=19), hematopoiesis 
(n=12), gene expression (n=10), cell death & survival (n=9), cell movement 
categories (n=8) and tissue morphology (n=8) were observed as activated after 3 
hours exposure to SLA surfaces. In contrast, the SMO surface exposure showed 
higher number of clusters belonging to the categories: cell death & survival (n=15), 
gene expression (n=8) and cellular development (n=8). Other categories showing 
high numbers of activated clusters on the titanium surfaces after 3 hours were: 
infectious disease (n=14 on SLA and n=11 on SMO) and cancer (n=10 on SLA and 
n=8 on SMO).  The comparisons made between 24 hours and 3 hours on both of the 
surfaces revealed large number of clusters categorized as belonging to “cell cycle” 
on both surfaces (n=12 on SLA and n=27). Unmatched categories on SLA and SMO 
surfaces showed developmental disorders category as having 7 activated clusters on 
SLA surface (24 hours vs. 3 hours), whereas DNA replication, recombination and 
repair showed 11 activated clusters on SMO.  
 The developmental disorders category was seen to have the highest number 
of clusters (n=10) that showed inhibition after 3 hours of exposure to SLA surfaces. 
Categories “cell death and survival” and “developmental disorders” were seen to be 
inhibited on SMO surfaces (n=3 for both). “Skeletal and muscular disorders clusters” 
(n=4) were also seen to be inhibited on SLA surfaces (3 hours vs. 0 hour). Numerous 
categories were seen to be inhibited when comparisons were made between 24 hours 
and 3 hours for both SLA and SMO surfaces. The inhibited categories worth 
mentioning were “cell death and survival” (n=8 on both SLA and SMO), “cellular 
development” (n=10 on SLA) and hematological diseases (n=9 on SMO). 
 Several unique functional annotation clusters were depicted by IPA upon 
analysis of the genes differentially regulated in 3 hours vs. base-line and 24 hours vs. 
3 hours comparisons. The most relevant clusters have been shown in Table 4-4. 
Higher numbers of relevant clusters were found to be activated when compared to 
inhibited clusters after 3 hours on both SLA and SMO. In contrast to this, more 
clusters were seen to be inhibited in 24 hours vs. 3 hours comparison.  
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Table 4-4: Relevant functional annotation clusters as depicted by IPA upon analysis of the genes 
showing differential regulation in 3 hours vs. base-line and 24 hours vs. 3 hours comparisons on SLA 
and SMO surfaces. 
SLA 3 hr vs. 0 hr SLA 24 hr vs. 3 hr SMO 3 hr vs. 0 hr SMO 24 hr vs. 3 hr 
Functions Annotation z Functions Annotation z Functions 
Annotation 
z Functions 
Annotation 
z 
Increased activation z-score (>+1.5) 
Transcription 
      
3.87  
Congenital 
anomaly of skeletal 
bone 3.19 Nuclear export 1.98 
Association of 
chromosome 
components 3.25 
Transcription of RNA 
      
3.77  
Congenital 
anomaly of 
musculoskeletal 
system 3.04 
Nuclear export of 
molecule 1.75 
Association of 
chromatin 2.79 
Expression of RNA 
      
3.70  
Craniofacial 
abnormality 2.61 
Nuclear export of 
mRNA 1.75 
Stabilization of 
chromosomes 2.47 
Transactivation 
      
3.55  
Association of 
chromosome 
components 2.79 Transactivation 3.54 Excision repair 2.36 
Expression of DNA 
      
3.03  
Association of 
chromatin 2.61 Transcription 2.55 
Alignment of 
chromosomes 2.33 
Transcription of DNA 
      
2.95  
Alignment of 
chromosomes 2.14 
Expression of 
RNA 2.54 
Segregation of 
chromosomes 2.01 
Activation of DNA 
endogenous promoter 
      
2.61  
Mismatch repair of 
DNA 1.96 
Transcription of 
RNA 2.52 
Binding of 
chromosomes 1.98 
Initiation of 
transcription 
      
2.14  Metabolism of DNA 1.78 
Activation of 
protein 2.22 
Chromosomal 
congression of 
chromosomes 1.91 
Repression of RNA 
      
2.42  
Chromosomal 
congression of 
chromosomes 1.66 
Expression of 
DNA 2.07 
Conformational 
modification of 
DNA 1.63 
DNA damage 
response of cells 
      
1.98  
Cycling of 
centrosome 2.54 
Transcription of 
DNA 2.03 
Hydrolysis of 
nucleotide 1.61 
Binding of DNA 
      
1.51  Replication of cells 2.31 
Repression of 
RNA 1.98 Repair of DNA 1.51 
Development of 
cardiovascular system 
      
3.37  Checkpoint control 2.08 
Activation of DNA 
endogenous 
promoter 1.75 
Mismatch repair of 
DNA 1.96 
Vasculogenesis 
      
2.96  Repair of cells 1.57 
Transport of 
mRNA 1.73 
Interphase of 
connective tissue 
cells 3.14 
Migration of 
endothelial cells 
      
1.99  Hypoplasia 2.65 Export of mRNA 1.69 
Interphase of 
fibroblasts 2.98 
Cell movement of 
endothelial cells 
      
1.84  
Hypoplasia of 
organ 1.98 
Metabolism of 
protein 1.91 
Cycling of 
centrosome 2.70 
Development of 
hematopoietic cells 
      
2.39  
Interphase of 
connective tissue 
cells 2.31 
Synthesis of 
protein 1.72 Checkpoint control 2.59 
Development of 
leukocytes 
      
2.34  
Re-entry into cell 
cycle progression 2.29 
Organization of 
cytoskeleton 2.88 
Proliferation of 
cells 2.39 
Development of blood 
cells 
      
2.28  
G1 phase of 
fibroblasts 2.24 
Organization of 
cytoplasm 2.86 
S phase of 
connective tissue 
cells 2.34 
Differentiation of blood 
cells 
      
2.26  
S phase of bone 
cancer cell lines 2.16 
Microtubule 
dynamics 2.62 Interphase 2.25 
Quantity of 
lymphocytes 
      
2.03  
Interphase of 
fibroblasts 2.08 
Proliferation of 
cells 2.21 
S phase of 
fibroblasts 2.12 
Differentiation of red 
blood cells 
      
2.00  
Interphase of bone 
cancer cell lines 1.60 M phase 2.14 
S phase of bone 
cancer cell lines 1.94 
Differentiation of 
leukocytes 
      
2.00  
Morphology of 
hematopoietic 
progenitor cells 2.22 
Cell cycle 
progression 2.06 S phase 1.93 
Quantity of B 
lymphocytes 
      
2.00  
Formation of 
neointima 1.94 
Re-entry into S 
phase 1.51 Cytokinesis 1.91 
Differentiation of 
hematopoietic 
progenitor cells 
      
1.81  
Morphology of 
lymphatic system 
component 1.72 
Development of 
connective tissue 3.20 
Cytokinesis of 
tumor cell lines 1.81 
Differentiation of 
mononuclear 
leukocytes 
      
1.80  
  
Differentiation of 
cells 3.07 
S phase 
checkpoint control 1.76 
Accumulation of 
myeloid cells 
      
1.75  
  
Development of 
leukocytes 1.75 
Re-entry into cell 
cycle progression 1.74 
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Quantity of 
mononuclear 
leukocytes 
      
1.75  
  
Differentiation of 
endothelial cells 1.74 Replication of cells 1.74 
Formation of 
fibronectin matrix 
      
1.73  
  
Development of 
blood cells 1.69 
G1 phase of 
fibroblast cell lines 1.57 
Quantity of blood cells 
      
1.64  
  
Apoptosis of 
hematopoietic cell 
lines 1.65 G1/S phase 1.53 
Development of 
lymphocytes 
      
1.61  
  
Differentiation of 
erythroid 
progenitor cells 1.52 Cell transformation 1.51 
T cell development 
      
1.59  
  
Proliferation of 
hematopoietic cell 
lines 1.51 Invasion of cells 1.59 
Differentiation of 
lymphocytes 
      
1.59  
  
Cell survival 2.78 
Entry into 
interphase 1.50 
Differentiation of 
hematopoietic cells 
      
1.58  
  
Cell viability 2.45 
Formation of 
vessel component 2.36 
T cell homeostasis 
      
1.57  
  
Cell viability of 
embryonic stem 
cell lines 1.99 
  
Metabolism of protein 
      
2.27  
  
Cytostasis 2.37 
  
Synthesis of protein 
      
2.07  
  
Cell cycle 
progression of 
tumor cell lines 1.74 
  
Shock response 
      
2.03  
  
Contact growth 
inhibition 1.73 
  
Polyubiquitination 
      
1.98  
  
Self-renewal of 
cells 1.59 
  Synthesis of 
glycosaminoglycan 
      
1.91  
  
Sprouting 1.62 
  
Differentiation of cells 
      
4.26  
  
Differentiation of 
connective tissue 
cells 2.37 
  
Cell survival 
      
3.68  
  
Differentiation of 
osteoblasts 2.36 
  
Cell viability 
      
3.19  
  
Bone cancer 1.94 
  
Formation of cells 
      
2.69  
  
Tumorigenesis of 
osteosarcoma 1.63 
  
Proliferation of cells 
      
2.62  
      
Quantity of cells 
      
2.56  
      
Cell cycle progression 
      
2.30  
      
M phase 
      
2.14  
      Proliferation of stem 
cells 
      
2.09  
      
Cytostasis 
      
2.09  
      Growth of plasma 
membrane projections 
      
2.55  
      
Nuclear export 
      
1.75  
      Nuclear export of 
molecule 
      
1.51  
      Endoplasmic reticulum 
stress response 
      
1.71  
      Endoplasmic reticulum 
stress response of 
cells 
      
1.71  
      Self-renewal of 
embryonic stem cells 
      
1.95  
      Proliferation of 
embryonic stem cells 
      
1.67  
      Differentiation of 
connective tissue cells 
      
1.90  
      
Bone cancer 
      
1.72  
      Differentiation of 
osteoblasts 
      
1.65  
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SLA 3 hr vs. 0 hr SLA 24 hr vs. 3 hr SMO 3 hr vs. 0 hr SMO 24 hr vs. 3 hr 
Functions 
annotation  z 
Functions 
annotation z 
Functions 
annotation z 
Functions 
annotation z 
Decreased activation z-score (<-1.5) 
Organismal death -5.79 Repression of RNA -2.73 Organismal death -5.06 DNA damage -3.03 
Growth failure -3.3 
Breakage of 
chromosomes -2.67 Splicing of mRNA -2.17 
Sister chromatid 
exchange -2.80 
Hypoplasia of 
organ -3.04 
Missegregation of 
chromosomes -1.98 
Processing of 
mRNA -1.71 Transactivation -2.26 
Hypoplasia -2.53 Processing of RNA -1.91 
Neuromuscular 
disease -1.98 
Activation of DNA 
endogenous 
promoter -1.97 
Cell death -1.88 
Proliferation of 
leukocyte cell lines -2.81 
Congenital 
anomaly of 
skeletal bone -1.76 
Transcription of 
DNA -1.85 
Apoptosis -1.54 
Proliferation of 
hematopoietic cell 
lines -2.75 
  
Expression of DNA -1.79 
Congenital 
anomaly of 
musculoskeletal 
system -2.93 
Quantity of 
hematopoietic 
progenitor cells -2.14 
  
Repression of DNA -1.64 
Congenital 
anomaly of skeletal 
bone -2.82 
Quantity of 
mononuclear 
leukocytes -2.06 
  
Missegregation of 
chromosomes -1.63 
Craniofacial 
abnormality -2.14 
Quantity of bone 
marrow cells -2.05 
  
Differentiation of 
cells -2.35 
Adipogenesis of 
fibroblast cell lines -1.71 
Quantity of blood 
cells -2.01 
  
Differentiation of 
embryonic cells -2.04 
Morphology of 
connective tissue -1.63 
Quantity of 
lymphocytes -1.94 
  
Sensitivity of cells -2.13 
Interphase of 
fibroblasts -1.52 
Quantity of 
leukocytes -1.92 
  
Delay in mitosis -2.10 
Chronic 
inflammation -1.67 
Differentiation of 
lymphocytes -1.84 
  
Cell death of 
antigen presenting 
cells -1.94 
Morphology of 
vessel -1.94 
Differentiation of 
mononuclear 
leukocytes -1.83 
  
Apoptosis of 
antigen presenting 
cells -1.81 
  
Differentiation of 
embryonic cells -2.45 
  
Cell death of 
macrophages -1.54 
  
Differentiation of 
cells -2.17 
  
Quantity of mitotic 
spindle -1.71 
  
Development of 
connective tissue -2.08 
  
Binucleation of 
cells -1.66 
  
Differentiation of 
connective tissue 
cells -1.87 
  
Bone marrow 
cancer -1.77 
  
Organization of 
cytoplasm -1.86 
    
  
Organization of 
cytoskeleton -1.86 
    
  
Delay in initiation of 
M phase -1.80 
    
  
Development of 
cardiovascular 
system -1.82 
    
  
Development of 
bone marrow -1.81 
    
  
Development of 
bone marrow cells -1.80 
    
  
Lymphopoiesis -1.76 
    
  
Development of 
lymphatic system 
component -1.71 
    
  
Differentiation of 
hematopoietic 
progenitor cells -1.66 
    
  
Differentiation of 
blood cells -1.62 
    
  
Development of 
blood cells -1.50 
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Cell death of 
fibroblast cell lines -1.74 
    
  
Formation of 
mitotic spindle -1.73 
    
  
Senescence of 
fibroblasts -1.64 
    
  
Apoptosis of 
fibroblast cell lines -1.62 
    
  
Senescence of 
fibroblast cell lines -1.55 
    
 
 
 The most relevant cluster that showed the highest activation score on SLA 
surface in 3 hours vs. base-line comparison was “differentiation of cells” (z=4.26), 
whereas “transactivation” was the most relevant cluster on SMO surface (z=3.56). 
Several clusters related to nucleic acid processing, gene expression and protein 
metabolism were seen to be activated on SLA and SMO surfaces within 3 hours of 
exposure. Clusters related to cell differentiation (including differentiation of 
osteoblasts and connective tissue cells) were also observed as activated on both SLA 
and SMO surfaces. The SLA surface demonstrated activation of several clusters 
related to development of vascular networks and stimulation of blood cell formation 
in 3 hours. The SMO surface also showed activation of some clusters related to 
differentiation of endothelial and blood cells. However, the SMO surface was also 
seen to activate the "apoptosis of hematopoietic cell lines” (z=1.65). Clusters related 
to cytoplasmic organization and cell cycle were activated on SMO surfaces.  Clusters 
relevant to bone formation and skeletogenesis (congenital anomaly of skeletal bone, 
congenital anomaly of musculoskeletal system and craniofacial abnormality) were 
seen to be activated on SLA surface (24 hours vs. 3 hours). The same clusters were 
observed as inhibited in the 3 hours vs. base-line comparison on SLA surface. No 
such clusters were seen to be regulated on the SMO surfaces either at 3 hours or in 
the 24 hours vs. 3 hours comparison. Chromosomal associations and organization 
clusters were seen to be activated on both SLA and SMO surfaces after 3 hours (24 
hours vs. 3 hours). Cell cycle related clusters were activated on both SLA and SMO 
surfaces in both comparisons. “Morphology of hematopoietic progenitor cells” 
(z=2.22), “formation of neointima” (z=1.94) and “morphology of lymphatic system 
components” (z=1.72) clusters were activated on SLA at 24 hours (24 hours vs. 3 
hours comparison). The cluster “formation of vessel component” (z=2.36), was 
found to be activated on the SMO surface in the 24 hours vs. 3 hours comparison.  
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 A few numbers of clusters were seen to be inhibited on both SLA and SMO 
surfaces at 3 hours. Most of the clusters inhibited were related to cellular death and 
failure of growth. One cluster, “chronic inflammation” (z=-1.67) was inhibited on the 
SLA surface after 3 hours. Several clusters related to quantity of blood cells and 
differentiation and development of the cardiovascular system were inhibited on the 
SLA surface as observed in the 24 hours vs. 3 hours comparison. The SMO surface 
was found to inhibit several pathways related to DNA processing and defense cells 
(antigen presenting cells and macrophages). 
4.3.6 Up-stream regulators 
 The IPA analysis was used to explore the list of potential upstream regulators 
with predicted activation scores (z-scores). Genes with predicted activation (z-
score>0) or inhibition (z-score<0) were further screened for their fold changes in the 
available data-set. Table 4-5 shows the list of genes (described as “correlated 
upstream regulators” henceforth) whose expression patterns (fold changes) positively 
correlated with their activation scores as predicted by IPA (upregulation for 
activation and downregulation for inhibition). Although, there were no correlated 
upstream regulators when SLA was compared to SMO after 3 hours; however, 
NUPR1 (Nuclear Protein, Transcriptional Regulator, 1) upstream regulator was 
predicted as activated (z-score=2.0). The SLA vs. SMO comparison at 24 hours 
revealed 8 correlated upstream regulators (6 activated and 2 inhibited). NUPR1 was 
observed as the gene showing highest activation z-score (3.8). The fold change for 
this gene was 3.4 (SLA vs. SMO at 24 hours). BMP2 and RUNX2 were amongst the 
8 correlated upstream regulators (predicted as activated).  
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Table 4-5:  Upstream regulators showing similar trends for activation z-scores and fold changes on SLA and SMO surfaces (SLA vs. SMO comparisons at 3 hours did not 
reveal any such upstream regulator) (IPA analysis of microarray data). 
(A) Activated 
SLA vs. SMO: 24 hr SLA: 3 hr vs. 0 hr SLA:24 hr vs. 3 hr SMO: 3 hr vs. 0 hr SMO: 24 hr vs. 3 hr 
Regulator z FC Regulator z FC Regulator z FC Regulator z FC Regulator z FC 
               
NUPR1 3.8 3.4 VEGFA 4.5 4.6 E2F1 5.5 3.5 VEGFA 4.2 5.0 E2F1 5.5 4.5 
PTEN 2.0 1.5 HIF1A 3.7 1.2 E2F2 4.1 1.0 EIF4E 3.3 1.8 E2F2 4.0 1.4 
MITF 1.9 1.2 CREM 3.3 7.1 TFDP1 2.0 2.0 CREM 3.2 6.6 FOXM1 3.5 7.3 
SQSTM1 1.9 2.3 TGFB3 2.7 4.6 CHEK1 1.8 2.9 MYC 2.4 4.4 TFDP1 2.2 2.2 
BMP2 1.0 5.7 CYR61 2.6 1.9 CCND3 1.7 5.4 CYR61 2.0 2.2 CCND3 1.7 5.0 
RUNX2 0.7 2.2 MYC 2.5 4.9 DDX58 1.7 10.3 TGFB3 1.9 2.7 COPS8 1.6 1.3 
   
ATF4 2.5 2.3 XIAP 1.6 1.8 ATF4 1.9 2.3 CHEK1 1.5 3.6 
   
AREG/AREGB 2.4 28.9 PLK4 1.6 10.4 MAP2K1 1.8 1.9 SPARC 1.1 1.5 
   
SRF 2.4 2.6 CDKN1B 1.6 5.3 MAPK1 1.5 1.5 FN1 1.1 12.6 
   
MAP2K1 2.2 1.6 CDK2 1.5 5.3 AREG/AREGB 1.5 24.0 CDK2 1.0 5.3 
   
ELAVL1 2.0 2.2 ITGA2 1.4 2.8 FOXO3 1.3 6.1 CDKN1B 1.0 7.5 
   
F2RL1 1.9 6.5 EIF2S1 1.3 1.6 GDNF 1.2 6.5 CKS1B 1.0 2.8 
   
KAT5 1.1 1.4 KIAA1524 1.1 6.0 SRF 1.1 2.8 SKP2 0.9 7.2 
   
WWTR1 1.0 3.4 TOPBP1 1.0 2.4 WWTR1 1.0 2.6 ADAM12 0.9 6.9 
   
ETS1 0.9 13.9 CKS1B 1.0 2.9 S1PR2 0.8 2.8 TYMS 0.8 2.9 
   
NR3C1 0.8 1.4 EIF2AK2 0.9 2.2 RIPK1 0.5 5.3 ATR 0.7 2.6 
   
EGR1 0.7 2.5 COPS8 0.8 1.6 JUNB 0.2 3.9 EGFR 0.5 2.3 
   
TGFB2 0.6 3.6 CCNE1 0.8 2.8 
   
CCNE1 0.3 3.6 
   
FGF1 0.5 3.3 CDK1 0.8 23.9 
      
   
GNB2L1 0.4 3.1 MYBL2 0.2 2.5 
      
   
PTGS2 0.4 4.2 
         
   
JUNB 0.3 4.0 
         
   
FOXO3 0.2 4.2 
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(B) Inhibited 
 
 
SLA vs. SMO: 24 hr SLA: 3 hr vs. 0 hr SLA:24 hr vs. 3 hr SMO: 3 hr vs. 0 hr SMO: 24 hr vs. 3 hr 
Regulator z FC Regulator z FC Regulator z FC Regulator z FC Regulator z FC 
               FAS -0.6 -1.1 DICER1 -0.3 -3.0 ETS1 -0.2 -2.6 CASP8 -0.1 -2.0 PPARD -0.1 -2.6 
FOXM1 -1.8 -2.1 TAF4 -1.8 -2.1 PPARD -0.4 -2.3 KIAA1524 -1.7 -1.6 RASSF5 -0.1 -2.5 
      
SMAD3 -0.5 -2.0 
   
RHOB -0.2 -2.4 
      
KITLG -0.6 -1.8 
   
ETS1 -0.2 -2.8 
      
CEBPB -0.6 -2.5 
   
CEBPB -0.5 -3.5 
      
FOXO3 -0.7 -2.8 
   
MXI1 -0.6 -2.4 
      
VGLL3 -0.8 -3.0 
   
GNB2L1 -0.6 -2.3 
      
ATF6 -0.9 -1.7 
   
INHBA -0.8 -3.7 
      
ST8SIA1 -1.0 -7.3 
   
PIM1 -0.8 -3.9 
      
FGFR1 -1.0 -1.7 
   
PPARG -0.9 -6.9 
      
REL -1.0 -3.5 
   
PRKCE -0.9 -2.0 
      
NR3C1 -1.2 -3.5 
   
LGALS3 -0.9 -1.5 
      
VEGFA -1.4 -2.1 
   
SPRY2 -1.0 -4.9 
      
PIM1 -1.5 -4.1 
   
RND3 -1.0 -1.3 
      
PPARG -1.6 -7.1 
   
SAT1 -1.0 -4.8 
      
ATF3 -1.7 -5.2 
   
IGF1R -1.0 -2.9 
      
TGFB3 -1.8 -5.4 
   
KITLG -1.1 -1.9 
      
F2RL1 -1.9 -4.9 
   
EGR2 -1.2 -3.8 
      
ITGB1 -2.2 -13.2 
   
VEGFA -1.3 -3.0 
      
CDKN1A -2.4 -2.4 
   
F2RL1 -1.5 -5.2 
      
CREM -2.8 -4.5 
   
NR3C1 -1.5 -2.5 
      
TCF3 -3.1 -1.9 
   
TGFB3 -1.6 -2.7 
            
PTEN -1.9 -1.7 
            
PPRC1 -1.9 -2.9 
            
BAG1 -2.0 -2.2 
            
FOXO3 -2.6 -2.5 
            
CREM -2.6 -4.7 
            
CDKN1A -2.7 -2.9 
            
ATF4 -3.2 -2.8 
            
NUPR1 -9.4 -7.4 
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 Time-course analysis (3 hours vs. base-line and 24 hours vs. 3 hours 
comparisons) was also performed on both of the surfaces. The 3 hours vs. base-line 
(0 hour) comparison revealed VEGFA, CREM, TGFB3, CYR61, MYC, ATF4, 
AREG/AREGB, SRF, MAP2K1, WWTR1, JUNB and FOXO3 among the correlated 
upstream regulators on both SLA and SMO surfaces (3 hours vs. base-line). HIF1A, 
ELAVL1, F2RL1, KAT5, ETS1, NR3C1, EGR1, TGFB2, FGF1, GNB2L1 and 
PTGS2 were only seen on SLA surface and EIF4E, MAPK1, GDNF, S1PR2 and 
RIPK1 were observed on SMO after 3 hours of exposure. The 24 hours vs. 3 hours 
comparisons on both SLA and SMO surfaces showed E2F1, E2F2, TFDP1, CHEK1, 
CCND3, CDKN1B, CDK2, CKS1B, COPS8 and CCNE1 as common activated 
upstream regulators. DDX58, XIAP, PLK4, ITGA2, EIF2S1, KIAA1524, TOPBP1, 
EIF2AK2, CDK1 and MYBL2 were seen as activated only on SLA surface (and not 
on SMO) when 24 hours expression was compared with 3 hours. FOXM1, SPARC, 
FN1, SKP2, ADAM12, TYMS, ATR and EGFR were observed as activated on SMO 
only (and not on SLA) upon 24 hours vs. 3 hours comparisons.  ETS1, PPARD, 
KITLG, CEBPB, FOXO3, NR3C1, VEGFA, PIM1, PPARG, TGFB3, F2RL1, 
CDKN1A and CREM were genes found to be inhibited on both SLA and SMO 
surfaces on the 24 hours vs. 3 hours comparison. The molecules SMAD3, VGLL3, 
ATF6, ST8SIA1, FGFR1, REL, ATF3, ITGB1 and TCF3 were inhibited only on 
SLA surface, while RASSF5, RHOB, MXI1, GNB2L1, INHBA, PRKCE, LGALS3, 
SPRY2, RND3, SAT1, IGF1R, EGR2, PTEN, PPRC1, BAG1, ATF4 and NUPR1 
were inhibited on SMO surfaces (24 hours vs. 3 hours). 
4.4 DISCUSSION 
 Per-Ingvar Brånemark’s discovery of the phenomenon of osseointegration in 
the late 1950s [21], heralded the drive to use titanium implants for restoring 
structural parts of the body. This also led researchers to start investigating implant 
design modifications that may have superior osseointegrative properties. In 1991, 
Buser et al. reported a positive correlation between implant micro-roughness and 
osseointegration, when they demonstrated superior osseointegration on SLA surfaces 
compared with electropolished and sand-blasted, medium-grit surfaces [1]. Ever 
since then, the improved osseointegrative property of micro-roughened titanium 
surfaces, like SLA has been a subject of intense research over the past few years and 
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several studies have validated the findings in terms of expression of osteogenic genes 
and markers [22-25].  
 The phenomenon of osseointegration is dependent on the process of 
osteogenic differentiation. Micro-roughened implant surfaces, like the SLA surface, 
by virtue of their property of “contact osteogenesis” [6], provide us with an in vitro  
substrate akin to the physiological micro-rough osteogenic niche. Several groups 
have been investigating the molecular mechanisms involved in the superior 
osseointegrative properties of micro-roughened surfaces compared with smooth 
surfaces. Superior osteogenic effects of micro-roughened surfaces have been 
substantiated in this report as well (Figure 4-1). Investigating the molecular 
dynamics of osteoprogenitor and osteoblast cells on SLA surfaces, and comparing 
them with the expression patterns on polished titanium (SMO) at the same instance, 
allow us to study the genetic mechanisms involved in the process of osteogenic 
differentiation and osseointegration. A time-course analysis of the gene expression 
pattern on both of the surfaces and a comparative assessment provides an opportunity 
to study the trail of genetic events that make the micro-roughened surface more 
conducive to osteogenic differentiation. Osteogenic differentiation has been 
conventionally known as a process wherein osteogenic cells undergo a series of 
molecular and morphological changes, leading to the formation of a calcified matrix 
and expression of markers like collagen type I, alkaline phosphatase, osteonectin, 
osteopontin, and osteocalcin [26]. However, the early molecular mechanisms that 
lead to these manifestations still remain elusive. Previous reports have described 
differential modulation of genes following early exposure to micro-roughened 
surfaces [2, 3, 9, 27, 28]. In this study, a whole genome microarray expression 
approach was used to ensure a comprehensive capture of the molecular changes in 
BCs following exposure to SLA and SMO titanium surfaces. To assess the time-
course of changes on SLA and SMO surfaces, the study included microarray based 
gene expression analyses at three time-points: base-line (or 0 hour-before exposure to 
either SLA or SMO surfaces), 3 hours and 24 hours.  
 Analysis of the microarray gene expression profiles on SLA and SMO 
surfaces and the comparisons between them at 3 hours and 24 hours showed a 
cascade of gene modulations resulting in upregulation and downregulation of several 
genes at both of the time-points. The GO clusters belonging to “biological processes” 
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domain were enriched between SLA and SMO surfaces at both 3 and 24 hours. The 
GO domain “biological processes”, tries to interpret a sequence of molecular 
functions that may lead to a particular biological process. Sixty-five percent of the 
clusters at 3 hours and 57% at 24 hours were categorized in the “biological 
processes” GO domain (SLA vs. SMO). A chain of genetic mechanisms leading to 
different physiological processes are triggered when bone cells are exposed to SLA 
surfaces as documented by Ivanovski et al. [25]. The number of genes differentially 
regulated between SLA and SMO surfaces was seen to increase over the period of 
assessment (between base-line and 3 hours and between 3 and 24 hours), indicating a 
sequential pattern of molecular events that lead to the course of biological processes. 
The genes, Rho GTP-binding protein family (RHOB) and Hermansky-Pudlak 
syndrome 1 (HPS1) were among the top ten genes showing higher expression on 
SLA surfaces compared to SMO after 3 hours exposure. RHOB is known to promote 
angiogenesis [29], cell adhesion of macrophages especially by regulation of integrins 
[30], and platelet activation [31]. It is known to be involved in signal transduction by 
the non-canonical Wnt/Ca
2+
 ligand WNT5A [32]. The Lin-7 Homolog B (LIN7B) 
gene and Kelch-Like Family Member 7 (KLHL7) genes are known to be involved in 
protein metabolism. The LIN7B helps in protein binding, whereas KLHL7 is known 
to assist in protein ubiquitination and degradation [33-35]. Higher expression of 
LIN7B and downregulation of KLHL7 on SLA surfaces (compared to SMO) 
indicates an early promotion of anabolic activity on SLA surfaces. 
 A clearly evident pro-osteogenic response was manifested on the SLA 
surfaces when compared with SMO surfaces, following 24 hours of exposure. The 
bone morphogenetic protein, BMP2 gene was seen to be highly upregulated 
(FC=5.70) on SLA surfaces compared to SMO surfaces at 24 hours (Table 4-2). The 
BMP2 protein was discovered by its ability to induce bone formation ectopically [36, 
37], and stimulation of the TGFβ/BMP pathway is known to be of prime importance 
in osteogenesis [38]. Therefore, higher expression of the BMP2 gene on SLA 
surfaces is a strong indication of the early modulation of pro-osteogenic cell 
signaling on these surfaces. Besides, the simultaneous upregulation of RUNX2 on 
SLA surfaces at 24 hours (FC=2.2), together with a positive activation z-score, 
strengthens our proposition. The gene showing highest upregulation on SLA surfaces 
(compared to SMO) at 24 hours was FBJ murine osteosarcoma viral oncogene 
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homolog B (FOSB) (FC=7.52). Overexpression of DeltaFOSB is known to increase 
osteoblastogenesis [39]. Regulator of Cell Cycle (RGCC) and C8orf4 were also seen 
to be upregulated on SLA (compared with SMO) after 24 hours. RGCC is known to 
be a negative regulator of angiogenesis and cytokine secretion [40, 41]. Higher 
expression of RGCC after 24 hours indicates a shift in the molecular processes from 
a pro-angiogenic phase (as observed at 3 hours time-point) to a pro-osteogenic phase. 
RGCC gene is also known to help in collagen synthesis [42], and thereby initiates the 
foundation of the mineralized matrix. Analysis of the functional clusters and 
upstream regulators also point towards the same phenomenon. Clusters related to 
“development of blood cells” and “differentiation of connective tissues” were 
repressed between 24 hours and 3 hours. The time-course analysis pattern also 
described similar findings. Clusters related to skeletogenesis were upregulated on 
SLA surfaces (24 hours vs. 3 hours on SLA) (Table 4-4). No such clusters were seen 
on the SMO surfaces. In fact, the first organogenesis cluster enriched using gene 
ontology analysis with DAVID was related to endochondral ossification, bone and 
skeletal development when gene expression between SLA and SMO at 24 hours was 
compared. The relevant genes differentially expressed between SLA and SMO 
surfaces and their correlation with the GO skeletal tissue development terms are 
shown in Figure 4-6. 
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Figure 4-6: 2D view of associations between genes differentially regulated on SLA (compared with 
SMO) and GO terms related to skeletal and bone formation (DAVID analysis – SLA vs. SMO 
following 24 hours of culture of osteoprogenitor cells). 
 
Cell signaling pathways together with cytoskeletal organization, cell 
proliferation and cell survival pathways seem to be modulated early on the SLA 
surface. C8orf4, a gene known to be a positive regulator of the Wnt pathway was 
upregulated on the SLA surface at 24 hours [43]. Increased response of the 
TGFβ/BMP pathway was demonstrated by the higher expression of BMP2.  Integrin-
α2 (ITGA2) was one of the upstream regulators found to be activated on SLA (24 
hours vs. 3 hours) and not on the SMO surface. ITGA2, is a key integrin molecule 
that is known to play an important role in osteogenesis on SLA surfaces through a 
WNT5A mediated response [44]. Another integrin molecule, Integrin-β1 (ITGB1) 
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was however found to be inhibited between 24 hours and 3 hours on SLA surfaces. 
Previous studies have reported an increased expression of ITGB1 on modified 
titanium surfaces [8, 44]; however, the interpretations in these studies have been 
based on comparison of modified surfaces with smooth surfaces and not as a time-
course pattern. Moreover, micro-topography mediated increase of ITGB1 is known 
to be obliterated by ITGA2 knock-downs indicating a greater role of ITGA2 than 
ITGB1 [45]. Clusters related to microtubule organization and motor activities were 
enriched between SLA and SMO surfaces at 24 hours. We further evaluated whether 
there was a tendency towards upregulation/downregulation of the genes for such 
processes. The differentially regulated genes belonging to the GO categories 
“microtubule cytoskeleton, cytoskeleton and microtubule motor activity” were 
extracted from the list and assigned a score of either +1 (if upregulated on SLA) or -1 
(if downregulated on SLA) and a sum was calculated. A net negative sum was 
observed for all the clusters. A possible inhibition of microtubular and cytoskeletal 
changes correlated with the pro-osteogenic response.  
 Activation of E2F1 and E2F2 genes was observed on both SLA and SMO 
surfaces (24 hours vs. 3 hours). The E2F transcription factors are responsible for 
cells to enter the S phase of cell cycle and thereafter undergo division [46]. Cellular 
development, proliferation and cell cycle related pathways were activated on both 
SLA and SMO surfaces over the time-course. Proliferation and cell cycle are integral 
part of the developmental process and are known to be important particularly in the 
early phase of development as seen in embryonic cells [47]. The transcription factor, 
ETS1 which is known to be expressed in dividing preosteoblastic cells was 
potentially inhibited on both of the SLA and SMO surfaces (24 hours vs. 3 hours) 
suggesting a shift towards maturation and differentiation of osteoprogenitor cells on 
both of the surfaces [48]. The co-inhibition of the pro-adipogenic PPARG indicates 
the same. However, the inhibition of PPARD, which is known as an inhibitor of 
PPARG activity [49] was also observed. This could possibly indicate a modulatory 
effect striking a balance between the different biological pathways. 
 The 3 hours assessments between SLA and SMO surfaces indicated an early 
activity on the SLA surface that leads to the creation of a pro-osteogenic niche. Gene 
ontology analysis using DAVID showed significant enrichment of clusters 
(enrichment scores ≥1.3) related to nucleic acid processing and mRNA conditioning 
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for signal transduction (Table 4-3). This effect was reflected upon analyzing the 
pattern of gene expression over a time-course: base-line, 3 hours and 24 hours. 
Although activation of clusters related to nucleic acid processing was observed on 
both SLA and SMO surfaces, clusters related to protein metabolism and 
glycosaminoglycans were more highlighted on the SLA surfaces within 3 hours 
indicating a preparatory phase before the actual process of osteogenesis is initiated. 
The SLA time-course analysis revealed several activated clusters related to 
development and differentiation of blood cells and vascularization (Table 4-4) within 
3 hours of exposure. High activation scores for vascular endothelial growth factor A 
(VEGFA) and hypoxia-inducible factor 1-alpha (HIF1A) identified them as the top 
two upstream regulators on SLA (3 hours vs. base-line) surfaces. Interestingly, both 
of the genes were themselves seen as upregulated at 3 hours. Although, VEGFA was 
also seen as the top upstream regulator on SMO surface; however, HIF1A wasn’t 
evident. Hypoxia inducible factors (HIFs) have been recently identified as key 
components inducing VEGFs and angiogenesis and they are known to be important 
for angiogenesis-osteogenesis coupling [50]. Recent research has shown that HIF1A 
expression from osteoblasts promotes blood vessel formation and osteogenesis [51]. 
High activation score coupled with a statistically significant upregulation strengthens 
the pro-angiogenic effects of SLA surface. Implant osseointegration is a process 
similar to any wound healing process. The process is initiated with the preparation of 
the implant bed and insertion of the implant. Blood with all its components (organic 
and in-organic) is the first tissue that interacts with the implant. Among the other 
genes identified as upstream regulators only on SLA surfaces (3 hours vs. base-line) 
were F2RL1, ETS1 and FGF1 and each of them are known to positively regulate 
angiogenic effects [52-54]. 
 The expression of clusters associated with immunological processes (e.g. 
lymphoid tissue structure and development, humoral cell trafficking, immune cell 
trafficking and cell mediated immune response, see Figure 4-4) was significantly 
higher on SLA surfaces than SMO surfaces at 3 hours. Immunological responses and 
inflammatory modulators are known to be of prime importance in bone healing and 
repair after a fracture. As mentioned before, implant insertion and osseointegration 
process is very similar to the process of fracture healing and the in vivo peri-implant 
hematoma is analogous to the fracture-hematoma [55]. Immunomodulatory factors 
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found in peri-implant hematoma are believed to be important for initiating a cascade 
of reactions leading to the migration of mesenchymal stem cells and osteoprogenitor 
cells towards the site of bone repair [55]. However, the immediate expression of 
immunomodulatory clusters in osteoprogenitor cells as observed on SLA surfaces 
indicates a larger role beyond the initial recruitment of osteogenic cells. Such 
molecules and their signaling networks possibly prepare the niche for the initiation of 
an osteogenic response, which was evident after 24 hours of exposure. This concept 
is further strengthened by the inhibition of “chronic inflammatory” cluster as 
observed on SLA surface (3 hours vs. base-line) suggesting stimulation of an acute 
immunomodulatory response in concert with suppression of chronic inflammation. 
4.5 CONCLUSION 
 A complex sequence of biological responses occur upon exposure of 
osteogenic cells to micro-roughened SLA surfaces and this eventually leads to the 
improved osteogenic differentiation in vitro and osseointegration in vivo. This study 
aimed to explore the early changes in alveolar bone-derived osteoprogenitor cells 
following exposure to SLA surfaces and comparing them with SMO surfaces, with 
intent to divulge the events that lead to improved osteogenic properties. The initial 
time-point of comparison (3 hours) revealed a pro-angiogenic and 
immunomodulatory response on the SLA surface, that wasn’t observed on the SMO 
surface. Our results also demonstrated an early pro-osteogenic response on the SLA 
surface compared to SMO surfaces (24 hours). The initial cascade of gene 
modulation potentially lays the foundation for the pro-osteogenic niche provided by 
the SLA surface and this response starts immediately post-exposure to the surfaces. 
The findings from the study elaborate the biological relevance of studying the 
immediate and early cellular response to micro-roughened titanium implant surfaces. 
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Abstract 
Topographically and chemically modified titanium implants are recognized to 
have improved osteogenic properties; however, the molecular regulation of this 
process remains unknown. This study aimed to determine the microRNA profile and 
the potential regulation of osteogenic differentiation following early exposure of 
osteoprogenitor cells to sand-blasted, large-grit acid-etched (SLA) and hydrophilic 
SLA (modSLA) surfaces. Firstly, the osteogenic characteristics of the primary 
osteoprogenitor cells were confirmed using ALP activity and Alizarin Red S 
staining. The effect of smooth (SMO), SLA and modSLA surfaces on the 
TGFβ/BMP (BMP2, BMP6, ACVR1) and non-canonical Wnt/Ca2+ (WNT5A, FZD6) 
pathways, as well as the integrins ITGB1 and ITGA2, was determined. It was 
revealed that the modified titanium surfaces could induce the activation of 
TGFβ/BMP and non canonical Wnt/Ca2+ signaling genes. The expression pattern of 
microRNAs (miRNAs) related to cell differentiation was evaluated. Statistical 
analysis of the differentially regulated miRNAs indicated that 35 and 32 miRNAs 
were down-regulated on the modSLA and SLA surfaces respectively, when 
compared with smooth surface (SMO). Thirty-one miRNAs that were down-
regulated were common to both modSLA and SLA. There were 10 miRNAs up-
regulated on modSLA and 9 on SLA surfaces, amongst which eight were the same as 
observed on modSLA. TargetScan predictions for the down-regulated miRNAs 
revealed genes of the TGFβ/BMP and non-canonical Wnt/Ca2+ pathways as targets. 
This study demonstrated that modified titanium implant surfaces induce differential 
regulation of miRNAs, which potentially regulate the TGFβ/BMP and Wnt/Ca2+ 
pathways during osteogenic differentiation on modified titanium implant surfaces. 
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5.1 INTRODUCTION 
Titanium has long been considered the preferred material for implants in 
dentistry and orthopedics owing to its physical, chemical and biocompatibility 
features. Increasing clinical use of implants has necessitated the need for improved 
healing, especially in sites where bone quality and quantity is less than ideal. Surface 
topography and chemistry have been shown to be important factors influencing the 
osteogenic properties of implant surfaces [1, 2].  
Micro-roughened surfaces such as the widely studied sand-blasted, large grit, 
acid-etched (SLA) titanium surfaces, potentially mimic the micro-rough biological 
bone tissue environment. The activities and characteristics of progenitor cells are 
influenced by their interaction with the implant surfaces [3]. Chemical modification 
of SLA, resulting in a hydrophilic surface (modSLA), has been shown to further 
improve osteogenic differentiation in vitro and osseointegration in vivo [4-11]. 
Investigation of the underlying molecular mechanisms responsible for the enhanced 
osteogenic properties of modified surfaces has been the focus of significant recent 
attention, and in vivo and in vitro gene expression studies have revealed differences 
in osteogenesis associated gene expression in response to SLA and modSLA  [12-
16]. Furthermore, studies investigating the associated biological mechanisms suggest 
that the TGFβ/BMP and Wnt signaling pathways are triggered early in the 
interaction between osteoprogenitors and implant surfaces [2, 13, 14, 17]. However, 
the detailed molecular mechanisms that regulate osteogenesis on these surfaces are 
still elusive and require further investigation.  
The activation and de-activation of key regulatory genes is crucial to the 
process of differentiation of progenitor cells. Micro-RNAs (miRNAs) have been 
shown to influence the pattern of gene expression by translational repression and 
gene silencing [18] and are vital regulators of the differentiation process [19]. 
MiRNAs have been found to be critical in the development of organisms and show 
differential expression profiles in different tissues [20]. It is believed that 40-70% of 
human genes are under the regulation of miRNAs [21]. Recent studies have 
identified the role of several miRNAs as regulators of a variety of osteogenic genes, 
including transcription factors, signaling molecules and their receptors [22].  
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The expression of miRNAs has not been investigated in relation to the 
modulation of osteogenic gene expression by the SLA and modSLA surfaces. 
Therefore, the present study aimed to compare the early pattern of expression of a 
panel of miRNAs associated with human cell development and differentiation in 
osteoprogenitor cells cultured on three titanium implant surfaces (modSLA, SLA and 
smooth polished) and assesses their prospective regulation of the initial molecular 
interactions on modified titanium implant surfaces. 
5.2 MATERIALS AND METHODS 
5.2.1 Titanium discs 
This study utilized discs (15 mm in diameter and 1 mm in thickness) of grade 
II commercially pure titanium which were supplied by Institut Straumann (Basel, 
Switzerland). Three different surfaces were studied – smooth polished (SMO), SLA 
and modSLA. The SLA surface modification was obtained by blasting the SMO 
surface with 250-500 µm corundum grit and acid etching with a hot solution of 
hydrochloric/sulfuric acids (Sa, arithmetic mean deviation of the surface=1.8 µm). 
The modSLA surface was obtained by rinsing the SLA discs under N2 protection and 
stored in an isotonic saline solution at pH 4-6. The surface topography for modSLA, 
SLA and SMO was visualized using Atomic Force Microscopy (AFM) (JPK 
Instruments AG, Berlin, Germany) as shown in Figure 5-1. The rms roughness 
values for modSLA, SLA ranged between 1.6 and 2.1 µm and SMO was between 
0.006-0.009 µm. 
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Figure 5-1: AFM visualization of surface topography of (A) modSLA, (B) SLA and (C) SMO. 
 
5.2.2 Cell culture 
Primary human osteoprogenitor cells established from redundant alveolar bone 
tissues obtained following third molar extraction surgery as previously described 
[23], were cultured in Dulbecco's Modified Eagle's Medium (DMEM) (Invitrogen, 
Mt Waverley, VIC, Australia) supplemented with 10% fetal bovine serum (FBS) 
(Thermo, In Vitro Technologies, Nobel Park, VIC, Australia) and antibiotics (100 
U/ml penicillin/100 μg/ml streptomycin).  
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The cells were confirmed as osteoprogenitors by characterizing their 
osteogenic differentiation potential. Briefly, the cells were seeded at a density of 5 × 
10
4
 cells/well in 24-well tissue culture plates and osteogenic differentiation was 
induced by supplementing the culture media with 100 nM dexamethasone, 0.2 mM 
L-ascorbic acid and 10 mM β-glycerophosphate for 21 days. Intracellular ALP 
activity was determined with the Quantichrom™ Alkaline Phosphatase Assay Kit 
(Gentaur Belgium BVBA, Kampenhout, Belgium), a p-nitrophenyl phosphate (pNP-
PO4) based assay. Briefly, the cells were rinsed twice with PBS, and lysed in 500µl 
of 0.2% Triton X-100 in MilliQ water, followed by 20 minutes agitation at room 
temperature. A 50 µl sample was then mixed with a 100 μl working solution and 
absorbance was measured after 5 min at 405 nm in a microplate reader. Extracellular 
matrix deposition was determined by fixing the cells in 4% paraformaldehyde and 
staining with a 1% Alizarin Red S solution.  
Following characterization, the osteoprogenitor cells were seeded at a density 
of 5 × 10
4
 cells/titanium disc placed in 24 well tissue culture plates (BD Falcon, 
North Ryde, NSW, Australia) and incubated in non-osteogenic media. The cells were 
allowed to interact with the surfaces for 24 hours. After 24 hours of incubation, the 
media was removed and the discs were washed with Phosphate buffered saline (PBS) 
once. They were subsequently processed for extraction of miRNAs. 
5.2.3 RNA isolation 
After 24 hours of incubation on the three titanium surfaces, the cells were 
washed with PBS and lysed using QIAzol lysis reagent (Qiagen Pty Ltd, Doncaster, 
VIC, Australia). Total RNA (including miRNA fraction) was isolated using the 
miRNeasy mini kit (Qiagen Pty Ltd, Doncaster, VIC, Australia) as per the 
manufacturer’s instructions. The kit allows purification of all RNA molecules with a 
minimum size threshold of 18 nucleotides, and is therefore suitable for analysis of 
both mRNA and miRNA expression. RNA integrity and concentration was measured 
using RNA 6000 Nano Chips and the Agilent Bioanalyzer 2100 System (Agilent 
Tech Inc., Santa Clara, USA).  
5.2.4 Quantitative real-time PCR 
cDNA was prepared from 1µg RNA templates by reverse transcription using 
DyNAmo
TM
 cDNA Synthesis Kit (Finnzymes Oy., Vantaa, Finland) according to the 
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manufacturer’s protocol. The mRNA expression of BMP2, BMP6, ACVR1, FZD6, 
WNT5A, ITGB1, and ITGA2 was investigated after 24 hours of culture on the 
different titanium discs. Primers were obtained from GeneWorks Pty Ltd 
(Hindmarsh, SA, Australia) and are summarized in Table 5-1.  Quantitative real time 
PCR (qPCR) reactions were performed using the ABI Prism 7000 Sequence 
Detection System (Applied Biosystems). The system enables direct detection of PCR 
products by measuring the increase in fluorescence caused by the binding of SYBR 
Green dye to double-stranded (ds) DNA. The reactions were incubated at 95 °C for 
10 minutes; and then 95 °C for 15 seconds and 60 °C for 1 minute for 40 cycles. 
PCR reactions were validated by observing the presence of a single peak in the 
dissociation curve analysis. The housekeeping gene glyceraldehyde-3-phosphate-
dehydrogenase (GAPDH) was used as an endogenous reference gene for analysis 
using the Comparative Ct (Cycle of threshold) value method. 
Table 5-1: Primer sequences used for real-time PCR analysis of gene expression. 
 
Gene name  Forward primer  Reverse primer  
   BMP2  CGCAGCTTCCACCATGAAGAATC  CCTGAAGCTCTGCTGAGGTG  
BMP6  CAGGAGCATCAGCACAGAGAC  GCTGAAGCCCCATGTTATGCTG  
ACVR1  AGTCATGGTTCAGGGAAACGG  ACCACAGCTGGGTACTGGAG  
FZD6  GCGGAGTGAAGGAAGGATTAG  ACAAGCAGAGATGTGGAACC  
WNT5A  TCTCAGCCCAAGCAACAAGG  GCCAGCATCACATCACAACAC  
ITGB1  GCCTGTTTACAAGGAGCTGAA  CTGACAATTTGCCGTTTTCC  
ITGA2  CAAGGCTGGTGACATCAGTTG  CAGGAAGCAGTTCTGCAGTTC  
GAPDH  TCAGCAATGCCTCCTGCAC  TCTGGGTGGCAGTGATGGC  
 
5.2.5 Real-time PCR-based miRNA expression profiling 
The expression profile of 88 miRNAs known to be associated with different 
stages of development, from stem cells to terminal differentiation, was assessed 
using the Human Cell Development & Differentiation miRNA PCR Array 
(SABiosciences, Frederick, Maryland, USA). The full list of miRNAs included on 
this·array·is·available·at·http://www.sabiosciences.com/mirna_pcr_product/HTML/
MAH-103A.html. For real time PCR amplification, 0.5µg of total RNA was initially 
used to convert miRNAs into first strand cDNA by using the RT
2
 miRNA First 
Strand Kit (SABiosciences, Frederick, Maryland, USA) as per the manufacturer’s 
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protocol. Real time PCR was subsequently performed using the RT
2
 SYBR Green 
qPCR Master Mix (SABiosciences, Frederick, Maryland, USA) and the ABI 7900 
Sequence Detection System (Applied Biosystems). The reactions were incubated at 
95 °C for 10 minutes for 1 cycle, and then 95 °C (15 seconds), 60 °C (for 30 
seconds) and 72 °C (for 30 seconds) for 40 cycles. PCR reactions were validated by 
observing the presence of a single peak in the dissociation curve analysis. The 
miRNA expression was normalized using the endogenous references: SNORD47, 
SNORD44, and RNU6-2.  
In order to identify potential targets for the differentially regulated miRNAs, 
computational predictions were performed using the online tool TargetScan [24]. The 
predictions are based on the identification of potential miRNA binding sites in the 
mRNA 3’ UTR region and thereby assigning a context score. TargetScan enables 
classifying a particular miRNA (within a miRNA family) with the lowest total 
context score as the “representative miRNA” for a target. To increase the probability 
of the target prediction we have specifically considered the representative miRNAs 
for the purpose of analyses in this study. As microRNAs function by translational 
repression or gene silencing, miRNAs potentially targeting genes associated with 
osteogenic differentiation should be down-regulated during the differentiation 
process. Therefore, the predicted targets for down-regulated miRNAs were further 
screened for genes colligated to the osteogenic differentiation process, and in 
particular the TGFβ/BMP and non-canonical Wnt/Ca2+ pathways, which have been 
shown to be regulated by titanium surface modification [2, 13, 14]. 
For the miRNA/mRNA expression, any sample having Ct values more than 33 
was not included in the analysis. The melting temperature of all the miRNAs were in 
the range 74-77.5 °C. The arrays used also had positive control miRNA and they had 
similar dissociation curves and melting temperatures. The melting temperatures for 
mRNAs analyzed were in the range 75.5 to 81.8 °C. 
5.2.6 Statistical analysis 
The experiments were carried out in triplicates. The relative levels of 
expression of mRNAs and miRNAs were compared between the cells cultured on 
modSLA, SLA and polished titanium discs using Student’s t test. The ΔCT value was 
obtained by subtracting the average Ct value of the endogenous references selected 
from the test mRNA or miRNA Ct value of the same samples. The ΔΔCT was 
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determined by subtracting the ΔCT of the control sample from the ΔCT of the target 
sample. The relative mRNA or miRNA quantification of the target gene was 
calculated by 2
-ΔΔCT
. Down-regulated miRNA values were calculated as the negative 
reciprocal of the 2
-ΔΔCT
 score. A value of p<0.05 was considered significant. 
5.3 RESULTS 
5.3.1 Osteogenic potential of primary human osteoprogenitor cells 
There was a significant increase in the ALP activity of the cells cultured with 
osteogenic differentiation media as compared to standard media (Figure 5-2A). The 
osteogenic culture media also induced positive Alizarin Red S staining (Figure 5-
2B). These assays confirmed that the primary alveolar bone derived cell cultures 
contain efficient osteoprogenitor cells. 
 
Figure 5-2: Osteogenic differentiation of alveolar bone-derived osteoblasts (n=3): (A) ALP activity 
observed after 21 days of culture in osteogenic media was significantly increased compared with the 
culture in growth media; (B) Osteoprogenitor cells after 21 days of culture in osteogenic media 
showed positive staining with Alizarin Red S. 
5.3.2 Effect of surface topography and hydrophilicity on the expression of 
BMP2, BMP6, ACVR1, FZD6, WNT5A, ITGB1, and ITGA2 
Previous studies showed that BMP2, BMP6, ACVR1, FZD6, WNT5A were 
differentially expressed by osteoprogenitor cells cultured on modSLA, SLA and 
SMO surfaces [13, 15]. In this study, the expression of BMP2, BMP6, ACVR1, 
FZD6, WNT5A, ITGB1, and ITGA2 was measured after 24 hours of culture on 
modSLA, SLA and SMO. A consistent pattern of expression was found for all of the 
genes under investigation with the highest level of expression found in response to 
modSLA, followed by SLA and SMO. BMP2, BMP6, ACVR1 and FZD6 were 
significantly up-regulated on the modSLA surface compared to the SMO surface. 
BMP6 was also significantly increased on the SLA compared with the SMO surface, 
whereas ACVR1 had significantly higher expression on modSLA compared with 
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SLA. WNT5A, ITGB1 and ITGA2 also showed up-regulation on the modified 
surfaces, although this was not statistically significant (Figure 5-3). 
 
Figure 5-3: Fold-change in expression of BMP2, BMP6, ACVR1, WNT5A, FZD6, ITGB1, ITGA2 on 
modSLA and SLA surfaces compared with expression on SMO surface. Relative expression of the 
genes was higher on modSLA and SLA surfaces as compared to SMO after 24 hours of culture (*p < 
0.05, when modSLA and SLA were compared with SMO surface; #p < 0.05, when modSLA was 
compared with SLA surface). 
5.3.3 miRNA expression profile 
Eighty-eight miRNAs associated with stem cell differentiation were studied 
using the Human Cell Development & Differentiation miRNA PCR Array 
(SABiosciences, Frederick, Maryland, USA). The expression of miRNAs on 
modSLA and SLA surfaces were compared with the control SMO surfaces (Figure 5-
4) and the statistically significant changes in expression were considered for 
analyses. In comparison to the SMO surface, 39 miRNAs were significantly down-
regulated and 11 miRNAs were significantly up-regulated (Figure 5-4 A&B) on the 
modSLA surface. Thirty-eight miRNAs were down-regulated and 10 miRNAs were 
significantly up-regulated on the SLA surface (Figure 5-4 C&D). Further systemic 
analysis of the expression profile using stringent criteria (fold change ≤-2.0, p-value 
<0.05) revealed 35 miRNAs down-regulated on the modSLA surface (Table 5-2A) 
 116 The MicroRNA Expression Profiling Study 
and 32 miRNAs were down-regulated on SLA surfaces (Table 5-2A). Similar 
stringent criteria for up-regulation (fold change ≥+2.0, p-value <0.05), revealed 10 
miRNAs to be up-regulated on modSLA (Table 5-2B) and nine miRNAs on SLA 
surfaces (Table 5-2B), each compared to SMO. Notably, 31 miRNAs that were 
down-regulated were common to both modSLA and SLA (miR-215, miR-10a, miR-
125b, miR-1, miR-218, miR-10b, miR-21, miR-126, miR-16, miR-195, miR-146b-
5p, miR-194, miR-7, miR-192, miR-99a, miR-100, miR-125a-5p, miR-137, miR-
146a, miR-424, miR-23b, miR-20b, miR-155, miR-378, miR-20a, miR-132, miR-17, 
miR-26a, miR-134, miR-452, miR-24). The miRNAs down-regulated on modSLA 
only were miR-503, miR-214 (fold change <-2.0), and miR-185 (fold change >-2.0). 
Meanwhile, let-7f (fold change <-2.0) and let-7a (fold change >-2.0) were seen to be 
down-regulated only on SLA. Among the up-regulated miRNAs (fold-change >+2 
and p<0.05), eight were common to both modSLA and SLA (miR-33a, miR-222, 
miR-127-5p, miR-15a, miR-210, miR-130a, miR-22, miR-181a), while let-7i and let-
7b were seen to be more than 2 fold up-regulated only on modSLA, and miR-18b 
was more than 2 fold up-regulated on SLA. A general trend of down-regulation of 
miRNAs was noted on modSLA surface compared with the SLA surface. 18 
miRNAs (miR-106b, miR-22, miR-92a, miR-93, miR-301a, miR-18a, miR-103, 
miR-424, miR-222, miR-18b, miR-345, miR-17, miR-185, miR-128, miR-130a, 
miR-127-5p, let-7g, miR-142-3p) were down-regulated significantly and one miRNA 
(miR-16) was up-regulated significantly on modSLA compared with SLA surfaces; 
however all of the differences were within the twofold threshold (Figure 5-4 E&F). 
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Figure 5-4: Relative miRNA expression profile of human osteoprogenitor cells on modSLA, SLA and 
SMO surfaces after 24 hours of culture: (A) relative expression – modSLA vs. SMO; (B) volcano plot 
– modSLA vs. SMO; (C) relative expression – SLA vs. SMO; (D) volcano plot – SLA vs. SMO; (E) 
relative expression – modSLA vs. SLA; (F) volcano plot – modSLA vs. SLA. The pink line indicates 
twofold change and the horizontal blue line in the graph indicates p-value = 0.05. 
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Table 5-2: miRNAs showing differential expression on different surfaces (modSLA, SLA and SMO) 
after 24 hours of culture. (A) miRNAs down-regulated on modified surfaces – modSLA and SLA 
when compared to SMO (fold change, p-value <0.05); and on modSLA compared to SLA (p-value 
<0.05); (B): miRNAs up-regulated on modified surfaces – modSLA and SLA when compared to SMO 
(fold change, p-value <0.05); and on modSLA compared to SLA. The miRNAs showing differential 
regulation either on modSLA or SLA (but not both) when compared with SMO are highlighted in 
italics. 
 
 
 
(A) 
        
         miRNA ID T-TEST Fold Change  miRNA ID T-TEST Fold Change  miRNA ID T-TEST Fold Change  
 
p value modSLA/SMO 
 
p value SLA/SMO 
 
p value modSLA/SLA 
         miR-503  0.0229 -15.76 miR-215  0.0091 -9.18 miR-18b  0.0376 -1.86 
miR-215  0.0096 -8.65 miR-10b  0.0073 -9.14 miR-92a  0.0087 -1.48 
miR-10a  0.0064 -7.65 miR-125b  0.0009 -7.79 miR-127-5p  0.0039 -1.43 
miR-125b  0.0011 -6.24 miR-126  0.0049 -7.78 miR-185  0.0094 -1.41 
miR-1  0.0172 -6.12 miR-16  0.0009 -7.72 miR-128  0.0281 -1.41 
miR-218  0.0104 -6.00 miR-1  0.0092 -7.53 miR-103  0.0356 -1.40 
miR-10b  0.0127 -5.88 miR-21  0.0006 -7.38 miR-142-3p  0.0031 -1.39 
miR-21  0.0014 -5.72 miR-194  0.0000 -7.06 miR-301a  0.0243 -1.39 
miR-126  0.0077 -5.68 miR-195  0.0010 -7.00 miR-345  0.0044 -1.38 
miR-16  0.0012 -5.55 miR-218  0.0018 -6.50 miR-93  0.0431 -1.38 
miR-195  0.0042 -5.19 miR-10a  0.0189 -6.30 let-7g  0.0064 -1.37 
miR-146b-5p  0.0033 -5.14 miR-146b-5p  0.0028 -6.10 miR-106b  0.0174 -1.35 
miR-194  0.0023 -5.12 miR-125a-5p  0.0029 -6.10 miR-17  0.0339 -1.30 
miR-7  0.0083 -4.98 miR-100  0.0006 -5.93 miR-18a  0.0047 -1.24 
miR-192  0.0027 -4.97 miR-137  0.0004 -5.90 miR-130a  0.0138 -1.24 
miR-99a  0.0019 -4.87 miR-99a  0.0000 -5.38 miR-222  0.0337 -1.22 
miR-100  0.0005 -4.82 miR-192  0.0054 -5.09 miR-22  0.0314 -1.15 
miR-125a-5p  0.0012 -4.81 miR-146a  0.0075 -4.64 miR-424  0.0353 -1.14 
miR-137  0.0027 -4.42 miR-155  0.0052 -4.64 
   miR-146a  0.0129 -4.38 miR-23b  0.0004 -4.31 
   miR-424  0.0014 -4.02 miR-424  0.0015 -4.23 
   miR-23b  0.0029 -3.79 miR-20b  0.0217 -4.03 
   miR-20b  0.0156 -3.76 miR-378  0.0046 -3.75 
   miR-155  0.0158 -3.30 miR-132  0.0030 -3.68 
   miR-378  0.0060 -3.27 let-7f  0.0440 -3.66 
   miR-20a  0.0074 -3.17 miR-7  0.0004 -3.65 
   miR-132  0.0014 -3.05 miR-26a  0.0301 -3.63 
   miR-17  0.0196 -2.93 miR-20a  0.0016 -3.17 
   miR-26a  0.0440 -2.91 miR-134  0.0042 -2.78 
   miR-134  0.0008 -2.82 miR-17  0.0242 -2.71 
   miR-452  0.0340 -2.50 miR-452  0.0264 -2.31 
   miR-214  0.0447 -2.30 miR-24  0.0106 -2.25 
   miR-24  0.0144 -2.21 
      miR-93  0.0050 -2.14 
      miR-92a  0.0105 -2.03 
      
miRNAs down-regulated on modified surfaces – modSLA and SLA when compared to SMO. 
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(B) 
miRNA ID T-TEST Fold Change  miRNA ID T-TEST Fold Change  miRNA ID T-TEST Fold Change  
 
p value modSLA/SMO 
 
p value SLA/SMO 
 
p value modSLA/SLA 
         miR-33a  0.0093 72.89 miR-33a  0.0094 69.65 miR-16  0.0219 1.16 
miR-222  0.0002 5.99 miR-222  0.0004 6.09 
   miR-127-5p  0.0111 4.42 miR-127-5p  0.0088 5.26 
   miR-15a  0.0011 4.01 miR-210  0.0066 3.51 
   miR-210  0.0069 3.31 miR-15a  0.0021 3.40 
   miR-130a  0.0154 2.70 miR-18b  0.0069 3.02 
   let-7b  0.0020 2.62 miR-130a  0.0145 2.79 
   miR-22  0.0093 2.41 miR-22  0.0109 2.29 
   let-7i  0.0363 2.24 miR-181a  0.0160 2.00 
   miR-181a  0.0157 2.16 
      
 
5.3.4 Target predictions for differentially regulated miRNAs 
Target predictions for the differentially regulated miRNAs using the online 
tool, TargetScan [24], revealed several potential targets for these miRNAs. miR-215 
and miR-125b were among the most highly down-regulated miRNAs on both the 
SLA and modSLA surfaces. Osteogenic genes like COL5A1, RUNX1, FOXN1, 
IGF1 were potential targets for miR-215. Similarly, TargetScan also predicted 
SCARB1, MAP2K7, VDR, NCOR2, BMPR1B, SEL1L, SMAD2, SMAD4, 
PPP2CA, COL4A3 genes as possible targets for miR-125b. The miRNAs, miR-503 
and miR-214 were significantly down-regulated on modSLA surface, and not on 
SLA surface (fold change ≤-2.0, p-value <0.05). Notably, several potential 
osteogenic targets were identified for miR-503 (CCND2, CCND1, CCNE1, 
DIXDC1, BTRC, HIPK2, IGF1R, BMPR1A, WNT3A, VEGFA, WNT4, CCND3, 
IGF1, FOSL1, ACVR2A) and miR-214 (CBL, FGFR1, CTNNB1, SENP2, CDH11, 
NOTCH2, NBL1, RUNX1, KREMEN1). TargetScan also predicted a number of 
genes as potential targets for the up-regulated miRNAs and these were screened for 
key inhibitors of osteogenesis. Several inhibitors were found to be targets for the up-
regulated miRNAs, e.g. miR-33a potentially targets CDK6, SMAD7, TWIST1 and 
miR-22 is predicted to target HDAC4. 
Previous studies have reported that the TGFβ/BMP and the non-canonical 
Wnt/Ca
2+
 signaling pathways are involved in the process of differentiation on 
modSLA and SLA surfaces [2, 13, 15]. Therefore, we further explored whether 
genes of the TGFβ/BMP and non-canonical Wnt/Ca2+ pathway were among the 
predicted targets for the down-regulated miRNAs. The Kyoto Encyclopedia of Genes 
Table 5-2B: miRNAs up-regulated on modified surfaces – modSLA and SLA when compared to 
SMO. 
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and Genomes (KEGG) pathway database, which records networks of molecular 
interactions in cells [25] was used to extract the list of genes associated with the 
TGFβ/BMP and non-canonical Wnt/Ca2+ pathways. The list of predicted targets for 
the significantly down-regulated miRNAs was matched for the genes of these 
pathways. Several genes for both the TGFβ/BMP and non-canonical Wnt/Ca2+ 
pathways were identified as potential targets for the miRNAs. The KEGG pathway 
database enables visualizing cell signaling networks as wire diagrams linking related 
genes [26] and therefore we adapted the two pathway maps from the KEGG database 
and listed the miRNAs which may be potential targets for the genes of these 
pathways (Figure 5-5). 
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Figure 5-5: miRNAs down-regulated on modSLA and SLA 
(compared to SMO) as potential regulators of TGFβ/BMP and non-
canonical Wnt/Ca
2+
 pathways for osteogenesis. The potential 
targets for the miRNAs downregulated on modSLA and SLA 
surfaces were screened for genes of the TGFβ/BMP and non-
canonical Wnt/Ca
2+
 pathways. The down-regulated miRNAs that 
are potential regulators of the genes have been listed in oval boxes. 
The colors of the miRNAs correspond with their predicted targets. 
Pathway diagrams are adapted from the KEGG pathway database. 
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5.4 DISCUSSION 
 Topographically modified titanium implant surfaces have been found to have 
improved osteogenic properties [1]. It has also been shown that additional chemical 
modification resulting in increased hydrophilicity leads to improved osseointegration 
in vivo [4, 6] and osteogenic properties in vitro [8-11]. The modSLA and SLA 
surfaces have been shown to have augmented osteogenic lineage commitment and 
differentiation [27]. However, the biological mechanisms responsible for these 
findings are not well elucidated, with TGFβ/BMP and Wnt signaling both implicated 
[2, 13, 15]. Although in vivo studies of gene expression during the osseointegration 
of dental implants have shown that it involves a variety of overlapping biological 
processes including inflammation, osteogenesis, angiogenesis and neurogenesis [12, 
17, 28], bone formation is the key phenotypic variable which is manipulated by 
surface modification, and hence the effect of titanium surface modification on 
osteoblasts and their progenitors has been the subject of considerable attention in the 
literature. To this end, the well characterized SLA surface has emerged as a widely 
used model that is believed to mimic the native microenvironment encountered by 
osteoprogenitor cells in vivo. It has been shown that cells differentiating in response 
to these substrates behave very differently compared with cells that are grown on 
culture plastic and are chemically differentiated using β-
glycerophosphate/dexamethasone. Hence, these surfaces are not only useful as in 
vitro models of clinical relevance to dentistry and orthopedics, but can be used more 
generally as physiologically relevant substrates for the study of important biological 
mechanisms responsible for differentiation along the osteogenic lineage. In this 
study, we report on the influence of surface topography on the expression of 
miRNAs, which are a group of relatively novel molecules which are known to 
regulate gene expression, by osteoprogenitor cells. 
Primary alveolar bone derived cells, rather than an engineered cell line, were 
used in this study in order to more closely replicate a physiologically relevant 
system. The osteogenic potential of the cells was confirmed by enhanced ALP 
expression and Alizarin Red S staining in response to osteogenic media. 
Furthermore, the responsiveness of the osteoprogenitor cells to the different implant 
surfaces was assessed in relation to the expression of a panel of genes (BMP2, 
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BMP6, ACVR1, FZD6, WNT5A, ITGB1 and ITGA2) that have been implicated as 
determinants of the response to surface modification [2, 13, 15]. More specifically, 
the TGFβ/BMP signaling pathway members BMP2, BMP6 and ACVR1 were all 
shown to have increased expression in osteoprogenitor cells using whole genome 
analysis [13]. Similarly, Olivares-Navarrete et al. [14] demonstrated the up-
regulation of the non-canonical Wnt signaling pathway genes WNT5A and FZD6 by 
osteoblasts in response to SLA and modSLA. Finally, the integrin α2β1 has been 
suggested to play an important role in the early response to the modified titanium 
surfaces and our study also found increased expression of ITGB1 and ITGA2 
following exposure to SLA and modSLA [29, 30]. The pattern of expression 
characterized by increased expression on modSLA, followed by SLA and SMO, is in 
agreement with previous reports, confirming that the response of these 
osteoprogenitor cells is consistent with the currently established literature. 
MicroRNAs are known to influence the gene regulation pattern by translational 
repression and gene silencing [18]. We explored the pattern of expression of 88 
micro-RNAs, known to be associated with stem cell differentiation, in well-
characterized primary osteoprogenitor cells following 24 hours exposure to 
modSLA, SLA and SMO titanium surfaces. Several studies have shown that gene 
expression is regulated during the early response to modified surfaces, and as 
regulators of gene expression, the miRNA expression was assessed at this early time-
point. A total of 31 miRNAs were seen to be significantly down-regulated and eight 
miRNAs were found to be up-regulated (beyond twofold change and p-value <0.05) 
on the modified surfaces compared with the polished titanium surfaces. Notably, 
only minor differences were observed on comparing the modSLA with SLA surface. 
This was consistent with the findings of a whole genome analysis comparing the 
response of similar primary osteoprogenitor cells to SMO, SLA and modSLA, 
whereby the magnitude of the difference between either SLA or modSLA and SMO 
were much greater than between SLA and modSLA [13]. 
Osteogenic differentiation has been reported to be regulated by miRNAs in 
various studies [22]. It is interesting to note that several miRNAs identified to be 
differentially regulated on the modified titanium surfaces correspond to findings in 
other studies investigating the effect of miRNAs on osteogenic differentiation. 
Mizuno et al. [31] showed that miR-125b inhibits osteogenic differentiation, and our 
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study also revealed critical down-regulation of this miRNA on modSLA and SLA 
surfaces. miR-16 has been found to be under-expressed in osteogenic differentiation 
[32]. This miRNA was observed to be significantly down-regulated (fold-change <-
5.0) on the modified surfaces. miR-26a has been reported to target SMAD1, and 
osteogenic differentiation of human adipose tissue-derived stem cells (hADSCs) is 
enhanced upon inhibiting miR-26a [33]. miR-1 and miR-21 have been documented 
to regulate myogenic [34] and adipogenic [35] differentiation respectively. These 
were also observed to be under-expressed on modSLA and SLA surfaces. miR-218 
was also seen to be down-regulated in our study. This miRNA potentially targets the 
RUNX2 gene; however, Zhang et al.’s study did not reveal a significant influence on 
osteogenic differentiation by this miRNA [36]. It is likely that a network of miRNAs 
work in synergy in order to influence the differentiation process.  
Implant surfaces like titanium have been predicted to influence osteoblastic 
translational process [37]. Physical and chemical modifications of titanium surfaces 
have been shown to induce differential regulation of miRNAs in osteoblast-like cells 
[38, 39]. Palmieri et al. had demonstrated several miRNAs to be differentially 
regulated in osteoblast-like MG63 (human osteosarcoma cell line) when cultured on 
discs coated with nano-TiO2 (anatase) on titanium surfaces and compared with 
machined grade 3 titanium, suggesting the molecular implications of surface micro- 
and nano-architecture [39]. The results of our study reveal the differential regulation 
of miRNAs as a consequence of modifications to surface chemistry and topography 
of titanium implants. miR-22, miR-93 and miR-17 were among the significantly 
down-regulated miRNAs when modSLA was compared with SLA and these 
miRNAs were also observed to be down-regulated in anatase treated titanium [39]. 
Further, miR-210 was up-regulated on both modSLA and SLA surfaces as seen on 
anatase-treated titanium surfaces [39].  
The findings of this study are in line with previous reports showing the 
influence of titanium surface modification on the differential regulation of several 
genes related to early osteogenic differentiation [13, 40]. In particular, several genes 
of the TGFβ/BMP and non-canonical Wnt pathways were identified as likely targets 
of the miRNAs that were down-regulated in response to the modSLA and SLA 
surfaces. Key genes of the TGFβ/BMP pathway which are likely to be under the 
regulatory control of miRNAs are BMPs, BMPRs and SMADs (Figure 5-5). Several 
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genes of the non-canonical Wnt/Ca
2+
 pathway, like WNT5A, CAMK2 family and the 
NFAT family of transcription factors were also potential targets (Figure 5-5), further 
corroborating with Olivares-Navarrete et al.’s [14] finding that the non-canonical 
Wnt/Ca
2+
 signaling pathway plays an important role in osteoblast maturation on 
these surfaces.  
 In this present study, we identified a number of predicted target genes for the 
differentially regulated miRNAs which were associated with osteogenesis and in 
particular the TGFβ/BMP and non-canonical Wnt pathways. This finding 
corroborates previous reports showing that osteogenic genes are up-regulated on 
modified titanium surfaces [13, 14, 41]. Since these target genes are only predictions, 
these molecular mechanisms need to be validated with further studies. 
5.5 CONCLUSION 
This study shows that the expression profile of microRNAs in osteoprogenitor 
cells is influenced by the exposure to topographically (SLA) and chemically 
(modSLA) modified titanium surfaces. The majority of miRNAs were down-
regulated in response to the SLA and modSLA surfaces compared to the smooth 
surfaces, with only relatively minor changes found between SLA and modSLA. 
These findings were consistent with the previous findings that surface modification 
can influence osteogenic differentiation in vitro and bone formation in vivo. 
Screening of the predicted gene targets for the differentially regulated miRNAs 
revealed several osteogenic genes as potential targets. Several genes of the 
TGFβ/BMP and non-canonical Wnt/Ca2+ pathway were predicted as targets for the 
down-regulated miRNAs. These results indicate that the expression of miRNAs 
influence the genetic mechanisms leading to osteogenic differentiation on modified 
titanium implant surfaces. 
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Abstract 
 
Objectives: Titanium implants surfaces with modified topographies have improved 
osteogenic properties in vivo. However, the molecular mechanisms remain obscure. 
This study explored the signaling pathways responsible for the pro-osteogenic 
properties of micro-roughened (SLA) and chemically/nanostructurally (modSLA) 
modified titanium surfaces on human alveolar bone-derived osteoprogenitor cells 
(BCs) in vitro.  
Materials & Methods: The activation of stem-cell signaling pathways (TGFβ/BMP, 
Wnt, FGF, Hedgehog, Notch) was investigated following early exposure (24 and 72 
hours) of BCs to SLA and modSLA surfaces in the absence of osteogenic cell culture 
supplements.  
Results: Key regulatory genes from the TGFβ/BMP (TGFBR2, BMPR2, BMPR1B, 
ACVR1B, SMAD1, SMAD5), Wnt (Wnt/β-catenin and Wnt/Ca2+) (FZD1, FZD3, 
FZD5, LRP5, NFATC1, NFATC2, NFATC4, PYGO2, LEF1) and Notch (NOTCH1, 
NOTCH2, NOTCH4, PSEN1, PSEN2, PSENEN) pathways were upregulated on the 
modified surfaces. These findings correlated with a higher expression of osteogenic 
markers bone sialoprotein (IBSP) and osteocalcin (BGLAP), and bone differentiation 
factors BMP2, BMP6, and GDF15, as observed on the modified surfaces. 
Conclusions: These findings demonstrate that the activation of the pro-osteogenic 
cell signaling pathways by modSLA and SLA surfaces leads to enhanced osteogenic 
differentiation as evidenced after 7 and 14 days culture in osteogenic media and 
provide a mechanistic insight into the superior osseointegration on the modified 
surfaces observed in vivo. 
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6.1 INTRODUCTION 
 The clinical success of implants depends on their osteogenic and 
osseointegrative properties. A number of studies have addressed the importance of 
the physical and chemical properties of the titanium implant surface in the 
phenotypic and functional regulation of osteoblast cells (Galli et al. 2012). 
Topographically modified titanium implant surfaces, such as the sand-blasted, large 
grit, acid-etched (SLA) titanium surface, and the chemically modified form of SLA 
(modSLA), have been shown to improve osteogenic properties, which lead to 
accelerated osseointegration and reduced healing times (Buser et al. 1991, 1999, 
2004; Roccuzzo et al. 2001; Bornstein et al. 2008; Lai et al. 2009; Bosshardt et al. 
2011; Donos et al. 2011b; Lang et al. 2011). Both SLA and modSLA surfaces exhibit 
a micro-roughened topography, while recent reports suggest that the modSLA 
surface also has a nano-structured topography (Wennerberg et al. 2011; Wennerberg 
et al. 2013). The modSLA and SLA surfaces have been widely utilized to study the 
interaction of modified titanium implants with osteogenic cells and have been shown 
to enhance osteoblastic differentiation compared to smooth surfaces (Schwartz et al. 
2001; Brett et al. 2004; Wieland et al. 2005; Zinger et al. 2005; Zhao et al. 2007; 
Olivares-Navarrete et al. 2011a,b; Vlacic-Zischke et al. 2011). As such, these 
surfaces represent a valuable model for the study of the cellular and molecular 
mechanisms of osteoblastic differentiation that may more closely replicate 
physiological responses compared to commonly utilized in vitro models 
incorporating chemically induced osteogenic differentiation. 
 The suitability of the micro-environment to promote osteogenic 
differentiation is crucial for appropriate osseointegration in vivo. However, the 
molecular mechanisms leading to the enhanced osteogenic differentiation following 
exposure to the SLA and modSLA surfaces are not fully elucidated. Several whole 
transcriptome profiling studies have revealed a differential gene expression profile of 
osteoprogenitor cells between 3 hours and 72 hours (Brett et al. 2004; Wall et al. 
2009; Vlacic-Zischke et al. 2011) of exposure to modSLA and SLA compared to 
smooth surfaces, suggesting that topographically induced cues exert an early 
influence on biological mechanisms that ultimately lead to enhanced 
osseointegration. Therefore, determining the early response of osteoprogenitor cells 
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to topographical cues is critical for understanding the cascade of events that 
ultimately leads to enhanced differentiation. 
Several signaling proteins and pathways are known to be important in the 
regulation of osteogenesis. The interplay and crosstalk between cell signaling 
pathways like TGFβ/BMP, Wnt, Notch (Zamurovic et al. 2004), Hedgehog (St-
Jacques et al. 1999; Mak et al. 2006) and FGF (Tsutsumi et al. 2001; Ito et al. 2008) 
guides osteogenic differentiation of progenitor cells. Recent studies have shown that 
both TGFβ/BMP and Wnt signaling are activated during in vivo guided bone 
regeneration (Ivanovski et al. 2011b) and are involved in the osteogenic response to 
SLA and modSLA surfaces (Donos et al. 2011b; Ivanovski et al. 2011a; Olivares-
Navarrete et al. 2011b; Vlacic-Zischke et al. 2011). The aim of the present study was 
to investigate the effect of pro-osteogenic topographical cues from modified titanium 
surfaces on the early response of key cell signaling pathways (TGFβ, Wnt, FGF, 
Notch, Hedgehog) that are important in regulating osteoprogenitor differentiation. 
6.2 MATERIALS AND METHODS 
6.2.1 Titanium discs 
All titanium discs used in this study were manufactured from Grade II 
commercially pure titanium (15 mm in diameter, 1 mm in thickness) and supplied by 
Institut Straumann (Basel, Switzerland). SLA surfaces were prepared by blasting the 
surface with 250-500 µm corundum grit and acid etching with a hot solution of 
hydrochloric/sulfuric acids. The modSLA surface was obtained by rinsing SLA discs 
under N2 protection and storage in isotonic saline solution at pH 4-6. This treatment 
has been shown to generate a chemically modified hydrophilic surface with reduced 
carbon surface contamination (Hamlet et al. 2012). Smooth/polished (SMO) titanium 
discs were used as the control surface for the study. 
6.2.2 Surface imaging 
The surface topography of the three titanium surfaces, modSLA, SLA, and 
SMO, was analyzed by scanning electron microscopy (SEM) (FEI Quanta 3D 
Focused Ion Beam SEM) and atomic force microscopy (AFM) (BMT Multiscan 
AFM, Karlsruher, Germany). The modSLA surfaces were removed from the isotonic 
saline solution, washed with deionised water and dried with a jet of argon gas for 
imaging using SEM and AFM. SEM imaging was performed in high vacuum 
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conditions using the Everhart-Thornley Detector. AFM imaging of the surfaces was 
performed in tapping mode using silicon AFM probes with a natural frequency of 
300 kHz at a scan rate of 0.2 Hz (Innovative Solutions Bulgaria Ltd., Sofia, 
Bulgaria). High-resolution thermal field emission scanning electron microscopy 
(JSM-7001F, Joel, French’s Forest, NSW, Australia) was used to assess the nano-
structure of the surfaces. 
6.2.3 Cell culture 
Primary alveolar bone derived osteoprogenitor cell (BCs) obtained from three 
healthy human volunteers were used for the study. These cells were established after 
culturing redundant tissues obtained following third molar extraction surgery using 
methods described previously (Haase et al. 2003; Xiao et al. 2003, 2004). The BCs 
were seeded at a density of 5 × 10
4
 cells/titanium disc placed in 24 well tissue culture 
plates (BD Falcon, North Ryde, NSW, Australia), and incubated at 37 °C in a 5% 
CO2 atmosphere in Dulbecco's modified Eagle's medium (DMEM) (Invitrogen, Mt 
Waverley, VIC, Australia) supplemented with fetal bovine serum (FBS) (Thermo, In 
Vitro Technologies, Nobel Park, Vic., Australia) and antibiotics (100 U/ml 
penicillin/100 μg/ml streptomycin). 
6.2.4 Cell morphology 
The morphology of osteoblastic cells on the modSLA, SLA, and SMO was 
studied using SEM. Cells were cultured in complete expansion media on the different 
surfaces for 24 hours and 72 hours as described above. After 24 and 72 hours of 
culture, the media was removed and the cells were fixed with 2% glutaraldehyde in 
0.1M sodium cacodylate buffer overnight. The samples were subsequently washed 
with 0.1M sodium cacodylate buffer for 10 minutes, and post-fixed with 1% osmium 
tetroxide for 1 hour. The samples were then washed with distilled water twice (10 
minutes each time) and gradually dehydrated in ethanol with increasing 
concentration (50%, 70%, 90%, and 100%). Finally, the samples were dried using 
critical point drying apparatus. To view the fixed cells with SEM they were coated 
with gold using a gold sputter coater. SEM imaging was performed under high 
vacuum as described previously (Mao et al. 2009). 
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6.2.5 RNA isolation and osteogenic gene expression pattern 
Total RNA was extracted using an Ambion RNAqueous kit (GeneWorks, 
Thebarton, SA, Australia) as per the manufacturer’s instructions, and RNA 
concentrations were assessed using a Nanodrop spectrometer (Thermo Scientific, 
Scoresby, Vic., Australia). Expression of the osteogenic genes bone sialoprotein 
(IBSP) and osteocalcin (BGLAP) was evaluated and compared between the 
modSLA, SLA, and SMO surfaces after exposing the cells to the titanium discs for 1, 
3, 7 and 28 days. cDNA was prepared from 100 ng RNA template using the 
DyNAmo
TM
 cDNA Synthesis Kit (Finnzymes Oy., Vantaa, Finland) according to the 
manufacturer’s protocol. The expression pattern of bone morphogenetic proteins, 
BMP2, BMP6, and GDF15, was also assessed at 24 and 72 hours. Taqman primers 
and probes were purchased from Applied Biosystems (Assay on demand, Applied 
Biosystems, Mulgrave, Vic., Australia). Quantitative real time PCR (qRT-PCR) 
reactions were performed using ABI Prism 7000 Sequence Detection System 
(Applied Biosystems) using TaqMan
®
 Universal PCR Master Mix (Invitrogen 
Australia Pty Limited, Vic., Australia). The reactions were incubated at 50 °C for 2 
min, followed by 10 min at 95 °C to activate the polymerase, and subsequently at 95 
°C (15 seconds) and 60 °C (for 1 minute) for 40 cycles. 
6.2.6 Gene expression profiling for stem cell signaling pathways 
The expression profile of 84 key genes involved in signal transduction 
pathways for maintenance and differentiation of immature cell types (TGFβ, Wnt, 
FGF, Notch, and Hedgehog) was assessed using the Human Stem Cell Signaling 
PCR Array (SABiosciences, Frederick, MD, USA). The full list of genes included on 
this·array·is·available·at·http://www.sabiosciences.com/rt_pcr_product/HTML/PAH
S-047A.html. cDNA was prepared from 100 ng RNA templates by reverse 
transcription using the RT
2
 First Strand Kit (SABiosciences) according to the 
manufacturer’s protocol and our previous work (Liu et al. 2009; Mareddy et al. 
2010). Quantitative real time PCR (qPCR) reactions were performed using the ABI 
Prism 7900HT Sequence Detection System (Applied Biosystems). The reactions 
were incubated at 95 °C for 10 minutes for one cycle, and then 95 °C (15 seconds), 
60 °C (for 1 minute) for 40 cycles. PCR reactions were validated by observing the 
presence of a single peak in the dissociation curve analysis. The endogenous 
reference genes used to normalize the calculations by comparative Ct (Cycle of 
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threshold) value method were β-2-microglobulin (B2M), hypoxanthine 
phosphoribosyltransferase 1 (HPRT1), ribosomal protein L13a (RPL13A), 
glyceraldehyde-3-phosphate-dehydrogenase (GAPDH), and β-actin (ACTB). 
6.2.7 Alizarin Red S staining and Calcium assay 
Extracellular matrix deposition on the titanium surfaces after culturing cells in 
osteogenic media (standard media supplemented with 100 nM dexamethasone, 0.2 
mM L-ascorbic acid, and 10 mM β-glycerophosphate) was assessed using Alizarin 
Red S staining. Briefly, after 7 and 14 days of culture, the media was removed and 
the cells were washed with PBS. The cells were then fixed using 4% 
paraformaldehyde and subsequently stained with 1% Alizarin Red S solution. Excess 
Alizarin Red stain was washed with ultrapure water; the samples were allowed to dry 
and then imaged with a Leica M125 stereo microscope (Leica Microsystems GmbH, 
Wetzlar, Germany). The Alizarin Red S staining was further assessed semi-
quantitatively using a colorimetric technique (Gregory et al. 2004). Briefly, the 
samples were incubated in 10% acetic acid for 30 minutes, mixed with mineral oil, 
and heated to 85 °C for 10 minutes and immediately transferred to ice. They were 
subsequently centrifuged, mixed with 10% ammonium hydroxide and the absorbance 
was measured at 405 nm. To quantify the calcium content after 7 and 14 days of 
culture in osteogenic media, calcium was extracted by incubating the samples in 
0.6N hydrochloric acid overnight and subsequently quantified using the 
Quantichrome
TM
 calcium assay kit (Gentaur Belgium BVBA, Kampenhout, 
Belgium) according to the manufacturer’s protocol (Han et al. 2012). The absorbance 
was measured at 612 nm. 
6.2.8 Statistical analysis 
The relative levels of expression of mRNAs were compared between the cells 
cultured on modSLA, SLA, and SMO titanium discs using the Student’s t-test. The 
critical value for significance was set at p<0.05. The ΔCT value was obtained by 
subtracting the average Ct value of the endogenous references selected from the test 
mRNA Ct value of the same samples. The ΔΔCT was determined by subtracting the 
ΔCT of the control sample from the ΔCT of the target sample. The relative mRNA 
quantification of the target gene was calculated by 2
-ΔΔCT
. Downregulated mRNA 
values were calculated as the negative reciprocal of the 2
-ΔΔCT
 score. The Ct values 
for each biological replicate were considered for analysis. Only the genes which 
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showed statistically significant difference in the level of expression on the surfaces 
for all the patients were considered as positive results. 
6.3 RESULTS 
6.3.1 Surface analysis 
The micro-textured structure of modSLA and SLA surfaces was clearly 
demonstrated on the SEM images (Figure 6-1a-c). No significant difference in the 
micro-topographical level architecture was observed when the modSLA surface was 
compared with the SLA surfaces. Micro-scale irregularities ranging between 3 and 5 
µm were commonly observed on both modSLA and SLA surfaces. These pit-shaped 
irregularities are the likely result of the sand-blasting procedure. The SMO surfaces 
exhibited a smooth architecture and do not show any micro-scale irregularities. The 
main topographical difference between the modSLA and SLA surfaces was the 
presence of nano-structures on the modSLA surface which could be detected using 
high-magnification SEM images. Clearly defined nano-structures were visible only 
on the modSLA surfaces, while SLA and SMO surfaces were devoid of any nano-
scale features (Figure 6-1d-i). 
Atomic force microscopy measurements of the surfaces also demonstrated 
similar micro-scale morphology on the modSLA and SLA, but not the SMO surface 
(Figure 6-2a-c). The BMT Multiscan AFM has the potential to scan z-axis deviations 
close to 50 µm. It revealed varying degrees of roughness on the modSLA and SLA 
surfaces (some peaks >±3 µm), but essentially they demonstrated very similar 
structural features. The root mean square (rms) roughness for both modSLA and 
SLA showed wide variations (0.8 µm-2 µm), due to the limitation in the total area 
that could be scanned with AFM. The z-axis visualization of the SMO surface did 
not show any sharp peaks. The rms roughness for the SMO surface ranged between 
0.006 and 0.015 µm. 
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Figure 6-1: Scanning electron microscope (SEM) images of (a) modSLA; (b) SLA; (c) SMO 
(Magnification-5,000x) showing micro-rough topography of modSLA and SLA surfaces; (d-i): SEM 
images at 50,000x magnification [(d) modSLA; (e) SLA; (f) SMO], and 100,000x [(g) modSLA; (h) 
SLA; (i) SMO] showing the presence of nano-structures only modSLA surfaces. 
 
 
Figure 6-2: Atomic force microscopy images of (a) modSLA, (b) SLA, and (c) SMO. 
6.3.2 Cell morphology on the discs 
Cellular morphology was significantly different between the micro-roughened 
(SLA and modSLA) surfaces compared with the smooth surface. Cells showed a 
more flattened morphology on the SMO surface when compared with the modSLA 
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and SLA surfaces at both 24 and 72 hours. In comparison with the SMO surface, the 
cells on the SLA and modSLA surfaces showed a more elevated appearance with 
cellular processes extending to the pits and the neighbouring cells. The cells 
exhibited more surface granules on the modSLA and SLA discs, possibly due to 
increased protein secretion in response to these surfaces. The granules and processes 
on the cells were seen to increase between 24 hours and 72 hours (Figure 6-3). 
 
Figure 6-3: Cell morphology on modSLA, SLA, and SMO. Scanning electron microscope (SEM) 
images of human alveolar bone-derived cells on (a) modSLA-24h (Magnification-800x); (b) SLA-24h 
(Magnification-800x); (c) SMO-24h (Magnification-800x); (d) modSLA-24h (Magnification-5000x); 
(e) SLA-24h (Magnification-5000x); (f) SMO-24h (Magnification-5000x); (g) modSLA-72h 
(Magnification-800x); (h) SLA-72h (Magnification-800x); (i) SMO-72h (Magnification-800x); (j) 
modSLA-72h (Magnification-5000x); (k) SLA-72h (Magnification-5000x); (l) SMO-72h 
(Magnification-5000x). 
6.3.3 Signaling pathways 
A total of 84 key genes involved in major signal transduction pathways 
(Fibroblast Growth Factor (FGF), Hedgehog, Notch, TGFβ, and Wnt) were assessed. 
The expression of these genes on the three surfaces (modSLA, SLA, and SMO) was 
compared at two early time-points (24 and 72 hours). Furthermore, the relative 
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expression of genes for each type of disc at 72 hours was compared with the 
expression at 24 hours. 
Twenty-four hours comparison 
A total of 16 genes were found to be significantly upregulated (p<0.05) on the 
modSLA, and 17 genes on the SLA surface compared to the SMO surface (Table 6-
1). No genes were downregulated between the modified surfaces and the smooth 
surface. Several genes of the Wnt, Notch, and TGFβ pathways showed significantly 
higher expression on these surfaces after 24 hours of exposure, with the majority of 
the upregulated molecules belonging to the Wnt signaling pathway (7/16 on 
modSLA and 9/17 on SLA). Furthermore, TGFβ signaling (4/16 and 2/17 
upregulated genes on modSLA and SLA, respectively) and Notch signaling (4/16 
and 5/17 upregulated genes on modSLA and SLA, respectively) were also activated 
on the modified surfaces after 24 hours. Only one gene (TCF7) showed increased 
expression on the modSLA compared to the SLA surface (Table 6-1). NFATC2 (Wnt 
pathway) showed the highest fold change (FC=9.03) when modSLA was compared 
with SMO (p-value=0.05). Indeed, NFATC2 also showed the highest fold change 
(8.23) (p-value=0.01) on the SLA surface (compared with SMO). 
Seventy-two hours comparison 
Ten genes were significantly upregulated on the modSLA surface and 18 genes 
on the SLA surface. Similar to the trend at 24 hours, the modSLA and SLA surfaces 
showed increased expression of genes of the Wnt (5/10 on modSLA and 4/18 on 
SLA), Notch (4/10 on modSLA and 6/18 on SLA), and TGFβ (1/10 on modSLA and 
6/18 on SLA) pathways. Only genes PSENEN (Notch) and SMAD3 (TGFβ) were 
observed to be significantly downregulated on the modSLA compared with the SLA 
surface (Table 6-1). FZD9 (Wnt pathway) was the gene showing the highest 
statistically significant (p<0.05) fold change on modSLA (FC=3.77) and SLA (FC= 
2.87). 
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Table 6-1: Cell signaling pathway genes showing statistically significant difference in expression pattern of human alveolar bone derived cells on modSLA, SLA, and SMO 
titanium surfaces after 24 hours and 72 hours of culture (n=3). 
 144 Activation of cell signaling pathways on modified titanium surfaces 
Seventy-two hours vs. twenty-four hours comparison 
The relative expression of genes on the modSLA, SLA, and SMO discs was 
compared between the two time-points (72 hours vs. 24 hours) (Table 6-2). Most of 
the genes (7 on modSLA, 8 on SLA, and 10 on SMO) were significantly down 
regulated at 72 hours when compared with 24 hours. Only two genes (SMAD3 on 
SLA and CXD2 on SMO) were upregulated at 72 hours. Three of the seven genes 
(ACVR1, BMPR2, SMAD1) downregulated on modSLA were part of the TGFβ 
superfamily, two (TCF7, BCL9L) belonged to the Wnt pathway and one (NOTCH2) 
to the Notch pathway. The genes that were downregulated on SLA included 
members of the TGFβ (2 of 8) (BMPR2, SMAD7), Wnt (4 of 8) (FZD1, LEF1, 
NFATC2, NFATC3) and Notch (1 of 8) (NOTCH4) pathways. Five of the 10 genes 
(ACVR1, BMPR1B, ENG, SMAD7, TGFBR3) differentially regulated on SMO 
were from the TGFβ pathway, three from the Wnt (FZD1, NFATC2, BCL9L), one 
(NOTCH3) from Notch. TCF7 and NFATC2, both from the Wnt pathway, were the 
most significantly downregulated on modSLA and SLA surfaces respectively at 72 
hours (-4.77 and -5.51, respectively). 
Table 6-2: Cell signaling pathway genes showing statistically significant difference in expression 
pattern of human alveolar bone derived cells at 72 hours (compared with 24 hours) on modSLA, SLA, 
and SMO titanium surfaces after 24 hours and 72 hours of culture (n=3). 
 
Notch, Wnt, and TGFβ/BMP pathway 
Notch, Wnt, and TGFβ pathway molecules were observed to be consistently 
upregulated on modSLA and SLA surfaces at both time-points. Figure 6-4 highlights 
the expression pattern of some of the key differentially regulated genes of the TGFβ 
(TGFBR2, BMPR2, BMPR1B, ACVR1B, SMAD1, and SMAD5), Wnt (FZD1, 
FZD3, FZD5, LRP5, NFATC1, NFATC2, NFATC4, PYGO2, and LEF1), and Notch 
pathways (NOTCH1, NOTCH2, NOTCH4, PSEN1, PSEN2 and PSENEN). Most of 
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the genes showed similar trends (expression on modSLA≥SLA>SMO). When 
modSLA was compared with SLA, very few genes showed statistically significant 
changes, although there was a general trend for higher expression associated with 
modSLA. 
 
Figure 6-4: Relative gene expression profile of key genes of TGFβ, Wnt, and Notch pathways on 
modSLA, SLA, and SMO titanium surfaces (Fold changes to SMO Day 1; *: p<0.05, modSLA vs. 
SMO; #: p<0.05, SLA vs. SMO; †: p-value<0.05, modSLA vs. SLA; ¶: p<0.05 modSLA 24 hours vs. 
72 hours; ◊: p<0.05, SLA 24 hours vs. 72 hours; ^: p<0.05, SMO 24 hours vs. 72 hours). ( 24 hours 
 72 hours). 
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Notch signaling 
The Human Stem Cell Signaling PCR array contains 9 genes of the Notch 
pathway (8 receptors/co-receptors and 1 transcription factor).  Four of the nine genes 
of the Notch pathway were upregulated on the modSLA surface at each time-point. 
The SLA surface showed upregulation of 5/9 genes of the Notch pathway at 24 hours 
and 6/9 genes at 72 hours. The Notch pathway receptor/co-receptor genes that were 
upregulated on modSLA were as follows: NOTCH2, PSEN1, PSENEN (both at 24 
and 72 hours); PSEN2 (at 24 hours); and NOTCH1 (at 72 hours). The receptor/co-
receptor genes (Notch pathway) highly expressed on SLA surface were as follows: 
PSEN1, PSEN2, PSENEN (both at 24 and 72 hours); NOTCH4 (at 24 hours); 
NOTCH1, NOTCH2, NOTCH4 (at 72 hours). The transcription factor RBPJL was 
seen to be upregulated only on the SLA surface (compared with SMO) at 24 hours. 
Wnt signaling 
The Human Stem Cell Signaling PCR array contains 25 genes of the Wnt 
pathway (12 receptors and 13 transcription factors and co-factors). The transcription 
factors of the Wnt signaling molecules that showed increased expression on modSLA 
were as follows: NFATC1, NFATC4, PYGO2 (both at 24 and 72 hours); LEF1 and 
TCF7 (at 24 hours). The receptors upregulated on modSLA were FZD1, LRP5 (at 24 
hours), FZD6, and FZD9 (at 72 hours). Wnt molecules upregulated on the SLA 
surface both at 24 and 72 hours were as follows: FZD1 (receptor) and PYGO2. The 
genes upregulated only at 24 hours were as follows: FZD3, FZD5, LRP5, VANGL2 
(receptors); NFATC1, NFATC2, NFATC3 (transcription factors/co-factors). The co-
receptors FZD8 and FZD9 were upregulated on SLA at 72 hours. 
TGFβ signaling pathway 
The array used for this study included 20 receptors (and co-receptors) and 15 
transcription factors (and co-factors) of the TGFβ superfamily. A number of genes  
of the TGFβ/BMP pathway were upregulated on the modified surfaces: the 
receptors/co-receptors ACVR1B, BMPR2, LTBP3 (upregulated on modSLA at 24 
hours); BMPR2 (upregulated on SLA at 24 hours); ACVRL1, ENG, TGFBR3 
(upregulated on SLA at 72 hours), TGFBR2 (upregulated on modSLA and SLA at 24 
hours and on SLA at 72 hours), and the  transcription factors and co-factors SMAD1 
(upregulated on modSLA at 24 hours), SMAD3 and SMAD6 (upregulated on SLA at 
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72 hours). Only three genes were seen to be differentially regulated when modSLA 
was compared with SLA (TCF7 was upregulated on modSLA at 24 hours, and 
PSENEN and SMAD were downregulated on modSLA at 72 hours). 
6.3.4 Mineralization properties and osteogenesis associated gene expression 
Higher Alizarin Red S staining and calcium deposition was observed on the 
modSLA and SLA surfaces compared with the SMO surface (modSLA>SLA>SMO) 
at days 7 and 14 (Figure 6-5a-e) following culture in osteogenic media. 
The temporal expression pattern of the osteogenesis-associated genes IBSP and 
BGLAP on the three surfaces was assessed after 1, 3, 7, and 28 days of culture in 
standard expansion media (Figure 6-5f-g). IBSP showed significant increase in gene 
expression on the modified titanium surfaces (modSLA and SLA) with increasing 
time. There was a higher expression of IBSP on the modSLA and SLA compared 
with the SMO surfaces at each time-point (Figure 6-5f). The relative expression of 
BGLAP was also observed to be higher on the modSLA and SLA compared with 
SMO surfaces (especially at days 7 and 28 days) (Figure 6-5g). The expression of the 
bone morphogenetic proteins, BMP2 and BMP6, was also higher on the modSLA 
and SLA compared with the SMO surfaces, and the expression was higher at 24 
hours compared with 72 hours on all surfaces (Figure 6-6), pointing to a role of 
BMPs in stimulating osteogenic differentiation of progenitor cells in the early phase 
of differentiation. The expression of GDF15 did not vary greatly between the 
surfaces or over time, although significantly higher expression was noted on 
modSLA at 72 hours.  
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Figure 6-5: Osteogenic properties of modSLA and SLA surfaces. (a, b, c) Alizarin Red S staining after 
14 days of culture in osteogenic media on (a) modSLA, (b) SLA, and (c) SMO showing higher 
mineralization on modSLA and SLA surfaces compared with SMO. (d) Quantification of Alizarin Red 
S staining on modSLA, SLA, and SMO surfaces after 7 and 14 days of culture in osteogenic media. 
(e) Calcium assay after 7 and 14 days of culture in osteogenic media on modSLA, SLA, and SMO 
surfaces showing calcium levels (modSLA>SLA>SMO). (*: p<0.05, modSLA vs. SMO; #: p<0.05, 
SLA vs. SMO; †: p<0.05, modSLA vs. SLA). (f) & (g) Temporal gene expression (IBSP and BGLAP) 
profile on modSLA, SLA, and SMO surfaces after 1, 3, 7, and 28 days of culture in complete 
expansion media (fold changes relative to SMO day 1) showing higher expression of genes on 
modSLA and SLA surfaces. p-value < 0.05 for following pairs: IBSP – modSLA vs. SMO (Day 1, 3 
and 28); SLA vs. SMO (Day 1 and 28); modSLA (Day 28 vs. Day 1 & Day 3; Day 7 vs. Day 3 & Day 
1); SLA (Day 28 vs. Day 1, 3 & 7; Day 7 vs. Day 3 & 1) BGLAP – modSLA (Day 28 vs. Day 7 & 1). 
 
*† 
*† 
# 
* 
* 
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Figure 6-6: Relative gene expression profile (BMP2-Bone morphogenetic protein-2, BMP6-Bone 
morphogenetic protein-6, GDF15-Growth differentiation factor 15) of human alveolar bone derived 
cells on modSLA, SLA, and SMO titanium surfaces after 24 and 72 hours of culture (n=3). (*: 
p<0.05, modSLA vs. SMO; #: p<0.05, SLA vs. SMO; †: p<0.05, modSLA vs. SLA, ¶: p<0.05 
modSLA 24 hours vs. 72 hours; ◊: p<0.05, SLA 24 hours vs. 72 hours; ^: p<0.05, SMO 24 hours vs. 
72 hours) ( 72 hours  24 hours). 
6.4 DISCUSSION 
Osteogenic differentiation is a process guided by activation and interaction of 
several cell signaling pathways (Lin & Hankenson 2011), namely TGFβ/BMP, Wnt, 
Notch (Zamurovic et al. 2004), Hedgehog (St-Jacques et al. 1999; Mak et al. 2006), 
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and FGF (Tsutsumi et al. 2001; Ito et al. 2008). These pathways are known to 
interact, but the precise nature of these interactions during osteogenic differentiation 
is unknown. In vitro osteogenic differentiation studies traditionally used to study cell 
and molecular mechanisms usually incorporate chemical mediators like β-
glycerophosphate, dexamethasone, and L-ascorbic acid into the culture media. 
However, the in vivo environment is not accurately replicated with this chemical 
method. Micro-roughened implant surfaces provide a favorable osteogenic 
environment and influence the differentiation potential of progenitor cells (Bagno et 
al. 2007). The well characterized SLA surface has emerged as a widely used model 
that is believed to mimic the microenvironment encountered by osteoblast cells in 
vivo, and hence represents an alternative, physiologically relevant model for studying 
osteogenic differentiation. The use of the modSLA surface in clinical dentistry has 
further reduced healing time associated with dental implants (Buser et al. 2004; Lang 
et al. 2011), and it has been shown to promote biological mechanisms associated 
with osteogenesis in both in vitro and in vivo studies (Buser et al. 1991, 2004; Donos 
et al. 2011a; Vlacic-Zischke et al. 2011). This surface is manufactured and stored 
under conditions resulting in a hydrophilic surface with reduced surface 
contamination. In this study, we found that this surface has a nano-structured 
topography, which is in agreement with a recent report of spontaneous nanostructure 
formation on the modSLA surface (Wennerberg et al. 2013). 
This study aimed to determine the effects of the pro-osteogenic environment 
created by modified titanium surfaces (modSLA and SLA) on the expression of cell 
signaling pathways during the early exposure of primary human BCs. The mRNA 
expression for several genes of the Wnt, Notch, and TGFβ/BMP, but not FGF or 
Hedgehog, signaling pathways was modulated by the titanium surface modification. 
These findings are supported by previous reports that have suggested that the 
TGFβ/BMP and Wnt signaling pathways are triggered early in the interaction 
between osteoblasts and implant surfaces (Wall et al. 2009; Ivanovski et al. 2011a; 
Olivares-Navarrete et al. 2011a; Vlacic-Zischke et al. 2011). A novel finding of the 
study is that Notch is an additional pathway that is triggered early in the response to 
these surfaces. TGFβ/BMP, Wnt, and Notch pathways have been known to be key 
cell signaling pathways involved in the process of osteogenesis (Zamurovic et al. 
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2004) and in vivo bone formation and healing (Ivanovski et al. 2011a,b), and these  
findings are in agreement with our observations. 
The Notch pathway associated presenilin molecules (PSEN1 and PSEN2), and 
Presenilin enhancer 2 (PSENEN) were constantly upregulated on both of the 
modified implant surfaces at both time-points. Presenilin molecules form part of the 
γ-secretase complex that is involved in the cleavage of Notch receptors (Taniguchi et 
al. 2002; Hemming et al. 2008), and the PSENEN product is a regulatory component 
of that complex (Kaether et al. 2006). Presenilin knockout models have demonstrated 
the importance of these genes in the signal transduction of the Notch pathway 
(Donoviel et al. 1999; Herreman et al. 1999). The Notch receptors, NOTCH1, 
NOTCH2 and NOTCH4 were also upregulated on these surfaces at both time points. 
Notch signaling is not only known to be important for osteogenic differentiation, but 
has also been shown to be instrumental for both BMP2-induced osteoblast 
differentiation and BMP signaling itself (Nobta et al. 2005). Given that we have 
previously demonstrated that SLA and modSLA surfaces induce BMP2 secretion 
(Vlacic-Zischke et al. 2011), it is likely that activation of the Notch pathway enables 
the coordination of other pathways leading to osteogenic differentiation. 
The results from this study revealed increased expression of transcription 
factors of the Wnt pathway, NFATC1, NFATC2, NFATC3, and NFATC4. These 
belong to the nuclear factor of activated T-cells (NFAT) family of transcription 
factors (Crabtree & Olson 2002). The NFAT transcriptional activation is prompted 
by stimulation of calcineurin via Wnt molecules such as WNT5A (Saneyoshi et al. 
2002). Interestingly, there was no differential regulation of the key molecule of the 
canonical Wnt signaling pathway, CTNNB1. This finding is in agreement with 
previous studies using the SLA and modSLA surfaces, which demonstrated the 
activation of the non-canonical calcium-dependent Wnt pathway (Olivares-Navarrete 
et al. 2010a; Olivares-Navarrete et al. 2011a,b). We also observed the upregulation 
of several receptors of the frizzled family: FZD1, FZD3, FZD5, FZD6, FZD8, and 
FZD9. As in the case of canonical Wnt signaling, the non-canonical Wnt ligands 
signal through the frizzled family of receptors; however, this is independent of the 
LRP5 and LRP6 co-receptors (Seifert & Mlodzik 2007; Slusarski & Pelegri 2007). 
We did find upregulation of the LRP5 co-receptor on both the modSLA and SLA 
surfaces at 24 hours; however, the Ct values were particularly high, and hence, the 
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significance of this finding is questionable. LRP6 did not show a significant increase 
in expression in response to the modified surfaces, and therefore, it is unclear 
whether there is any activation/inhibition of the canonical Wnt signaling pathway. 
Olivares-Navarrete et al.’s work in 2010 indicated that the canonical Wnt signaling 
pathway is important in the early phase of osteo-differentiation, whereas the non-
canonical Wnt/Ca
2+
 pathway is critical in the later stages of differentiation on 
modSLA and SLA surfaces (Olivares-Navarrete et al. 2010b). However, their later 
study in 2011 (Olivares-Navarrete et al. 2011a) showed that the canonical Wnt 
signaling does not play a role in osteogenic differentiation on micro-structured 
surfaces. Wang et al.’s recent work (Wang et al. 2012) discusses the activation of the 
canonical Wnt/β-catenin pathway and not the non-canonical pathway as an important 
regulator of osteogenic differentiation on micropitted/nanotubular titanium surfaces. 
These observations could possibly be attributed to the time-points (day 3 and day 7) 
for their study. 
The TGFβ/BMP pathway activation was manifested through upregulation of 
the receptors BMPR2 and TGFBR2 at 24 hours on both modSLA and SLA. Vlacic et 
al’s whole genome microarray based study (2011) showed upregulation of several 
genes of the TGFβ/BMP following 72 hours of in vitro culture on the modSLA and 
SLA surfaces. Our recent work describing the microRNA expression profiles on 
modSLA and SLA surfaces explored the possibility of potential regulation of the 
TGFβ/BMP and Wnt/Ca2+ pathways on these surfaces (Chakravorty et al. 2012). The 
coordinated stimulation of TGFβ, Wnt, and the Notch pathways on the modified 
titanium implant surface is possibly responsible for their improved osteogenic and 
osseointegration properties. Based on the results of the study, we summarized the  
cascade of molecular events (Figure 6-7) to illustrate the interactions between these 
pathways leading to the upregulation of osteogenic transcription factors like Runt-
related transcription factor 2 (Runx2) and osterix (Osx). The activation of the three 
signaling pathways (TGFβ, Wnt and Notch) is synchronized with each other, leading 
to a condition prone to osteogenesis. The immediate interaction of BCs with the 
topographically modified titanium implant surfaces stimulates them to over-express 
ligands and receptors for these pathways and this initiates the downstream chain of 
events. The increased expression of ligands BMP2, BMP6, and GDF15 at 24 hours, 
described in this study strengthens the findings we previously reported (increased 
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expression of ligands BMP2, BMP6 and WNT5A) (Chakravorty et al. 2012). 
Binding of the ligands with their receptors directs the activation of downstream 
mediators. Therefore, switching-on the TGFβ/BMP pathway leads to activation of 
the receptor-regulated SMADs (R-SMADs) that along with the common-mediator 
SMAD (co-SMAD) translocate into the nucleus. Similarly, the canonical Wnt/β-
catenin activation causes translocation of the active de-phosphorylated form of β-
catenin into the nucleus. Concerted activity of the TGFβ/BMP and canonical Wnt/β-
catenin cascade leads to activation of Runx2 (Lin & Hankenson 2011). The non-
canonical Wnt/Ca
2+
 pathway causes activation of the Nuclear factor of activated T-
cells (NFATs) molecules which conglomerates with another transcription factor, 
osterix (Osx) (Koga et al. 2005), that in turn is under the regulation of Runx2. Notch 
pathway is known to induce Osx expression (Engin et al. 2008). The subsequent 
inter-play between the osteogenic transcription factors eventually leads to osteogenic 
differentiation and osseointegration. 
 
Figure 6-7: Schematic diagram representing the inter-relationship and cross-talk between TGFβ/BMP, 
Wnt, and Notch signaling pathways, that leads to osteogenic differentiation on the modified titanium 
implant surfaces (modSLA and SLA). 
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Comparison of the gene expression pattern on the different discs between the 
two time-points illustrated the importance of the early cellular response to 
topographical cues. The majority of the genes showing differential expression 
between 72 and 24 hours were downregulated at 72 hours. This suggests that the 
early activation of the cell signaling pathways on titanium surfaces occurs within the 
first 24 hours. The gene expression of TGFβ/BMP receptors like BMPR2, BMPR1B, 
and TGFBR3 was downregulated on all surfaces at 72 hours, possibly as a 
consequence of negative feedback control of gene expression due to translational 
repression. Translational repression has been shown to be more efficient in 
controlling the sequence of gene expression (Swain 2004), and our observations 
could be the result of the temporal feedback.  The NFATC molecules  (NFATC2 and 
NFATC3) were also shown to be downregulated at 72 hours compared to 24 hours, 
possibly indicating early modulation of the Wnt/Ca
2+
 signaling cascade on the 
implant surfaces. The downregulation of the Notch pathway was reflected in 
decreased receptor gene expression (NOTCH2 on modSLA and NOTCH4 on the 
SLA surface). It is noteworthy that these same receptors were seen to be upregulated 
on the surfaces at 24 hours (also at 72 hours when compared with SMO surfaces). 
Although the differentially regulated genes on the modified surfaces were 
upregulated at 72 hours when compared to the control, the relatively lower 
expression at 72 hours (when compared to 24 hours) provides insight into the 
temporal sequence of the gene expression associated with osteogenic differentiation 
in response to surface micro-roughness. 
The osteogenic influence of the modified surfaces was demonstrated by 
confirming the upregulation of the osteogenic markers, integrin-binding sialoprotein 
(IBSP) and osteocalcin (BGLAP) at 24 and 72 hours, compared with smooth 
surfaces. Furthermore, we also showed that the modified surfaces stimulated the 
expression of the pro-osteogenic differentiation factors BMP2, BMP6, and GDF15, 
in keeping with previous reports (Vlacic-Zischke et al. 2011). The mineralization 
potential of modSLA and SLA surfaces was confirmed by earlier and higher Alizarin 
Red S staining and calcium content, as well as changes in osteoblast cell morphology 
in the form of increased cellular processes and secretory granules. These findings 
demonstrate that the activation of the pro-osteogenic cell signaling pathways by 
modSLA and SLA surfaces leads to enhanced osteogenic differentiation and matrix 
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mineralization and provide mechanistic insight into the superior osseointegration on 
the modSLA and SLA surfaces that is observed in vivo. The correlation between the 
accelerated expression of the TGFβ/BMP, Wnt, and Notch signaling pathways and 
the superior osteogenic properties of modSLA and SLA surfaces, as described in this 
study, emphasize the importance of these signaling pathways in bone formation, and 
therefore, modulation of these pathways using chemical and biological modulators 
may result in improved bone formation in demanding clinical conditions. 
This study also showed that the vast majority of the statistically significant 
changes in gene expression were found in the comparison of both modSLA and SLA 
with SMO, but not between SLA and modSLA. This suggests that surface micro-
roughness, common to both SLA and modSLA, rather than the distinguishing 
features of modSLA (nano-roughness, hydrophilicity, reduced surface 
contamination), is predominantly responsible for promoting osteogenic 
differentiation. Further, it implies that hydrophilicity may accelerate clinical 
osseointegration by also influencing biological mechanisms other than those directly 
associated with osteogenesis, such as indirectly promoting bone formation via an 
immunomodulatory effect on the inflammatory response (Hamlet et al. 2012). 
6.5 CONCLUSIONS 
The results of the study show that the pro-osteogenic cues of the modSLA and 
SLA surfaces promote the early activation of TGFβ/BMP, Wnt (especially the 
Wnt/Ca
2+
 pathway), and Notch pathways, which are likely to be responsible for the 
subsequent accelerated differentiation of the osteoprogenitor cells. The differences in 
the gene expression pattern between the modSLA and SLA surfaces were subtle, 
indicating that the surface micro-roughness feature that is common to both surfaces 
is primarily responsible for the activation of TGFβ/BMP, Wnt, and Notch pathways 
early in the process of osteogenic differentiation. 
6.6 SUPPLEMENTARY MATERIAL 
The expression pattern of keys genes involved in signal transduction on 
modSLA and SLA surfaces were compared with the control SMO surfaces at each 
time-point (24 hours and 72 hours). Expression patterns were also compared between 
modSLA and SLA surfaces (Figure 6-8 and 6-9). Furthermore, the relative 
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expression of genes for each type of disc at 72 hours was compared with the 
expression at 24 hours (Figure 6-10). 
 
Figure 6-8: Relative gene expression profile of human alveolar bone derived cells on modSLA, SLA, 
and smooth (polished) (SMO) titanium surfaces after 24 hours of culture. (a: Relative expression on 
modSLA vs. SMO; b: Volcano plot – modSLA vs. SMO;  c: Relative expression on SLA vs. SMO; d: 
Volcano plot – SLA vs. SMO; e: Relative expression on modSLA vs. SLA; f: Volcano plot – 
modSLA vs. SLA. The black line indicates a fold change of 1, pink line indicates 2 fold change and 
the horizontal blue line in the graph  indicates p-value = 0.05). 
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Figure 6-9: Relative gene expression profile of human alveolar bone derived cells on modSLA, SLA, 
and smooth (polished) (SMO) titanium surfaces after 72 hours of culture. (a: Relative expression on 
modSLA vs. SMO; b: Volcano plot – modSLA vs. SMO; c: Relative expression on SLA vs. SMO; d: 
Volcano plot – SLA vs. SMO; e: Relative expression on modSLA vs. SLA; f: Volcano plot – 
modSLA vs. SLA. The black line indicates a fold change of 1, pink line indicates 2 fold change and 
the horizontal blue line in the graph  indicates p-value = 0.05). 
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Figure 6-10: Relative gene expression profile of human alveolar bone derived cells on modSLA, SLA 
and SMO (polished) titanium surface. (a: Relative expression on modSLA 72 hours vs. 24 hours; b: 
Volcano plot – modSLA 72 hours vs. 24 hours;  c: Relative expression on SLA 72 hours vs. 24 hours; 
d: Volcano plot – SLA 72 hours vs. 24 hours; e: Relative expression on SMO 72 hours vs. 24 hours; f: 
Volcano plot – SMO 72 hours vs. 24 hours. The black line indicates a fold change of 1, pink line 
indicates 2 fold change and the horizontal blue line in the graph  indicates p-value = 0.05). 
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Abstract 
Superior osseointegration and in vitro osteogenic differentiation properties of 
micro-roughened titanium implant surfaces, like the sand-blasted, large grit, acid-
etched (SLA) and its successor, the chemical modified hydrophilic SLA (modSLA) 
surfaces, have provided us with critical molecular cues pertaining to the process of 
osteogenesis. Our previous studies have demonstrated the upregulation of the pro-
osteogenic TGFβ/BMP & Wnt/Ca2+ cell signaling pathways and a simultaneous 
downregulation of microRNAs with putative targets in these pathways, on the 
modSLA and SLA surfaces compared with smooth polished (SMO) surfaces. The 
present study aimed at exploring the influence of two such miRNAs (miR-26a & 
miR-17) on the TGFβ/BMP & Wnt/Ca2+ pathways during osteogenesis. Osteogenic 
differentiation studies on human osteoblast-like SAOS-2 cells overexpressing miR-
26a & miR-17, showed lower expression of TGFβ/BMP & Wnt/Ca2+ genes and 
osteogenic markers. Osteo-inhibitory effects of intrinsic miR-26a & miR-17 were 
also demonstrated by inducing osteo-differentiation in presence of pro-inflammatory 
cytokine, TNFα. The higher expression of miR-26a & miR-17, coupled with lower 
expression of TGFβ/BMP and Wnt/Ca2+ pathways, in presence of TNFα, 
strengthened the correlations between them and osteoinhibition. Dual luciferase 
reporter assays confirmed WNT5A and SMAD1 as targets for miR-26a; and 
PPP3R1, NFAT5 and BMP2 as targets for miR-17, establishing the role of miR-26a 
and miR-17 in the regulation of TGFβ/BMP and Wnt/Ca2+ pathways. Further, 
exploring the cross-talk between the TGFβ/BMP & Wnt/Ca2+ pathways using 
recombinant human BMP2 and KN-93 (Wnt/Ca
2+
 pathway inhibitor), demonstrated a 
positive influence of the TGFβ/BMP pathway on the activation of the Wnt/Ca2+ 
pathway. Finally, the study observed an accelerated mineralization and osteogenic 
differentiation on polished titanium surfaces upon the use of inhibitors for miR-26a 
and miR-17 (i-miR-26a and i-miR-17), thereby highlighting the impact of 
suppressing miRNAs that inhibit the pro-osteogenic TGFβ/BMP & Wnt/Ca2+ 
pathways. Therefore, the study concluded an intricate miRNA modulated control of 
cell signaling pathways that guide osteogenesis in pro-osteogenic environments. 
Synthetic miRNA modulators are novel clinical options to achieve superior 
osseointegration especially in compromised conditions. 
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7.1 INTRODUCTION 
Small non-coding RNA molecules, known as microRNAs (miRNAs) 
(approximately 22 nucleotides residues in length) have been recently identified as 
important regulators of genetic mechanisms leading to translational repression and 
gene silencing [1]. MicroRNAs have been found to be critical in the developmental 
stages of organisms and are differentially expressed in different tissues [2]. Such 
RNAs are therefore considered vital for the initiation and propagation of various 
biological processes. They are considered as key regulators of the cellular 
development and differentiation process [3] and have been shown to influence the 
process of bone formation [4] and osseointegration [5].  
 Osseointegration is a dynamic biological process that eventually leads to a 
functional union of orthopedic and dental implants with the surrounding bone tissue. 
The clinically established micro-roughened titanium implant surfaces, like the sand-
blasted, large-grit, acid-etched (SLA) and its successor, the chemically modified, 
modSLA surfaces, are known to have improved osseointegration and bone formation 
compared with smooth and polished (SMO) surfaces [6, 7]. Osseointegration is 
known to occur either via new bone formation on the implant surface from 
surrounding bone (distance osteogenesis), or by direct deposition of new bone on the 
surface of the implant (contact osteogenesis) as seen commonly on micro-roughened 
surfaces [8]. Therefore, the micro-rough SLA and modSLA surfaces provide 
interesting cues regarding the molecular regulation process during bone formation. 
Gene expression and cell signaling studies on SLA and modSLA surfaces have 
demonstrated early stimulation of the pro-osteogenic TGFβ/BMP and Wnt/Ca2+ cell 
signaling pathways [9-12]. Recently, we have demonstrated differential regulation of 
several microRNAs on these surfaces. Several of the miRNAs downregulated on the 
modSLA and SLA surfaces compared with SMO surfaces have been shown to have 
predicted targets in the TGFβ/BMP and Wnt/Ca2+ pathways [13]. 
 The microRNAs, miR-26a and miR-17 have been recently described to 
modulate the process of osteogenic differentiation and bone formation [4, 14]. These 
microRNAs were found to be downregulated on modSLA and SLA surfaces 
compared with SMO surfaces after 24 hours of culture of osteoprogenitor cells [13]. 
Although, both miR-26a and miR-17 are seen to have several putative targets in the 
TGFβ/BMP and Wnt/Ca2+ signaling pathways; yet their role in the functional 
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regulation of these pathways during the process of osteogenic differentiation hasn’t 
been explored. The aim of this study was to explore the role of these microRNAs in 
modulation of the TGFβ/BMP and Wnt/Ca2+ pathways during the process of 
osteogenic differentiation and to further study the inter-relationship between these 
two cell signaling pathways. 
7.2 MATERIALS AND METHODS 
7.2.1 Titanium implant surfaces 
All the titanium discs used for this study (modSLA, SLA and SMO) were 
provided by Institut Straumann (Basel, Switzerland) and were manufactured from 
grade II commercially pure titanium. Briefly, the SLA surfaces were prepared by 
sand-blasting the titanium surface with corundum (250-500 µm) and etched with acid 
– hot solution of hydrochloric/sulfuric acids. The modSLA surfaces were obtained by 
rinsing the SLA discs in a nitrogen environment and stored in isotonic saline solution 
at a pH=4-6. The process is known to produce a hydrophilic surface with reduced 
carbon contamination on the surface [15]. Polished titanium surfaces with smooth 
mirror-finish were categorized as SMO surfaces. 
7.2.2 MicroRNA mimics and inhibitors 
Synthetic microRNA mimics - miR-26a (mature ID: miR-26a-5p) and miR-17 
(mature ID: miR-17-5p); and negative control (miR-NC) were purchased from 
Ambion® (Life Technologies - Applied Biosystems,  Mulgrave, VIC, Australia). The 
synthetic miRNA inhibitors for miR-26a-5p (i-miR-26a) and miR-17-5p (i-miR-17) 
and negative control (i-miR-NC) were obtained from Sigma Aldrich Pty Ltd. (Castle 
Hill, NSW, Australia). 
7.2.3 Cytokines, growth factors and cell signaling modulators 
The pro-inflammatory cytokine, recombinant human Tumor Necrosis Factor-α 
(TNFα) was purchased from Gibco® (Life Technologies - Applied Biosystems, 
Mulgrave, VIC, Australia). Recombinant human bone morphogenetic protein-2 
(HumanKine
TM
 BMP2) and KN93, an inhibitor of Ca
2+
/calmodulin-dependent 
protein kinases II (CAMKII-the read-out of the Wnt/Ca
2+
 pathway) were obtained 
from Sigma Aldrich Pty Ltd. (Castle Hill, NSW, Australia). 
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7.2.4 Cell culture 
Human alveolar bone derived osteoprogenitor cells (BCs) were collected from 
healthy volunteers. Cells were cultured from redundant tissues following third molar 
extraction surgery as described previously [16-18]. BCs (5 × 10
4
 cells/disc) were 
exposed to modSLA, SLA, and SMO surfaces (six discs of each kind were used) for 
6 and 24 hours and cultured as discussed in details in our earlier reports [12, 13]. 
Human osteoblast-like SAOS-2 cells were used to study the role of miR-26a and 
miR-17 during osteogenic differentiation. Osteogenic differentiation was induced by 
supplementing the standard culture media (Dulbecco's Modified Eagle's Medium 
(DMEM) + 10% fetal bovine serum (FBS) and antibiotics – 100 U/ml penicillin/100 
μg/ml streptomycin) with 100 nM dexamethasone, 0.2 mM L-ascorbic acid and 10 
mM β-glycerophosphate (standard osteogenic media). Cytokine experiments were 
conducted by supplementing osteogenic media with TNFα (0.5 ng/ml) and 
comparing them with controls without cytokines. The inter-relationship between 
TGFβ/BMP and the non-canonical Wnt/Ca2+ pathways were studied on BCs cultured 
in standard media with/without HumanKine
TM
 BMP2 and KN93, and compared with 
appropriate controls. 
7.2.5 Transfections 
MicroRNA mimics and inhibitors were transfected using X-tremeGENE HP 
DNATransfection Reagent (Roche Diagnostics Australia Pty Limited, Castle Hill, 
NSW, Australia). Briefly, miRNA-mimics/inhibitors (30 pmoles) were mixed with 
the transfection reagent in Opti-MEM® I Reduced Serum Media (Life Technologies 
- Applied Biosystems, Mulgrave, VIC, Australia) (in absence of antibiotics), and 
incubated for 30 minutes at room temperature before adding to the cells. After six 
hours, the transfection mixes were replaced with standard osteogenic media. 
Transfection protocol was confirmed by transfecting positive control microRNA 
(miR-1) (Pre-miR™ hsa-miR-1 miRNA Precursor Positive Control from Ambion® 
by Life Technologies - Applied Biosystems,  Mulgrave, VIC, Australia) and 
observing the downregulation of Twinfilin-1 (PTK9) gene by quantitative real-time 
polymerase chain reaction (qPCR). Further, the transfection efficiencies were tested 
by qPCR for miR-26a and miR-17. 
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7.2.6 TGFβ/BMP and Wnt/Ca2+ pathway interactions 
The interaction between TGFβ/BMP and Wnt/Ca2+ pathways was studied using 
stimulants and inhibitors for these pathways. Recombinant human BMP2 
(HumanKine
TM
 BMP2) is known to activate the BMP pathway, and leads to 
phosphorylation of the intra-cellular transducer molecules for the pathway (SMADs). 
The chemical, KN93 is known to inhibit the Wnt/Ca
2+
 pathway read-out, 
Ca
2+
/calmodulin-dependent protein kinase (CAMKII). Human osteoprogenitor cells 
were cultured in standard media and supplemented with HumanKine
TM
 BMP2 (10 
ng/ml) and/or KN93 (10 µM). 
7.2.7 Dual luciferase reporter gene constructs 
The predicted targets in the TGFβ/BMP and Wnt/Ca2+ pathways for miR-26a 
and miR-17 (based on TargetScan predictions as described in our previous work 
[13]), were cloned into the pmirGLO Dual-Luciferase miRNA Target Expression 
Vector (Promega Australia, Alexandria, NSW, Australia). The predicted target 
regions for the genes were cloned between the SacI and XbaI regions in the 
pmirGLO vector such that the potential target is inserted 3’ of the firefly luciferase 
gene (SacI and XbaI restriction enzymes purchased from Genesearch Pty Ltd., 
Arundel, QLD, Australia). The ligated products were transformed into Alpha-Select 
Silver Efficiency Competent Cells obtained from Bioline (Aust) Pty Ltd (Alexandria, 
NSW, Australia). The genes considered for experimental target validation are 
detailed in Table 7-1. Following the transformations, single colonies were picked and 
cultured in Luria Broth (LB)/Ampicillin (100 µg/ml). Plasmids were extracted after 
16 hours of culture using Nucleospin Plasmid extraction kit (Macherey Nagel GmbH 
& Co. KG, Dueren, Germany). The plasmids sequences were verified by sequencing 
at the Australian Genome Research Facility Ltd (AGRF) (University of Queensland, 
Brisbane, Australia). 
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Table 7-1: TGFβ/BMP and Wnt/Ca2+ pathway genes predicted as targets for miR-26a and miR-17 and 
chosen for the experimental target validation using luciferase assay. 
 
 
 
 
 The microRNAs, miR-26a & miR-17 and TGFβ/BMP & Wnt/Ca2+ pathways relationship 173 
7.2.8 Luciferase assays 
Hep2 (HeLa derivative) cells were used for the luciferase assays. The cells 
were co-transfected with 10 pmoles of either miR-26a/miR-17 or miR-NC mimic and 
50 ng of their predicted gene plasmids, using X-tremeGENE HP DNA Transfection 
Reagent (Roche Diagnostics Australia Pty Limited, Castle Hill, NSW, Australia). 
The protocol was similar to miRNA mimics transfections as described above. 
Briefly, the plasmid and miRNA mimic were incubated for 30 minutes with the 
transfection reagent separately in Opti-MEM® I Reduced Serum Media (Life 
Technologies - Applied Biosystems, Mulgrave, VIC, Australia) (in absence of 
antibiotics). This mix was used to incubate Hep2 cells for 6 hours, following which 
the media was replaced with standard culture media. Luciferase assays were 
performed after 24 hours using the Dual-Glo® Luciferase Assay System (Promega 
Australia, Alexandria, NSW, Australia) as per the manufacturer’s protocol. The 
firefly luciferase activity was measured using a luminometer and was normalized 
using the the Renilla luciferase internal control. 
7.2.9 Quantitative real-time polymerase chain reaction (qPCR) 
cDNA for the detection of mRNAs (gene expression) was prepared from RNA 
templates by reverse transcription using DyNAmo
TM
 cDNA Synthesis Kit 
(Finnzymes Oy., Vantaa, Finland) according to the manufacturer’s protocol. For the 
detection of microRNAs, cDNA was prepared using the miRCURY LNA
TM
 
Universal RT microRNA PCR (Exiqon A/S, Vedbaek, Denmark). The mRNA 
expression levels for genes of the TGFβ/BMP and Wnt/Ca2+ pathways and the 
miRNAs, miR-26a and miR-17, were investigated. The full list of genes and primers 
used for detection of mRNAs are shown in Table 7-2. The microRNA primers sets 
were purchased from Exiqon A/S (Vedbaek, Denmark) (miRCURY LNA
TM
 
Universal RT microRNA PCR LNA
TM
  PCR primer sets: hsa-miR-26a-Product No. 
204724; hsa-miR-17-Product No. 204771 and U6 snRNA-Product No. 203907). 
Quantitative real time PCR (qPCR) reactions were performed using ABI PCR 
machines (ABI Prism 7900HT Sequence Detection System, ABI Prism 7000 
Sequence Detection System and ABI Prism 7300 Sequence Detection System - 
Applied Biosystems). Consistency with the starting amount of RNA (≥100 ng) was 
maintained for each part of the study. The reactions were incubated at 95 °C for 10 
minutes for 1 cycle, and then 95 °C (15 seconds), 60 °C (for 1 minute) for 40 cycles. 
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PCR reactions were validated by observing the presence of a single peak in the 
dissociation curve analysis. The housekeeping gene, glyceraldehyde-3-phosphate-
dehydrogenase (GAPDH) was used as an endogenous reference gene for analysis of 
mRNAs using the Comparative Ct (Cycle of threshold) value method. The ΔCT value 
was obtained by subtracting the average Ct value of the endogenous references 
selected from the test mRNA Ct value of the same samples. U6 snRNA (hsa, mmu, 
rno) was used as the reference miRNA gene for analysis of miRNA expressions. The 
relative levels of expression of mRNAs and miRNAs were compared between the 
samples using the Student’s t-test. The critical value for significance was set at 
p<0.05. Fold changes were calculated relative to the control sample in each case. 
Table 7-2: List of gene primers used for the study. 
 
Gene name  Forward primer (5’→3’) Reverse primer (5’→3’) 
   
WNT5A  TCTCAGCCCAAGCAACAAGG  GCCAGCATCACATCACAACAC  
FZD6  GCGGAGTGAAGGAAGGATTAG  ACAAGCAGAGATGTGGAACC  
FZD2 GTGCCATCCTATCTCAGCTACA GACCAGGTGAGGATCCAGAG 
BMP2  CGCAGCTTCCACCATGAAGAATC  CCTGAAGCTCTGCTGAGGTG  
BMP6  CAGGAGCATCAGCACAGAGAC  GCTGAAGCCCCATGTTATGCTG  
BMPR1A CCTGGGCCTTGCTGTTAAATTCA TCCACGATCCCTCCTGTGAT 
SMAD1 GTATGAGCTTTGTGAAGGGC TAAGAACTTTATCCAGCCACTGG 
SMAD4 CTCCAGCTATCAGTCTGTCAG CCCGGTGTAAGTGAATTTCAAT 
SMAD5 TCATCATGGCTTTCATCCCACC GCTCCCCAACCCTTGACAAA 
GAPDH  TCAGCAATGCCTCCTGCAC  TCTGGGTGGCAGTGATGGC  
 
7.2.10 Western Blotting 
 To assess for the activation of the TGFβ/BMP and Wnt/Ca2+ pathways, cells 
were first washed with cold PBS and then lysed with Hepes-Triton protein lysis 
buffer (20 mM Hepes, 2 mM EGTA, 1% Triton X-100, 10% Glycerol, pH=7.4). The 
lysis buffer was supplemented with appropriate dilutions of protease inhibitor 
(cOmplete ULTRA Tablets, Mini, EDTA-free, EASYpack - Roche Diagnostics 
Australia Pty Limited, Castle Hill, NSW, Australia) and phosphatase inhibitors 
(PhosSTOP Phosphatase Inhibitor Cocktail Tablets - Roche Diagnostics Australia 
Pty Limited, Castle Hill, NSW, Australia). The total protein concentration was 
calculated by using the BCA Protein Assay Kit (bicinchoninic acid) (Thermo 
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Scientific Pierce Protein Biology Products, Rockford, Illinois, USA). The protein 
samples were fractionated by gel electrophoresis in 10% polyacrylamide gels under 
reducing conditions and were transferred to nitrocellulose membranes. The 
membranes were blocked with 5% bovine serum albumin (BSA) and probed with 
primary antibodies overnight at 4 °C. The next day, the blots were washed with Tris 
Buffered Saline-Tween (TBST) and then probed with their appropriate secondary 
antibodies. The blots were again washed (three times) with TBST and then imaged 
either using enhanced chemiluminescence (ECL) or fluorescence based methods. 
The antibodies used for the study are listed in Table 7-3. 
Table 7-3: List of antibodies used for Western Blots. 
 
7.2.11 Alkaline phosphatase activity and Alizarin-Red S staining 
Intracellular ALP activity was determined with the Quantichrom™ Alkaline 
Phosphatase Assay Kit (Gentaur Belgium BVBA, Kampenhout, Belgium), a p-
nitrophenyl phosphate (pNP-PO4) based assay. Osteoblastic cells were rinsed twice 
with PBS, and lysed in 200µl of 0.2% Triton X-100 in MilliQ water, followed by 20 
minutes agitation at room temperature. A 50 µl sample was then mixed with a 100 μl 
working solution and absorbance was measured after 5 min at 405 nm in a 
microplate reader. Extracellular matrix deposition was determined by fixing the cells 
in 4% paraformaldehyde and staining with a 1% Alizarin-Red S solution. 
7.3 RESULTS 
7.3.1 Expression of miR-26a & miR-17 and key BMP and Wnt/Ca2+ genes on 
modified titanium implant surfaces 
qPCR based evaluation of the pattern of expression of the microRNAs on the 
modified titanium surfaces compared with SMO surfaces following 6 hours of 
exposure of BCs showed lower expression of miR-26a and miR-17 on modSLA and 
SLA surfaces (modSLA<SLA<SMO) (Figure 7-1). The expression of the genes: 
BMP2, BMP6 (TGFβ/BMP pathway), WNT5A and FZD6 (Wnt/Ca2+ pathway) were 
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seen to be higher on modSLA and SLA surfaces (modSLA and SLA > SMO 
surfaces) following 24 hours of culture of BCs on modSLA, SLA, and SMO surfaces 
(Figure 7-1). 
 
Figure 7-1: qPCR expression analysis of miR-26a & miR-17 and genes of TGFβ/BMP and Wnt/Ca2+ 
pathway on modSLA, SLA & SMO surfaces. (y-axis: relative fold changes to SMO)(*: p<0.05, 
modSLA vs. SMO; #: p<0.05, SLA vs. SMO; p<0.05, †: p<0.05, modSLA vs. SLA). Lower 
expression of miR-26a and miR-17 on modSLA and SLA surfaces compared with SMO surfaces was 
observed (6 hours exposure). This was associated with increased expression of TGFβ/BMP (BMP2, 
BMP6) and Wnt/Ca
2+
 (WNT5A, FZD6) genes (24 hours exposure) on modSLA and SLA surfaces.  
7.3.2 Effect of osteo-inhibitory environment on expression of miR-26a & miR-
17 and TGFβ/BMP & Wnt/Ca2+ genes 
Osteo-inhibitory environment was created by supplementing osteogenic media 
with the pro-inflammatory cytokine - TNFα (0.5 ng/ml) and was used to culture 
osteoblast-like SAOS-2 cells. Osteogenic media without any cytokine 
supplementation was used as control for these experiments. Inhibition in osteogenic 
differentiation was confirmed by observing reduced ALP activity and Alizarin Red S 
staining in presence of cytokine (Figure 7-2A). qPCR analysis demonstrated higher 
expression of miR-26a and miR-17 in presence of TNFα during osteogenic 
differentiation (Figure 7-2B). This was coupled with decreased expression of BMP2 
and WNT5A (key ligands for the TGFβ/BMP and Wnt/Ca2+ pathways, respectively) 
(Figure 7-2B). Reduced expression of SMAD4 and SMAD5 was also observed in 
presence of cytokines (Figure 7-2B). 
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Figure 7-2: Effect of osteo-inhibitory environment on expression of miR-26a & miR-17 and 
TGFβ/BMP and Wnt/Ca2+ genes (A) Alizarin Red S staining and ALP activity levels after 3 & 7 days 
of culture in osteogenic media (OM) (Control) or in presence of OM+TNFα 0.5 ng/ml (TNFα) 
confirm OM+TNFα as osteoinhibitory environment. (*: p<0.05, Control vs. TNFα). (B) qPCR 
expression analysis of miR-26a & miR-17 and genes of TGFβ/BMP and Wnt/Ca2+ pathway in osteo-
inhibitory environment (OM+TNFα 0.5 ng/ml: designated as TNFα) compared to OM (Control). 
Higher expression of miR-26a and miR-17, simultaneous with lower expression of BMP2, SMAD4, 
SMAD5 (TGFβ/BMP) and WNT5A (Wnt/Ca2+) was observed in OM+TNFα (y-axis: relative fold 
changes to Control) (*: p<0.05, Control vs. TNFα) following 3 days of culture. 
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7.3.3 Over-expression of miR-26a and miR-17 and their effect on TGFβ/BMP 
and Wnt/Ca
2+
 pathway 
Synthetic miRNA mimics, miR-26a and miR-17 were transfected into human 
osteoblast-like, SAOS-2 cells and osteogenic differentiation was induced. The 
mRNA expression pattern of important genes of the TGFβ/BMP and Wnt/Ca2+ 
pathway was examined (Figure 7-3). qPCR analysis showed a significantly decreased 
expression of the WNT5A (representative ligand for the non-canonical Wnt/Ca
2+
 
pathway) in miR-26a and miR-17 samples after 24 hours of transfection of the 
miRNAs. The differences persisted even after 3 days of culture. The non-canonical 
receptor, FZD2 was seen to have lower expression within 24 hours of transfection 
with miR-17, and subsequently all the test samples showed higher expression (except 
for miR-17 at day 14). A sharp decline in the expression of FZD2 was observed in 
miR-26a overexpressing cells after 72 hours. There were no other noteworthy 
differences observed at other time-points, except at day 14, where it showed 
significantly reduced expression with miR-26a and miR-17 samples compared to 
miR-NC. BMP2 was significantly downregulated in miR-17 overexpressing cells at 
day 1 and 3 (compared with miR-NC). The expression of BMP2 wasn’t appreciable 
at day 14 in miR-17 transfected samples. BMP2 expression was decreased when 
miR-26a was overexpressed (significant differences were observed after three days). 
miR-26a and miR-17 samples showed higher expression of BMP2 at day 7. 
BMPR1A showed decreased expression within one day of miR-26a overexpression, 
although higher expression was observed at later time-points (day 7 and day 14). 
Decreased expression levels were observed with miR-17 transfections compared with 
miR-NC almost at each time-point. BMPR2 and SMAD4 demonstrated similar 
trends, except at day 1 with miR-17 overexpression. SMAD1 showed reduced 
expressions with miR-26a and miR-17 samples (especially at days 1 and 3). 
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Figure 7-3: qPCR expression analysis of genes of the TGFβ/BMP (BMP2, BMPR1A, BMPR2, 
SMAD1, and SMAD4) and Wnt/Ca
2+
 pathway  (WNT5A, FZD2) after transfecting cells with miR-
mimics and inducing osteogenic differentiation (miR-NC: negative control)(y-axis: fold change 
relative to miR-NC day 1). Lower expression of the genes was observed in miR-26a and miR-17 
overexpressing cells compared to miR-NC (especially after 1 and 3 days of culture in OM following 
transfection).  
 
The effects of overexpressing miR-26a and miR-17 on the cell signaling 
pathways were further tested at the level of protein expression. The read-outs of the 
Wnt/Ca
2+
 (phospho-CAMKII and pan-CAMKII) and TGFβ/BMP pathway (phospho-
SMAD1/5/8 and total SMAD1/5/8) were observed (Figure 7-4). A relatively lower 
expression of phospho-CAMKII was observed in cells transfected with miR-26a 
samples compared with miR-NC (at day 1 and day 3). Lower expression of phospho-
CAMKII and pan-CAMKII was also observed with miR-17 cells at day 1; however, 
the expression levels seemed to improve in these samples by day 3. The expression 
of phospho-CAMKII was seen to be lower even at day 3 in miR-26a transfected 
cells. However, this wasn’t overtly obvious with miR-17 at that time-point. The 
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expression of phospho-SMAD1/5/8 was significantly lower in miR-17 expressing 
cells (both at day 1 and day 3) indicating a decreased activation of the TGFβ/BMP 
pathway. 
 
Figure 7-4: Western Blots following 1 and 3 days of transfecting miR-26a and miR-17.  Phospho-
CAMKII and pan-CAMKII are read-outs for the Wnt/Ca
2+
 pathway; and phospho-SMAD1/5/8 is the 
read-out for the activation of TGFβ/BMP pathway. Lower expression of read-outs of Wnt/Ca2+ and 
TGFβ/BMP pathways was observed following miR-26a and miR-17 transfections. 
 The effects of miR-26a and miR-17 over-expression on mineralization and 
osteogenic differentiation of cells was also studied (Figure 7-5). A lower Alizarin 
Red S staining was noted in miR-26a and miR-17 transfected cells in comparison 
with miR-NC (day 7 and day 14). Alkaline phosphatase (ALP) activity in the 
transfected samples was also assessed at days 1, 3, 7 and 14. The miR-26a and miR-
17 over-expressing cells were seen to have lower ALP activity (normalized to total 
protein) relative to miR-NC at each time-point. miR-26a was seen to have a 
relatively higher activity compared to miR-17 at day 7; however, it showed a drop at 
day 14. 
 
Figure 7-5: Osteogenic differentiation following miR-26a and miR-17 transfections. Alizarin Red S 
staining images after 7 and 14 days of culturing miRNA-mimic transfected SAOS-2 cells in 
osteogenic media (OM) (miR-NC: Negative Control; miR-26a & miR-17). Reduced matrix deposition 
was observed in miR-26a and miR-17 transfected cells when compared with miR-NC controls at each 
time-point demonstrating inhibition of osteogenic differentiation in miR-26a & miR-17 transfected 
cells. ALP activity also demonstrated similar features. The ALP activity values were consistently 
lower in miR-26a and miR-17 transfected cells. 
 The microRNAs, miR-26a & miR-17 and TGFβ/BMP & Wnt/Ca2+ pathways relationship 181 
7.3.4 Target validation experiments 
Bioinformatics based target predictions using the online tool, TargetScan with 
a focus on the Wnt/Ca
2+
 and TGFβ/BMP pathways (according to KEGG pathway 
[19] based map), predicted several targets for the miR-26a and miR-17. The details 
of this sorting and predictions can be found in our previous work [13]. The miRNAs 
and their potential targets with their seed matching regions are shown in Table 7-1. 
The predicted target regions were cloned into the pmirGLO Dual-Luciferase vector 
(target region inserted 3’ of the firefly luciferase gene). The different clones were co-
transfected with the predicted miRNAs separately into Hep2 cells. The clones were 
also co-transfected with miR-NC (as a negative control). The luciferase activities 
(Firefly-F and Renilla-R) were tested after 24 hours of transfections and the ratios 
were calculated (F/R). 
 
Figure 7-6: Target validation experiments for miR-26a and miR-17 using Dual-luciferase reporter 
assays. Lower relative firefly luminescence in miR-26a/miR-17 compared to miR-NC asserted 
WNT5A and SMAD1 as targets for miR-26a and PPP3R1, NFAT5 and BMP2 as targets for miR-17 
(Fold changes in F/R ratios for miR-26a/miR-17 relative to miR-NC F/R ratios). 
Fold changes were calculated as Ratio=(F/R)miR-26a/miR17/(F/R)miR-NC. Ratios <1, 
were also noted as the negative reciprocal of the ratio (-1/Ratio). The WNT5A     
(FC: -2, p=0.007) (Wnt/Ca
2+
 pathway) and SMAD1 (FC: -1.7, p=0.004) (TGFβ/BMP 
pathway) showed statistically significant decline in F/R ratios with miR-26a. 
PPP3R1 (FC: -1.4, p=0.038), NFAT5 (FC: -1.5, p=0.048) (Wnt/Ca
2+
 pathway) and 
BMP2 (FC: -1.7, p=0.0004) (TGFβ/BMP pathway) showed significantly lower F/R 
ratios (miR-17/miR-NC). The relative Firefly/Renilla luciferase ratios (miR-26a or 
miR-17/miR-NC co-transfections) are shown in Figure 7-6. 
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7.3.5 TGFβ/BMP and Wnt/Ca2+ cross-talk 
To test whether the Wnt/Ca
2+
 pathway and the TGFβ/BMP pathway influence 
each other’s expression, activation and inhibition strategies were used. The impact of 
Wnt/Ca
2+
 pathway inhibition on the activation of the TGFβ/BMP pathway was tested 
using KN93 (selective Ca
2+
/calmodulin-dependent protein kinase II inhibitor). Cells 
were stimulated with Humankine
TM
 recombinant BMP2 for 60 minutes and 120 
minutes in the absence and presence of KN93. Simultaneously, un-stimulated 
controls (with and without KN93) were tested for activation of TGFβ/BMP pathway. 
No difference was observed in the level of expression of phospho-SMAD1/5/8 in 
presence or absence of KN93 (Figure 7-7A). 
 
Figure 7-7: The TGFβ/BMP & Wnt/Ca2+ pathway cross-talk. (A) Human osteoprogenitor cells were 
stimulated with recombinant human BMP2 in presence or absence of KN93 (inhibitor of Wnt/Ca
2+
 
pathway). Presence of KN93 did not change the level of activation of the TGFβ/BMP pathway 
(activation of phospho-SMAD1/5/8 - the read-out for the pathway). (B) Effect of stimulation of the 
TGFβ/BMP pathway on the activation of phospho-CAMKII and pan-CAMKII (read-outs for the 
Wnt/Ca
2+
 pathway). Higher expression of Wnt/Ca
2+
 pathway read-outs was observed when 
osteoprogenitor cells were stimulated with BMP2. 
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 Therefore, inhibition of the Wnt/Ca
2+
 pathway did not seem to affect the 
activation/inhibition of the TGFβ/BMP pathway. Further, the influence of the 
activation of TGFβ/BMP pathway on the Wnt/Ca2+ pathway activation was also 
tested.  Human osteoprogenitor cells were stimulated with recombinant human 
BMP2 (10 ng/ml), and the expression of phospho- and pan-CAMKII was evaluated 
using Western Blot. The expression of CAMKII was seen to increase in cells 
following stimulation with BMP2 indicating a positive influence of BMP2 
stimulation on Wnt/Ca
2+
 pathway (Figure 7-7B). 
7.3.6 Inhibition of miR-26a and miR-17 improves osteogenic differentiation on 
smooth surfaces 
Synthetic inhibitors of miR-26a (i-miR-26a) and miR-17 (i-miR-17) were 
transfected into SAOS-2 cells and exposed to SMO (smooth/polished) titanium 
surfaces. A negative control miRNA inhibitor (i-miR-NC) was also transfected into 
SAOS-2 cells and incubated on SMO surfaces. qPCR analysis of BMP2 (TGFβ/BMP 
pathway) and WNT5A (Wnt/Ca
2+
 pathway) showed higher expression in i-miR-26a 
and i-miR-17 transfected cells (Figure 7-8A). The effect on the expression BMP2 
seemed more prominent at day 1. In contrast to this, i-miR-26a and i-miR-17 were 
seen to have more striking effects on WNT5A at day 3. Osteogenic differentiation 
was initiated and the effects of inhibition of miR-26a and miR-17 on the 
mineralization and ALP activity on SMO surface (indicators of osteoblastic 
differentiation) were evaluated. Higher Alizarin Red S staining demonstrated 
increased deposition of calcified matrix with i-miR-26a and i-miR-17 after 7 days of 
culture on SMO surfaces (Figure 7-8B). A higher ALP activity was observed in i-
miR-26a and i-miR-17 transfected cells cultured on SMO surfaces (Figure 7-8C). 
The results implied an accelerated osteogenic differentiation especially at an early 
stage following inhibition of miR-26a and miR-17. 
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Figure 7-8: Effects of inhibitors of miR-26a (i-miR-26a) and miR-17 (i-miR-17) on smooth polished 
(SMO) surfaces. (A) Relative expression of BMP2 (TGFβ/BMP pathway) and WNT5A (Wnt/Ca2+ 
pathway) following transfection of i-miR-26a and i-miR-17 transfected cells on SMO surfaces. Higher 
expression BMP2 and WNT5A was observed with i-miR-26a and i-miR-17 (y-axis: fold change 
relative to i-miR-NC day 1). (B) Alizarin Red-S staining after 7 days of transfection with i-miR-26a 
and i-miR-17 and culturing on polished titanium surfaces (SMO) in osteogenic media. Higher staining 
was observed with i-miR-26a and i-miR-17 indicating enhanced osteogenic differentiation when miR-
26a and miR-17 are inhibited. (C) Relative ALP activity on SMO surfaces in presence of i-miR-26a 
and i-miR-17 (y-axis: fold change to i-miR-NC day 7) (*: p<0.05 i-miR-NC vs. i-miR-26a; †: p<0.05 
i-miR-NC vs. i-miR-17; #: p<0.05 i-miR-26a vs. i-miR-17). 
7.4 DISCUSSION 
Micro-roughened titanium implant surfaces like the topographically modified, 
SLA and the chemically modified hydrophilic, modSLA surfaces, have become 
established as dental implants with improved osseointegration properties compared 
with their smooth and polished counterparts. Several studies have been investigating 
the molecular mechanisms involved in improved osseointegration properties of these 
surfaces [9-13, 20-23]. Osseointegration, like any other biological process occurs as 
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a culmination of a complex cascade of genetic interactions, involving sequential 
pattern of activation of cell signaling pathways. MicroRNAs regulate the expression 
of genes at the translational level [1] and thus control the activation and repression of 
cell signaling processes involved in differentiation of cells and tissues. 
Our recent studies have observed an early expression of cell signaling pathway 
molecules like the TGFβ/BMP and Wnt/Ca2+ on these surfaces and correlated them 
with the expression of microRNAs [12, 13]. Further, the microRNAs, miR-26a and 
miR-17 were found to have key cell signaling ligands of the Wnt/Ca
2+
 and 
TGFβ/BMP pathways as potential targets (miR-26a-WNT5A and miR-17-BMP2). 
These pathways are known to be activated during the process of osteogenic 
differentiation and osseointegration [24]. This study aimed at investigating the role 
of miR-26a and miR-17 in the early regulation of the key pro-osteogenic TGFβ/BMP 
and Wnt/Ca
2+
 signaling pathways during the process of osteogenesis. The study 
further explored the interaction of the TGFβ/BMP and Wnt/Ca2+ pathways to get an 
insight into how these pathways influence each other during osteogenesis. 
The expression of miR-26a and miR-17 on modSLA, SLA, and SMO surfaces 
was tested using qPCR method. The relative lower expression of miR-26a and miR-
17 on modSLA and SLA surfaces (compared with SMO), was evident within 6 hours 
of exposure of human osteoprogenitor cells to the titanium surfaces. This observation 
was in agreement with our previous study, where these miRNAs were seen to be 
downregulated on the modSLA and SLA surfaces compared with SMO following 24 
hours of exposure [13]. Furthermore, the study also confirmed the higher expression 
of the key molecules of the TGFβ/BMP (BMP2 and BMP6) and Wnt/Ca2+ (WNT5A 
and FZD6) pathway genes. These findings are in agreement with the higher 
expression of TGFβ/BMP and Wnt/Ca2+ pathways on the topographically modified 
titanium surfaces as demonstrated in several studies [9-13]. 
The modSLA and SLA surfaces, by virtue of their micro-roughened 
topography and their ability to induce “contact osteogenesis” [25], are regarded as 
pro-osteogenic platforms akin to the bone micro-topography and are considered as 
physiologically relevant substrates to study the process of osteogenesis [12, 13]. We 
postulated that the miRNA and mRNA expression patterns on these surfaces are 
possibly a result of the pro-osteogenic response on these surfaces and tested whether 
these molecules are differentially regulated in osteo-inhibitory environments. To test 
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this supposition, osteogenic differentiation of osteoblastic cells was induced in 
absence (controls) or presence of TNFα - a pro-inflammatory cytokine that is known 
to create osteo-inhibitory conditions [26]. The osteo-inhibitory effect of pro-
inflammatory cytokines was confirmed by observing relatively lower deposition of 
calcified matrix in presence of TNFα. The microRNAs, miR-26a and miR-17 were 
seen to be upregulated in presence of TNFα within 3 days. Simultaneously, the 
TGFβ/BMP (BMP2, SMAD4, SMAD5) and Wnt/Ca2+ pathway genes (especially 
WNT5A) were seen to be downregulated. The non-canonical Wnt/Ca
2+
 receptor 
FZD2 demonstrated variable expression and wasn’t very conclusive. However, FZD2 
was seen to be downregulated over the course of time between day 3 and day 7. 
Previously, Liu et al. had demonstrated the inhibition of Wnt/Ca
2+
 signaling pathway 
in inflammatory conditions [27] and this corroborates with our observations. They 
had also discussed higher expression and activation of Wnt/β-catenin pathway in 
inflammatory conditions. The expression of some of the members of the Wnt/β-
catenin pathway genes was explored in this study as well; however, the results 
weren’t conclusive to establish a trend (either activation/inhibition). The inhibition of 
TGFβ/BMP pathway in inflammatory conditions has been recorded in several studies 
[28-30]. 
The effects of miR-26a and miR-17 over-expression in osteoblastic cells were 
examined subsequently. Synthetic miR-mimics were transfected using chemical-
based methods to induce transient transfections, such that we may be able to explore 
their impact on the TGFβ/BMP and Wnt/Ca2+ pathways. Comparisons between the 
miR-NC samples and untransfected controls did not show any significant differences 
and hence strengthened the suitability of the experimental model and study 
comparisons. Therefore, to keep all parameters consistent, subsequent comparisons 
were made with miR-NC as the control. The miRNA mimics were transfected and 
osteogenic differentiation was induced following transfections. Gene and protein 
expression, ALP activity and Alizarin Red S staining were performed at different 
time-points. The effects of miR-26a and miR-17 on the cell signaling pathways were 
most evident at the earlier time-points (days 1 and 3). The later time-points (days 7 
and 14) were found to have relatively higher gene expression for most of the 
molecules. This could possibly be attributed to the fact that the initial inhibitory 
effect of the miRNAs on the signaling pathways becomes unmasked. These 
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unmasked cells, in presence of osteogenic supplements start expressing the pro-
osteogenic signaling molecules. Pro-osteogenic cell signaling processes peak during 
the early stages of differentiation and start waning following the initial highs, leading 
to lower expression of signaling molecules with a synchronized increase in 
expression of differentiation markers. The diminution in cell signaling molecules 
over a time-course during osteogenesis has been reported previously [12, 14]. 
Therefore, the relative higher expression of cell signaling molecules observed at later 
time-points in miR-26a and miR-17 overexpressing cells is possibly because the 
unmasked cells, in presence of osteogenic supplements start expressing the pro-
osteogenic signaling molecules at a later time-point and this is observed to be higher 
compared to miR-NC, where the signaling peaks have started waning. The early 
inhibition of the pro-osteogenic TGFβ/BMP and Wnt/Ca2+ pathways was clearly 
seen to delay the process of osteogenic differentiation (Figure 7-5).  
The early impact of miR-26a and miR-17 on TGFβ/BMP and Wnt/Ca2+ 
pathways was evident at the level of the protein read-outs for the pathways. 
Activation of the TGFβ/BMP pathway leads to phosphorylation of SMAD1/5/8 and 
therefore, decreased levels of phospho-SMAD1/5/8 indicate a reduced activation of 
the pathway [31, 32]. The Ca
2+
/calmodulin-dependent protein kinase (CAMKII) is a 
molecule that gets activated upon stimulation of the Wnt/Ca
2+
 pathways. Upon 
activation of the non-canonical Wnt pathway, Ca
2+
/calmodulin activates the protein 
CAMKII, which soon becomes auto-phosphorylated. CAMKII (including phospho-
CAMKII) is established as a read-out of the non-canonical Wnt/Ca
2+
 pathway [33]. 
Over-expressing miR-26a and miR-17 demonstrated reduced activation of both of 
the pathways. Lower activation of CAMKII was observed with both miR-26a and 
miR-17 at days 1 and 3 (especially phospho-CAMKII with miR-26a and pan-
CAMKII with miR-17 – Figure 7-4). The phosphorylation of SMAD1/5/8 was also 
seen to be reduced with miR-26a and miR-17 (Figure 7-4). 
Targetscan’s seed-based algorithm [34] predicted several targets genes in the 
TGFβ/BMP and Wnt/Ca2+ pathways (Table 7-1). Experimental validation of these 
potential targets indicated WNT5A and SMAD1 as targets for miR-26a and PPP3R1, 
NFAT5 and BMP2 as targets for miR-17, thereby confirming that their influence on 
the TGFβ/BMP and Wnt/Ca2+ pathways is actually via an RNA-interference 
mediated mechanism. Targeting the key ligands for both of the pathways (WNT5A 
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and BMP2) implies an inhibition of the initiation for the pathways. This coupled with 
the decreased expression of the read-outs of the pathways (CAMKII and phospho-
SMADs) confirmed the regulation of both of the cell signaling pathways by miR-26a 
and miR-17. Inhibition of osteogenic differentiation following transient transfections 
with miR-26a and miR-17 further elaborates the significance of early activation of 
the TGFβ/BMP and Wnt/Ca2+ pathways in the process of osteogenesis. Previously, 
other groups have reported the regulation of lineage commitment between 
osteogenesis and adipogenesis by miR-17 targeting BMP2 [35]; and miR-26a has 
been shown to modulate osteogenic response by targeting SMAD1 [14]. Although, a 
couple of studies have discussed the promotion of osteogenic differentiation with 
miR-26a [36, 37], other reports have discussed its negative influence on osteogenesis 
[4, 14]. Studies showing improved osteogenesis have either reported an increased 
expression of miR-26a at a late time-point during differentiation [36], or had a 
sustained delivery of miR-26a using an in vivo delivery system [37]. Further, this in 
vivo study had also described higher mineralization in mesenchymal stem cells 
(BMMSCs) with miR-26a mimic. This could possibly be attributed to the sustained 
high levels of miR-26a as observed in transfected samples in their study, as opposed 
to a steady decline in the fold-change levels of miR-26a (between miR-26a 
transfected and negative controls) in our study. The increasing levels of the 
expression of genes of TGFβ/BMP and Wnt/Ca2+ pathways at later time-points (miR-
26a compared with controls) as observed in here are also in agreement with this. 
Moreover, the protein expression of osteogenic markers, RUNX2 and OCN do not 
seem to differ much between mimics and controls in their study [37]. Although, the 
RUNX2 and OCN gene expression were seen to be higher in miR-26a mimic, yet on 
a time-course analysis for the mimic, it was seen to be gradually decreasing between 
2 and 14 days. 
The dual-luciferase reporter assay technique incorporating putative short target 
sequences (based on bioinformatics-based predictions) is an established model for 
target validation experiments for miRNAs [38]. Target predictions for miR-26a and 
miR-17 were performed using the online tool, TargetScan and only the targets 
showing these miRNAs as “representative miRNAs” (based on the context scores 
calculated) were chosen for analysis. These putative targets were screened for genes 
of the TGFβ/BMP and Wnt/Ca2+ pathways. The details for this analysis maybe found 
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in our previous work [13]. The target regions for miR-26a and miR-17 were inserted 
3’ of the firefly luciferase gene of pmirGLO Dual-Luciferase miRNA Target 
Expression vector. A significant drop in firefly luciferase signal (luminescence was 
normalized to the Renilla internal control) was observed with miR-17-PPP3R1, miR-
17-NFAT5, miR-17-BMP2, miR-26a-WNT5A and miR-26a-SMAD1 and therefore 
both of the miRNAs were seen to have targets in TGFβ/BMP and Wnt/Ca2+ 
pathways. 
The results from the study substantiated that the repression of the TGFβ/BMP 
and Wnt/Ca
2+
 pathways delays the process of osteogenesis. Activation of 
TGFβ/BMP pathway during osteogenesis has been established for long [39]. The role 
of Wnt/Ca
2+
 pathway in osteogenic differentiation is being unraveled only recently 
[27]. To explore the relationship between these two pathways, the TGFβ/BMP 
cascade was stimulated using BMP2 in presence and absence of KN93. KN93 is a 
potent inhibitor of the non-canonical Wnt/Ca
2+
 pathway [40]. No difference in the 
level of phosphorylation of SMAD1/5/8 was observed in presence or absence of 
KN93, indicating that the TGFβ/BMP pathway is independent of the stimulation of 
Wnt/Ca
2+
 pathway. In contrast to this, stimulation with BMP2 was seen to increase 
the level of expression of CAMKII (Figure 7-7). This indicates a positive influence 
of the TGFβ/BMP pathway on the activation of the Wnt/Ca2+ pathway. Other studies 
have also suggested that the non-canonical Wnt/Ca
2+
 pathway is activated following 
the stimulation of the TGFβ/BMP pathway [41, 42]. In fact, the non-canonical Wnt 
ligand, WNT5A is known to be under the influence of BMP2 guided pathways 
during osteogenesis [41]. Although, a previous study by Olivares–Navarrete et al. 
had described the stimulation of BMP2 and BMP4 when cultures on micro-
roughened modSLA and SLA surfaces were supplemented with WNT5A [20]; 
however, unlike in this study, they did not explore the effects of blocking the 
Wnt/Ca
2+
 pathway. Their findings could possibly be attributed to stimulation of the 
BMP molecules via other WNT5A-guided mechanisms beyond the Wnt/Ca
2+
 
pathway. Indeed, a more detailed exploration of these interactions with more 
sophisticated techniques like gene knock-out models in the future, may divulge 
greater details regarding the complex interactions between the two pathways.  
Finally, the study observed an accelerated mineralization and osteogenic 
differentiation along with relatively higher expression of BMP2 and WNT5A on 
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polished titanium surfaces upon the use of i-miR-26a and i-miR-17 (inhibitors), 
thereby highlighting the impact of eliminating the inhibitors of the pro-osteogenic 
signaling pathways in the early phase of differentiation. 
7.5 CONCLUSION 
Modulation of pro-osteogenic cell signaling pathways, TGFβ/BMP and 
Wnt/Ca
2+
 by microRNAs is imperative in the process of osteogenic differentiation in 
vitro and osseointegration in vivo. miR-26a and miR-17 mimics were seen to repress 
the expression of several key molecules of the TGFβ/BMP and Wnt/Ca2+ pathways 
in the early phase of osteogenic differentiation and thereby delaying the osteogenic 
processes. The use of synthetic inhibitors (i-miR-26a and i-miR-17) during early 
phase of osteodifferentiation on polished titanium surfaces was found to accelerate 
the process of osteogenesis. It is concluded that the use of modulators for miR-26a 
and miR-17 may be considered to improve osseointegration of titanium surfaces, 
which may be more beneficial in clinically demanding situations, like in regions with 
compromised bone formation thereby allowing faster osseointegration. 
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8.1 INTRODUCTION 
Osseointegration is a biological phenomenon that results in the structural and 
functional integration of an implant surface with the surrounding bone. This process 
shapes the structural framework and eventually helps in healing a fractured bone to 
regain its original shape. Implants are also known to provide the foundation for 
restoration of missing parts of the skeleton, as in case of dental implants. Implants 
are routinely used in cosmetic dentistry and have become the mainstream modality to 
restore lost or damaged parts of teeth. Since the inception of the concept of 
osseointegration by Prof. Brånemark in the 1950s and -60s [1, 2], titanium has 
remained the material of choice for dental implants, owing to its properties like high 
strength-to-weight ratio, resistance to corrosion and inertness to body fluids. The 
continued search to achieve faster and better osseointegration has lead researchers to 
experiment with various structural and topographical modifications. Micro-
roughened titanium implants are known to osseointegrate better compared with their 
machined and polished counterparts [3]. 
Research on the topographical modifications of titanium led to the 
development of the sand-blasted, large grit, acid-etched (SLA) dental implants by 
Institut Straumann AG (Waldenburg, Switzerland). In vivo and in vitro experimental 
evidences have proven its superior osseointegration and bone formation properties 
compared with smooth surfaces [4, 5] and it remains the gold standard in implant 
dentistry since its introduction in the clinics in 1994. Subsequently, Straumann 
designed another modification of the SLA surface to achieve higher wettability, and 
created the chemically modified hydrophilic, modSLA (also known as SLActive®) 
surface. The hydrophilic modification is known to improve osseointegration further 
[6] and achieve faster healing in vivo [7]. Both SLA and modSLA implants have 
been known to have a similar surface architecture, when visualized using scanning 
electron microscope (SEM) and atomic force microscope (AFM) [8, 9].  
Micro-roughened titanium surfaces like the SLA and modSLA surfaces are 
known to induce osseointegration by the principle of “contact osteogenesis” wherein 
new bone formation occurs directly on the implant surface as described by Osborn 
and Newesley [10, 11] and therefore, serve as interesting models to study osteogenic 
differentiation and osseointegration. Although, several studies have reported the 
improved osseointegration and bone formation properties of modified surfaces, the 
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underlying molecular mechanisms responsible for the improved osteogenic 
properties have been difficult to identify. Previous studies on the modSLA and SLA 
surfaces had demonstrated differential regulation of several genes on them; however, 
an organized study identifying and describing the molecular sequence of events was 
missing. Therefore, this PhD project used a structured approach to study the 
regulation of key molecular cascades on these surfaces, by microRNAs that are 
known to modulate gene expression in biological processes. The project 
subsequently studied the regulation of the two most consistently activated pro-
osteogenic cell signaling pathways (TGFβ/BMP and Wnt/Ca2+ pathways) by two 
miRNAs (miR-26a and miR-17) that were observed to be differentially regulated on 
the modSLA and SLA surfaces compared with SMO surfaces. 
8.2 THE STUDIES 
MicroRNAs are small RNA molecules that influence patterns of gene 
expression and eventually mediate various biological processes, like 
osseointegration, by translational repression and gene silencing [12]. MicroRNAs, by 
virtue of their functional mechanisms, come in action immediately before gene 
expression. Therefore, in order to determine the microRNAs modulating the 
molecular mechanisms for improved osteogenic effects of modSLA and SLA 
surfaces, it was important to identify an early time-point that demonstrated a pro-
osteogenic genetic profile on the modSLA and SLA surfaces compared with SMO 
(smooth polished) titanium surfaces.  Although, several studies had demonstrated the 
early modulation of gene expression on the topographically modified titanium 
implants like, modSLA and SLA surfaces [9, 13, 14], yet none of the studies looked 
into the initial interactions of osteogenic cells with these topographically modified 
implant surfaces and how these interactions lead to the generation of a pro-
osteogenic niche. Therefore the first part of this project aimed at exploring the early 
interactions of osteoprogenitor cells with SLA surfaces using a whole genome 
transcriptomic profile in comparison with SMO surfaces.  
The study wanted to assess the early course of molecular events and 
microarray technology with its potential to measure the expression levels of large 
numbers of genes simultaneously, was considered as one of the most adept 
techniques to evaluate these changes at the transcriptome level. Experimental 
observations from our group have shown that osteoblasts, like other adherent cells, 
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attach to the substrates within the first three hours of exposure; and therefore, the 
earliest molecular events guiding them towards osteogenic differentiation were 
expected to happen after 3 hours. This prompted us to analyze the microarray gene 
expression pattern firstly after 3 hours of exposure to the titanium surfaces and 
subsequently at 24 hours. The differentially expressed genes were categorized into 
functional clusters using the Database for Annotation, Visualization and Integrated 
Discovery (DAVID) [15] and Ingenuity Pathways Analysis (IPA) tool (Ingenuity® 
Systems, www.ingenuity.com, Redwood City, CA, USA) to find the genetically 
enriched biological processes.  
The microarray study revealed a clearly evident pro-osteogenic response on 
SLA surfaces compared with SMO surfaces after 24 hours of exposure, and this 
wasn’t obvious at 3 hours. This observation laid the foundation for the next stage of 
the project where the microRNA expression profile was investigated. The temporal 
comparisons for SLA and SMO surfaces (especially 3 hours) in the microarray study 
revealed a pro-angiogenic and immunomodulatory response on the SLA surfaces that 
wasn’t observed on the SMO surface. These interactions indicate a preparatory phase 
before the actual process of osteogenesis. Previous studies using endothelial 
progenitor cells and macrophage-like cells had also demonstrated similar pro-
angiogenic [16] and immunomodulatory effects [17] on topographically modified 
surfaces. Similar effects using osteoprogenitor cells as observed here recognize the 
contributory role of osteogenic cells on these “pre-osteogenic” biological processes. 
Enrichment of pro-osteogenic clusters after 24 hours of exposure confirmed the early 
osteogenic response of topographically modified titanium surfaces. A striking 
observation from this part of the work was the upregulation of the bone 
morphogenetic protein-2 (BMP2) gene (fold change=5.7) (SLA compared with 
SMO), which is known to activate the functioning of the TGFβ/BMP pathway - a 
pathway known to be instrumental in the osteogenic differentiation process [18, 19]. 
This was substantiated even in the subsequent studies, where TGFβ/BMP pathway in 
general and the BMP2 molecule in particular were found to be consistently 
upregulated on the modified titanium surfaces [8, 9].  
The study also confirmed higher deposition of minerals (calcium and 
phosphorus) in cultures on SLA surfaces compared with SMO surfaces and this was 
indicative of higher osteogenic differentiation on modified surfaces. Improved in 
vitro osteogenic differentiation may be considered as a reflection of the ameliorated 
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in vivo osseointegration properties of topographically modified surfaces compared to 
SMO surfaces.  
 The second part of the project focused on investigating the role of 
microRNAs in the process of osteogenic differentiation on micro-roughened 
surfaces. As described above, the microarray expression analysis established a clear 
pro-osteogenic genetic profile on modified titanium surfaces compared with SMO 
surfaces following 24 hours of exposure. To study whether the differential gene 
expression on topographically modified titanium surfaces is an outcome of the 
microRNA regulation, this part of the project explored the microRNA expression 
profile on the modified titanium implant surfaces in comparison with SMO surfaces 
following 24 hours of exposure. The chemically modified hydrophilic titanium 
(modSLA) surface was included in the study owing to the further improvement in 
osseointegration (compared to SLA) as demonstrated in recent studies [7, 20-22].  
The microRNA study, firstly affirmed the higher expression of key genes 
already known to be differentially expressed on the modSLA and SLA surfaces 
compared with SMO surfaces [13, 23, 24], in order to ascertain the pro-osteogenic 
response of modSLA and SLA surfaces at 24 hours. BMP2, BMP6, ACVR1 
(TGFβ/BMP pathway), WNT5A, FZD6 (Wnt/Ca2+ pathway), ITGB1 and ITGA2 
(integrins) showed higher expression on modSLA and SLA surfaces compared with 
SMO surfaces after 24 hours of exposure. Subsequently, the microRNA expression 
profile on modSLA, SLA and SMO surfaces was evaluated. The Human Cell 
Development & Differentiation miRNA PCR Array (SABiosciences, Frederick, 
Maryland, USA) was selected as the panel of microRNAs to be tested for this 
purpose. Using this array enabled us to specifically study the microRNAs that are 
known to be instrumental in the process of cell differentiation. Moreover, studying a 
select panel of miRNAs allowed the use of a PCR-based technique which is more 
stringent rather than a microarray [25]. Further, the miRNA expressions were 
normalized to the mean expression of three endogenous small RNA controls - 
SNORD47, SNORD44, and RNU6-2, allowing for more stringent comparisons.  
Analysis of the expression profile for the microRNAs revealed several 
miRNAs to be down-regulated on the modSLA and SLA surfaces compared with 
SMO surfaces. It is worth noting that majority of the miRNAs found to be down-
regulated were common to both modSLA and SLA. Similar observation was made 
for the miRNAs that were upregulated on the micro-roughened surfaces. Among the 
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different miRNAs upregulated on modSLA and SLA, eight were common to both. 
Relatively minor differences were observed between the expression profile on 
modSLA and SLA surfaces, with a general trend towards lower expression on 
modSLA surfaces compared with SLA surfaces. These findings were further 
strengthened when the activation of cell signaling genes was studied in the 
subsequent part of the project. Both of the modified surfaces were seen to have 
higher expression of key regulatory genes of pro-osteogenic cell signaling pathways, 
(specifically the TGFβ/BMP, non-canonical Wnt/Ca2+ and Notch pathways) 
compared with the smooth surface. Only minor differences in the gene expression 
were observed between modSLA and SLA surfaces. These observations suggest that 
the surface micro-roughness feature of modSLA and SLA surfaces has a greater role 
to play in the pro-osteogenic molecular interactions of osteoprogenitor cells with 
titanium surfaces. The superior osseointegration of modSLA compared with SLA as 
seen in in vivo settings could possibly be due the interaction of cells that do not 
belong to osteogenic lineage (e.g. blood cells), which come in contact with the 
surfaces earlier than the MSCs and osteoblasts. 
The microRNA expression profile study further explored the correlation 
between the downregulation of miRNAs and the upregulation of TGFβ/BMP and 
non-canonical Wnt/Ca
2+
 pathways on modSLA and SLA surfaces, using 
bioinformatics-based prediction models (TargetScan). TargetScan is an online 
bioinformatics tool that can predict targets for miRNAs by identifying potential 
binding sites in the mRNA 3’ UTR region. TargetScan was specifically chosen as the 
prediction tool owing to its context score assigning algorithm for miRNAs, which 
according to Witkos et al., is the only existing model that correlates well even at the 
protein level [26]. They further commented that among the various target prediction 
tools, TargetScan with a precision of 51% and a sensitivity of 12% is the only tool, 
besides PicTar, whose prediction results match well at the in vivo level as well. 
TargetScan predictions demonstrated several genes of the TGFβ/BMP and non-
canonical Wnt/Ca
2+
 pathways to be putative targets for the downregulated miRNAs 
and hence a potential regulation of these pathways during the process of bone 
formation on micro-roughened surfaces emerged as a possible reason for their 
superior osteogenicity. As Notch pathway genes were also seen to be upregulated on 
the micro-roughened surfaces, a potential regulation of the Notch pathway was also 
explored; however no noteworthy findings were observed. This possibly indicates the 
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role of “non-miRNA” mediated mechanisms for the stimulation of this pathway 
during osteogenesis on micro-roughened surfaces. The target predictions also 
revealed several inhibitors of osteogenesis as potential targets for the upregulated 
miRNAs, suggesting other pro-osteogenic mechanisms that get triggered following 
the interaction of micro-rough surfaces with osteoblastic cells. The findings from this 
part of the study advocated for further in-depth functional studies to be under-taken 
to understand the molecular regulation of pro-osteogenic cell signaling pathways by 
microRNAs during osteogenesis.  
 The existing literature and empirical findings from the project were 
suggestive of the differential regulation of several genes belonging to various cell 
signaling pathways and especially the TGFβ/BMP and Wnt/Ca2+ pathways [13, 24, 
27-29]. However, none of the previous studies had used a comprehensive approach 
to explore the cell signaling pathways stimulated on the topographically modified 
surfaces. Further, as described above, the previous part of the project had observed 
downregulation of several miRNAs that had putative targets in the TGFβ/BMP and 
Wnt/Ca
2+
 pathways. Thus, the next part of the project aimed to identify the response 
of key cell signaling pathways in osteoprogenitor cells, following 24 and 72 hours 
exposure to modSLA & SLA surfaces in comparison with SMO surfaces. For this 
purpose, human alveolar osteoprogenitor cells were cultured on modSLA, SLA, and 
SMO surfaces for 24 and 72 hours. A PCR-based array technique (Human Stem Cell 
Signaling PCR Array - SABiosciences, Frederick, MD, USA) with its potential to 
examine the expression of a large set of genes from relatively small quantities of 
experimental samples allowed us to investigate the activation and upregulation of 
various cell signaling pathways simultaneously.  
The key regulatory genes from the TGFβ/BMP, Wnt (especially the non-
canonical Wnt/Ca
2+
) and Notch pathways were upregulated on the modified surfaces. 
The findings correlated with higher expression of osteogenic markers on modSLA 
and SLA surfaces. These findings demonstrated that the activation of the pro-
osteogenic cell signaling pathways on modSLA and SLA surfaces leads to enhanced 
osteogenic differentiation and provided a mechanistic insight into the superior 
osseointegration properties of modSLA and SLA surfaces as seen in vivo. Enhanced 
osteogenic differentiation on the modified surfaces was confirmed by the higher 
mineralization on modSLA and SLA surfaces. Further, the comparisons between 24 
and 72 hours showed a relative lower expression of cell signaling pathway genes at 
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72 hours on all the surfaces, which further justified our 24 hour time-point for 
studying the microRNA expression profile. Pro-osteogenic molecular responses are 
thus shown to be triggered early during the interaction of osteoblastic cells with 
modified surfaces. Therefore, miRNAs guiding these changes need to respond early 
in this process as well. The results from the miRNA expression profiling study 
confirmed this conjecture. Further, phenotypic changes in osteoprogenitor cells 
cultured on titanium surfaces for 24 and 72 hours showed increase in the number of 
surface granules, possibly indicating increased protein synthesis. This could 
additionally mean that the cells start exhibiting more maturing phenotypes to prepare 
and nurture the osteogenic niche. As discussed above, the relatively minor 
differences between the modSLA and SLA surfaces further reinforced the fact that 
topographical modifications of implant surfaces have a greater impact on their 
osteogenic properties, than chemical alterations. 
 Although, the initial parts of this project demonstrated that several of the 
microRNAs showing lower expression on modSLA and SLA surfaces (compared 
with SMO) have putative targets in the TGFβ/BMP and Wnt/Ca2+ pathways that 
correlated well with the higher expression of these pathways; yet studies confirming 
the functional regulation of these two pathways by miRNAs during osteogenesis 
were still lacking. Therefore, the final part of the project explored the regulatory role 
of two microRNAs (miR-26a and miR-17) on the TGFβ/BMP and Wnt/Ca2+ 
pathways during osteogenesis. The microRNAs, miR-26a and miR-17 were 
specifically selected for the following reasons:  
 Both miR-26a and miR-17 were observed to be downregulated on the 
modSLA and SLA surfaces compared with SMO.  
 The microRNAs, miR-26a and miR-17 were found to have putative targets in 
TGFβ/BMP and Wnt/Ca2+ pathways.  
 More importantly, miR-26a was seen to be potentially targeting the key non-
canonical Wnt/Ca
2+
 pathway ligand, WNT5A and miR-17 was found to target 
the key TGFβ/BMP ligand, BMP2. 
 This study used synthetic miRNA mimics owing to concerns with expression 
levels for miRNAs achieved with plasmid-based techniques. Moreover, the primary 
purpose of the study was to investigate the early effects of miRNAs on the cell 
signaling pathways and so transient transfections with miRNA mimics were suitable 
for the purpose. In order to investigate deeper into the molecular signaling during 
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osteogenic differentiation, the study explored the cross-talk between the two cell 
signaling pathways as well.  
 The expression of miR-26a and miR-17 on the modified titanium surfaces 
following 6 hours of culturing confirmed a lower expression on modSLA and SLA 
surfaces compared to SMO surfaces. This was seen to guide the higher expression of 
important molecules of the TGFβ/BMP (BMP2 and BMP6) and Wnt/Ca2+ pathways 
(WNT5A and FZD6) at 24 hours. These findings substantiate the previous findings 
of the project as described earlier. The regulatory role of miR-26a and miR-17 on the 
cell signaling pathways was evaluated subsequently using synthetic miRNA mimics. 
Inducing osteogenic differentiation in human osteoblast-like SAOS-2 cells following 
transfection of these miRNAs, demonstrated delayed mineralization and ALP 
activity compared to negative controls. Simultaneously, the TGFβ/BMP and 
Wnt/Ca
2+
 pathways showed reduced expression in miR-26a and miR-17 transfected 
cells suggesting an inhibitory impact on both pathways. This strengthens the 
supposition that early downregulation of miRNAs on modSLA and SLA surfaces 
potentially release the inhibitory effects on the signaling pathways, thereby inducing 
their expression. Luciferase target confirmation assays confirmed several molecules 
of the two pathways as targets for miR-26a and miR-17. Further, the TGFβ/BMP & 
Wnt/Ca
2+ 
pathway cross-talk experiments suggest that the Wnt/Ca
2+ 
pathway acts 
downstream to the TGFβ/BMP pathway. Finally, the study using inhibitors of miR-
26a & miR-17 showed higher osteogenic differentiation on polished titanium 
surfaces suggesting an accelerated osteogenic differentiation; and thereby 
demonstrated the potential of enhancing osteogenesis and possibly osseointegration 
especially in regions with compromised bone. 
 Figure 8-1 summarizes the overall study design and the key findings of the 
project. All the findings of the project taken together indicate towards an intricate 
miRNA modulated control of the TGFβ/BMP and Wnt/Ca2+ cell signaling pathways 
during osteogenesis. The initial interactions of osteoblastic cells seem to have a 
complementary role in preparation of the cellular niche by stimulating vascular and 
immunological processes, in an effort to make the environment conducive for 
osteogenic differentiation. Following the initial activity, the early events on modified 
surfaces clearly show the triggering of “pro-osteogenic” mechanisms and stimulation 
of the osteogenic differentiation process. Thus, miRNAs having inhibitory action on 
the “pro-osteogenic” cell signaling pathways (specifically the TGFβ/BMP and 
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Wnt/Ca
2+
) tend to get suppressed on the modSLA and SLA surfaces and this possibly 
withdraws the inhibitory effects on molecular processes. Subsequently, pro-
osteogenic cell signaling pathways - especially TGFβ/BMP and Wnt/Ca2+ are 
activated early on the modified surfaces and this probably culminates in an 
accelerated osteogenic response on the micro-roughened surfaces. Extrinsic 
modulation of miRNAs, like miR-26a and miR-17 as described in the last part of the 
project could possibly regulate the cell signaling pathways and help in superior 
osteogenesis/osseointegration in clinically challenging situations. 
 
Figure 8-1: Flow-diagram describing the key findings of the project 
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8.3 LIMITATIONS & FUTURE DIRECTIONS 
The findings of this project are based on in vitro experimental models using 
osteogenic cells (osteoprogenitor and osteoblast-like SAOS-2 cells), developed to 
understand the molecular regulation of osteogenesis as observed in laboratory 
settings. Osseointegration is a complex biological process that occurs as a 
culminating event, following the interaction of different types of cells present in the 
implant bed. The implant bed is populated not only by osteogenic cells 
(osteoprogenitor, osteoblasts and osteocytes) but also by cells of the hematopoietic 
origin (osteoclasts and blood cells). The results from this PhD project specifically 
identify the role of interaction of osteogenic cells with topographically modified 
implant surfaces. Although, osseointegration, being the process of structural and 
functional integration of implant surfaces with the surrounding bone, is highly 
dependent on these interactions, nevertheless we cannot rule out the possible 
influence of other cells, which may be more important to explain the superior 
osseointegration of modSLA compared with SLA surfaces as observed in clinical 
settings. As the primary aim of this project was to understand the pro-osteogenic 
mechanisms involved in osteogenesis, especially on topographically modified 
implant surfaces, this project did not focus on the other cell types. Further, it should 
be noted that the limited range of sample types used (modSLA, SLA and SMO) may 
restrain the generalization of the conclusions drawn.  
Primary osteoprogenitor cells used in the studies were established after 
culturing redundant tissues obtained following third molar extraction surgery using 
methods described previously [30]. Using primary cells ensures the use of 
physiologically relevant cells and it is expect that the data obtained are more 
pertinent. However, primary cells are prone to inter-subject variability and the 
observations may vary with different cell types. Nevertheless, the essence of the 
findings should not be undermined, as they identify some of the critical trends 
observed as a result of the interactions with implant surfaces and the use of 
biological replicates made the findings more stringent. Subsequently, the study 
moved on to investigate the molecular regulation of the cell signaling pathways by 
microRNAs in human osteoblast-like SAOS-2 cells as primary human 
osteoprogenitor cells are difficult to transfect and inconsistent in their expression of 
exogenously administered genes. Moreover, such modulations by external agents are 
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expected to be consistent in all cell types. This PhD project used synthetic 
microRNA mimics to study their role in osteogenesis. It may be interesting to study 
the impact of sustained inhibition of these microRNAs using modalities that can 
induce stable and persistent transfections. 
MicroRNAs are known to have several potential targets and may regulate more 
than one gene. This project has focused on the influence of miR-26a and miR-17 on 
the TGFβ/BMP and Wnt/Ca2+ pathways. It is possible that these microRNAs have 
influence on several other genes and proteins that may be important for osteogenesis. 
One of the future directions should aim for other potential targets of these miRNAs. 
Besides, miR-26a and miR-17, the microRNA expression profiling study found 
several other microRNAs that are differentially regulated. Their role in 
osseointegration remains to be investigated. A special area of focus maybe the 
miRNAs found to be upregulated on the modSLA and SLA surfaces (compared with 
SMO), as inhibitors of osteogenesis were found to be putative targets for some of 
these upregulated miRNAs. Further, pathway analysis of all the predicted targets of 
the differentially regulated miRNAs could identify other molecular pathways that 
maybe of significance. The third part of the project found a consistent upregulation 
of the Notch pathway genes on the modified titanium surfaces. The relevance of this 
finding has not been explored here. Experimental designs to study the role of Notch 
pathway in osseointegration and its interactions are needed in the future.  
To understand the biological and clinical relevance of the findings of this 
project, we need to investigate the molecular events in an in vivo setting. An animal 
model for osseointegration, for example a mouse or rat model, needs to be developed 
in the future to study the modulation of the molecular events. Inhibitors of miR-26a 
and miR-17 may be used in this model to observe their effects on osseointegration. 
To study the influence of the TGFβ/BMP and Wnt/Ca2+ in an in vivo setting, 
synthetic enhancers (like recombinant BMP2 and WNT5A) and inhibitors (like 
Dorsomorphin for BMP pathway and KN93 for Wnt/Ca
2+
 pathway) of these 
pathways maybe used following placement of titanium implants. The in vivo animal 
model will help us in understanding the relevance of the inhibition of miR-26a and 
miR-17 in a biologically relevant situation and perhaps will be able to lay the 
foundation for their prospective use in clinical settings. 
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MicroRNAs are considered important for regulation of gene expression 
patterns. However, this layer of network for gene regulation during the process of 
osteogenesis on implant surfaces has received scant attention so far. The findings of 
this PhD project described an intricate modulation of the molecular pathways by 
microRNAs following the interaction of osteogenic cells with topographically 
modified titanium surfaces. The topographical cues from modSLA and SLA surfaces 
enable us to reveal the microRNAs that get differentially regulated to give rise to the 
pro-osteogenic effects of these surfaces. Further, the studies confirmed the 
stimulation of pro-osteogenic TGFβ/BMP and Wnt/Ca2+ pathways on these surfaces 
that lead to their subsequent improved osteogenic differentiation. Finally, the last 
part of the project discusses the functional studies using miR-26a and miR-17. The 
study further demonstrates the ability of modulating these miRNAs to induce an 
early stimulation of the TGFβ/BMP and Wnt/Ca2+ pathways and ultimately achieve 
an accelerated osteogenesis.  
This PhD project forms the ground-work to use therapeutic microRNA 
modulators to improve osseointegration on different types of implant surfaces. 
Moreover, the pro-osteogenic effects of modSLA and SLA surfaces have enabled us 
to study the early molecular events during bone formation in an in vitro setting 
(without using chemical supplements) and consequently provided us with important 
clues regarding the process of bone formation in general. Therefore, this PhD project 
also reveals potential clinical targets to improve bone formation in compromised 
conditions. 
MicroRNAs are interesting therapeutic targets that have started coming to 
limelight recently. Modified antisense miRNA oligonucleotides (AMOs) (also 
known as “antagomirs”) are being used for different purposes like gene target 
validation and experimental therapy models [1] and maybe considered as future 
therapeutic options to enhance clinical outcomes in orthopedics and implant 
dentistry. Different types of AMOs are known, however the ones designed with 
locked nucleic acids (LNAs) have been used to effectively knock-down miRNAs in 
in vivo settings [2]. The use of AMOs provides us with interesting models to work 
with, especially in animal models for our future studies. Another modality used to 
inhibit endogenously expressed microRNAs is “microRNA sponge”. MicroRNA 
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sponges are tandem repeats of mRNA binding sites that can act as decoys to which 
the endogenous microRNAs can bind [2]. The current project findings encourage us 
to explore the possibility of using microRNA modulators, like antagomirs and/or 
miRNA sponges that can be coated on to titanium implant surfaces. Implants coated 
with such modulators with potential to release them in the early phases of healing, 
may be able to achieve faster osseointegration especially in regions where 
osseointegration is difficult to achieve, for example the posterior maxilla.  
In summary, this PhD project has been able to establish the critical role of 
microRNAs in the early molecular response of osteoprogenitor cells following 
exposure to topographically modified titanium surfaces that leads to their improved 
osteogenicity. Further, the project demonstrated the regulation of the two crucial pro-
osteogenic cell signaling pathways (TGFβ/BMP and Wnt/Ca2+) by miR-26a and 
miR-17 during the process of osteogenic differentiation. It is expected that the results 
of this project form the ground-work for future research projects to enhance bone 
formation in general and osseointegration of implant surfaces in specific. 
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Appendix-1:  
 
List of microRNAs profiled using the Human Cell Development & 
Differentiation miRNA PCR Array (SABiosciences, Frederick, Maryland, 
USA).  
http://www.sabiosciences.com/mirna_pcr_product/HTML/MAH-103A.html 
 
 
 
miR-106b  miR-488  miR-214  miR-133b  
let-7e  miR-215  miR-21  miR-520g  
miR-20b  miR-24  miR-18b  miR-33a  
miR-125a-5p  miR-192  miR-345  miR-124  
miR-125b  miR-18a  let-7c  miR-208a  
miR-122  miR-100  miR-26a  miR-142-5p  
miR-155  miR-9  miR-101  miR-370  
miR-126  miR-137  miR-17  miR-150  
miR-22  miR-452  miR-129-5p  miR-128  
miR-92a  miR-15a  miR-96  miR-15b  
miR-141  miR-134  miR-183  miR-130a  
miR-378  miR-103  miR-210  miR-127-5p  
miR-10a  miR-424  miR-223  miR-498  
miR-182  miR-20a  let-7a  let-7b  
miR-302a  let-7i  miR-518b  miR-302c  
miR-93  miR-222  miR-194  miR-219-5p  
miR-1  miR-99a  miR-503  let-7g  
miR-181a  miR-206  miR-218  miR-375  
miR-146b-5p  miR-195  let-7d  miR-7  
let-7f  miR-132  miR-205  miR-146a  
miR-196a  miR-16  miR-10b  miR-371-3p  
miR-301a  miR-23b  miR-185  miR-142-3p  
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Appendix-2: 
 
Signal transduction genes profiled using the Human Stem Cell Signaling PCR 
Array (SABiosciences, Frederick, Maryland, USA). 
http://www.sabiosciences.com/rt_pcr_product/HTML/PAHS-047A.html 
 
Pluripotency Maintenance Pathway:  
Receptors: IL6ST (GP130), LIFR.  
Transcription Factor: STAT3.  
 
Fibroblast Growth Factor (FGF) Signaling Pathway:  
Receptors: FGFR1, FGFR2, FGFR3, FGFR4.  
Transcription Factor: CDX2.  
 
Hedgehog Signaling Pathway:  
Receptors & Co-Receptors: PTCH1, PTCHD2, SMO.  
Transcription Factors & Co-Factors: GLI1, GLI2, GLI3, SUFU.  
 
Notch Signaling Pathway:  
Receptors & Co-Receptors: NCSTN, NOTCH1, NOTCH2, NOTCH3, NOTCH4, 
PSENEN, PSEN1, PSEN2.  
Transcription Factor: RBPJL.  
 
TGFβ Superfamily Signaling Pathway:  
Receptors & Co-Receptors: ACVRL1, ACVR1, ACVR1B, ACVR1C, ACVR2A, 
ACVR2B, AMHR2, BMPR1A, BMPR1B, BMPR2, ENG, LTBP1, LTBP2, LTBP3, 
LTBP4, RGMA, TGFBR1, TGFBR2, TGFBR3, TGFBRAP1.  
Transcription Factors & Co-Factors: EP300, SMAD1, SMAD2, SMAD3, SMAD4, 
SMAD5, SMAD6, SMAD7, SMAD9, CREBBP, E2F5, RBL1, RBL2, SP1, ZEB2. 
 
Wnt Signaling Pathway:                                                                                                       
Receptors: FZD1, FZD2, FZD3, FZD4, FZD5, FZD6, FZD7, FZD8, FZD9, LRP5, 
LRP6, VANGL2.                                                                                         
Transcription Factors & Co-Factors: BCL9, BCL9L, CTNNB1, LEF1, NFAT5, 
NFATC1, NFATC2, NFATC3, NFATC4, PYGO2, TCF7L1, TCF7L2, TCF7. 
 
 
